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I'll be fine - if you give me a minute, a man's got a 








Science ultimately is the act of discovering new 
knowledge and when you learn about science in 
school, you’re not actually doing science, you’re 
learning the knowledge that people discovered 
previously and it’s more like studying “history of 
science” […]. To actually get in a lab and to get 
your hands on experiments that are actually 
discovering new knowledge is so hard and it takes 
so long. 
 






La science a une grosse probabilité de merder. 
 






True perfection has to be imperfect. I know that 
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A large catalogue of modified nucleosides is found within RNAs. Most of these 
chemical modifications have been known for the past fifty years. However, the first 
epitranscriptomic studies are recent and shed light to a new layer of gene expression 
regulation. To date, less than ten RNA modifications have been studied at the 
transcriptomic level due to the difficulty to determine their distribution at the single-
nucleotide resolution. 
 
The dihydrouridine RNA modification (D) is a product of the reduction of uridine 
by a conserved family of dihydrouridine synthases (Dus) and has been exclusively 
studied within the context of tRNA and rRNA biology. Despite its universal conservation 
among the three domains of life, little is known about the biological relevance of this 
modification. 
 
Taking advantage of the previously reported fluorescent labeling of tRNAs at 
dihydrouridylated positions, we have developed D-seq (dihydrouridine-sequencing), a 
sensitive method to detect the transcriptome-wide distribution of dihydrouridines, 
which we confirmed with dot blot and primer extension assays. Remarkably, the D-seq 
pipeline could be easily applied to other RNA modifications that are sensitive to the 
rhodamine labeling and for which the cognate RNA modifying enzyme mutants are 
available. 
 
Among the 372 putative dihydrouridylated sites found on the yeast 
transcriptome, 60% were located on well-known positions of tRNAs. Surprisingly, the 
remaining predicted sites were found onto messenger RNAs. The dissection of D 
distribution revealed an enrichment on coding sequences and a non-random 
distribution on codons. Unlike coding RNAs, hypodihydrouridylated tRNAs were 
remarkably more abundant than their modified counterparts. The conservation of this 
feature in another eukaryote is currently under investigation on a human transcriptome. 
 
Interestingly, the E. coli coding transcriptome was devoid of any detectable 
dihydrouridine in the tested condition, implying that mRNA dihydrouridylation could be 
eukaryotic-specific. Our data also suggest that a novel yet uncharacterized bacterial 
Dus enzyme modifies the 23S rRNA and might target other RNA species. 
 
Altogether, our data demonstrate the reliability of the unbiased D-seq technique 
to map the dihydrouridine at the single-nucleotide resolution. Moreover, we propose 
dihydrouridine as a potential new internal mRNA modification in Eukarya. 
 
There’s an urgent and high demand for additional technology developments 
for all kinds of RNA modifications.  
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Une thèse, ce ne sont au final que quatre années d’une vie. Mais n’est-ce pas 
mieux si celles-ci resteront un fabuleux souvenir? On ne parle pas de recherche ici, on 
parle de l’humain. La recherche, c’est un concentré de frustrations qui, de manière un 
peu sado, sont parfois excitantes. C’est ce qui nous fait tenir, cet espoir d’avoir un 
résultat (une fois tous les six mois, ça nous suffit au final… quoique !). Et puis, ce qui 
nous fait tenir – en tout cas moi – ce sont les gens qui nous entourent. Gandhi disait  
« un sourire ne coûte rien et produit beaucoup ». Je pense que c’est la même chose 
avec un merci. Alors, merci à vous ; 
 
Tout d’abord Damien, bien évidemment. Mon « promoteur » comme on dit en 
Belgique, « chef » comme on l’appelle au labo. Mais pas un chef autoritaire, non, plutôt 
un leader à l’oreille attentive. De jeune biologiste fraîchement diplômé – sachant à 
peine ce qu’était une modification de l’ARN – tu as fait de moi un scientifique qui a 
confiance en sa recherche et sa connaissance, tout en ne nous faisant jamais oublié 
que nous n’étions au final tous que bien ignorants par rapport à la connaissance du 
monde. Et savoir qu’on ne sait pas, c’est une philosophie qui me servira toute ma vie. 
Je n’ai pas dû être un thésard facile tous les jours – on se souviendra de cet interview 
à la RTBF où j’ai légèrement fait du forcing ou de ma dépression presque chronique 
devant l’absence de phénotype de mon mutant –,  mais tu as toujours su trouver le 
positif et je t’en remercie. 
 
J’ai longtemps hésité à me réorienter dans la recherche en sciences sociales, 
pour étudier mes phénomènes de collègues. Mais au final, les litres de larmes de rire 
versées valaient mieux que n’importe quelle étude sociologique. Je me dois de 
commencer par Mamy Valoch – la plus scintillante et pétillante étoile de la galaxie 
comme elle a « exigé » que je l’appelle dans ces remerciements – sinon elle va 
déprimer (« pourquoi personne ne me comprend ? ») et noiera son chagrin dans des 
Krisprolls pâté crème (« je ne grignote jamais entre les repas »). Well, par quoi 
commencer ? Merci à toi, ô Premier Agent Spécialisé Principal Supérieur Avancé et 
tous les adjectifs du dictionnaire, pour ces citations bouddhistes, « t’y es déjà allé, toi, 
à l’Hôtel Sainte-Maxime ? », ces jeux du rond à ne plus finir, « c’était votre sœur », tes 
restes de pâtes bolos, gras de poulet et j’en passe, « qui êtes-vous ? », ces remix de 
Beethoven, « Sodome et Gomorrhe », etc. J’hésite même à te remercier pour tous ces 
U&P que tu n’as pas été chercher, pour m’avoir mis à bout exprès pour que je dise 
« Valoooooch », « Vieille charogne » ou « Valérie Migeot », pour m’avoir appris la 
meilleure recette de pesto-crème du monde, pour m’avoir montré avec tant d’intérêt la 
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oh broque de viol, comment on imprime Popi ? ». Oui, merci pour tout ça. Reste 
toujours aussi jeune dans ta tête, c’est ça qui compte et c’est ça qu’on aime ! Pour les 
suivants, je ferai pas ordre alphabétique, pas de jaloux ! Carlito, pardi ! Non seulement 
tu sais que j’ai toujours été impressionné (jaloux ?) de tes connaissances à la fois wet 
et dry – et d’ailleurs un merci infini pour ton apport essentiel (le mot est faible) et de 
qualité au projet dihydrouridine –, mais surtout pour ta Vishnu-attitude. J’espère que 
tu te rappelleras avec émotion de mes crises de nerf sur Excel et des légers 
tapotements sur le bureau J. Bonne humeur, sourire, volonté, amateur de bière, 
disponible, intéressé, voici le portrait non-exhaustif de notre Carli-Carlo – parfois 
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Carlocifer, mais ça nous faisait tellement rire – à qui je souhaite tout le meilleur au 
Canada… mais avec une personnalité aussi lumineuse que la tienne, je ne me fais 
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veux me marrer), les vieux survivants du Cercle Bio (pas moyen de s’ennuyer avec 
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futiles) de chercheur. 
 








I. THE CENTRAL DOGMA OF MOLECULAR BIOLOGY 
A. Historical considerations 
My own thinking (and that of many of my colleagues) is based on two general 




Sixty years after the Francis Crick’s statements on protein synthesis, the Central 
Dogma is still considered as the simplest and most accurate model to define the 
molecular biology. However, the Central Dogma alone cannot explain the flow of 
genetic information in living organisms. Contrary to what is commonly held in 
textbooks, the dogma does not mention that the nucleic acid sequence acts as a code 
for the amino acid sequence – this latter is called the Sequence Hypothesis. The 
Central Dogma should instead be defined as a negative statement implying that 
transfer of information originating from protein does not occur. The idea of a precise 
alphabet that permits the sequential flow of information from nucleic acids to proteins 
can be drawn by the combination of both principles (Crick, 1970). In this manuscript, 
and for the sake of convenience, the expression of Central Dogma will be used to refer 
to the DNA à RNA à protein transfer of information. 
 
For decades, molecular biologists have studied the biochemical features of 
DNA, RNA and proteins and the biological processes that correlate them with one 
another (transcription and translation). Many breakthroughs considerably complexified 
the basic Central Dogma, leading to the investigation of unexpected layers of 
regulation (e.g. DNA methylation, RNA-dependent transcriptional interference, co-
translational control of protein folding, etc.). Because the Central Dogma has been 
validated in all Domains of life, the interest of the scientific community for DNA-, RNA- 
and protein-related researches has never stopped growing. 
B. RNA: a key player in the Central Dogma… and beyond 
Finally, DNA appeared […]. RNA is then relegated to the intermediate role that 
it has today – no longer the centre of the stage, displaced by DNA and the 




The Central Dogma usually implies that the fate of a biological system is to 
perform a specific function (protein) from a well-organized source of information (DNA). 
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Although it is a true statement (with exceptions), it relegates RNA to a second role in 
which it is an intermediate molecule that connects information and function. However, 
RNA plays a pivotal role in the Central Dogma by potentially being at the origin of 
(molecular) life (point ii.) and by being tightly regulated (point iii.). Moreover, RNA can 
be far more than a coding messenger and displays numerous functions beyond the 
Central Dogma (point iv.). 
ii. RNA in the story of life 
When the first experimental evidence of a self-splicing RNA was published in 
1982 – along with the revolutionary concept of ribozyme –, the idea that catalytic RNAs 
could be at the origin of life emerged (Kruger et al., 1982). One year later, Altman and 
colleagues described the conditions in which the RNase P enzymatic RNA cleaves a 
tRNA precursor (Guerrier-Takada et al., 1983). These discoveries, awarded by the 
1989 Nobel Prize in Chemistry, led to the establishment of the RNA world hypothesis 
(Gilbert, 1986). In his one-page article, Gilbert exposed that if a unique molecule – 
such as RNA – can combine both the informational and catalytic properties, then an 
RNA world could have emerged from the prebiotic soup. He explained a five-step 
process in which; (i) RNA molecules replicate themselves, (ii) some daughter 
molecules acquire a function, (iii) RNA molecules undergo recombinations and 
mutations, which therefore widen the range of catalytic activities, (iv) with the 
development of RNA adapters that carry amino acids and a sort of ancestral ribosomal 
activity, the first proteins are synthesized, and (v) by reverse transcription, the more 
stable DNA replaces the RNA as a holder of the information. Altogether, these works 
pointed out RNA as the potential main character in the story of life. 
iii. RNA-related regulations 
At the biochemical level, RNA is a versatile polymer with molecular features 
ranging from its ability to form base pairs with other nucleic acids to its folding 
capacities (reviewed in (Geisler and Coller, 2013)). These characteristics make the 
RNA a highly dynamic and regulated biomolecule. 
 
Intricate mechanisms act together to fine-tune the production of RNAs 
(transcriptional activity or synthesis through an RNA-dependent RNA polymerase) that 
are then monitored by RNA surveillance pathways. When RNA does not meet the 
quality standards, it is degraded by specific (e.g. nonsense-mediated decay) or more 
general (e.g. eukaryotic and archaeal exosomes or bacterial degradosome) 
machineries. The RNA production/degradation dichotomy ensures proper biological 
functions and will not be described here. Nevertheless, it is important to mention that 
RNA – this simple intermediate – is obviously at the core of numerous regulatory 
pathways. 
a. An example of how RNA is regulated: tRNA QC 
Due to the vital role of tRNAs in translation, cellular pathways exist to control 
their functional integrity. A quality control (QC) mechanism has been shown to act on 
an hypomethylated1 form of the precursor tRNAiMet (pre-tRNAiMet). The 
hypomethylation most likely leads to the misfolding of the transfer RNA (tRNA) that is 
                                            
1 The concept of modified RNA (e.g. methylation) is introduced thereafter (Introduction II.) 
 
12 
therefore polyadenylated by the Trf4 poly(A) polymerase, subunit of the TRAMP 
complex (Trf4/Air2/Mtr4 Polyadenylation complex). The Rrp6 3’-5’ exoribonuclease is 
then recruited and degrades the hypomethylated pre-tRNAiMet (Kadaba et al., 2004; 
Kadaba et al., 2006; Megel et al., 2015). This TRAMP-dependent decay that acts on a 
pre-tRNA is called the nuclear surveillance pathway (Fig. 1A). 
 
Mature tRNAs also undergo degradation when they are hypomodified. Yeast 
mutants for nonessential RNA modifications displayed rapid tRNA decay (RTD) at 
37°C (Fig. 1B) (Alexandrov et al., 2006). The degradation was then shown to depend 
on 5’-3’ exoribonucleases such as Rat1 and Xrn1 (Chernyakov et al., 2008). 
Investigations on the molecular features of tRNAs targeted by RTD revealed that they 
are subjected to non-canonical 3’-CCACCA addition or 3’-polyadenylation (Wilusz et 
al., 2011). 
iv. Beyond the Central Dogma: the noncoding world 
Although they are noncoding, tRNAs and ribosomal RNAs (rRNAs) are 
associated with the Central Dogma because their most obvious function is to help 
decoding messenger RNAs (mRNAs). However, high-throughput transcriptional 
analyses revealed the existence of many more noncoding RNA species, with up to 
85% of the human genome being transcribed – whereas the exome represents less 
than 2% of the genome (Djebali et al., 2012). This pervasive transcription generates 
short and long ncRNAs that are associated with specific genomic regions (telomeric 
transcripts, promoter-associated RNAs, etc.), that have well-established functions 
(small-interfering RNAs, long (intergenic) noncoding RNAs, etc.) and/or that are 
expressed in a specific physiological context (yeast meiotic transcripts, mammalian 
DNA damage RNAs, etc.) (Tisseur et al., 2011). 
 
Cech and Steitz amazingly reviewed what they called the noncoding RNA 
revolution (Cech and Steitz, 2014). They emphasized that noncoding RNAs (ncRNAs) 
are not only involved in translation (as for rRNAs and tRNAs), but also in a wide variety 
of biological processes. The description of how noncoding RNAs can be functional is 
beyond the scope of this manuscript. However, two interesting examples are given; 
a. MALAT1, a functional long noncoding RNA 
Among the 16,000 long noncoding RNAs (lncRNAs) encoded by the human 
genome, MALAT1 (Metastatis-Associated Lung Adenocarcinoma Transcript 1) is one 
of the most abundant with about 3,000 copies/cell. MALAT1 is a 7kb-long RNA that is 
known to be processed by the RNase P ribonuclease, resulting in the formation of two 
fragments; (i) a short RNA that is exported to the cytoplasm and (ii) a long RNA that is 
nuclear-retained and localizes to the nuclear speckles (Wilusz et al., 2008) (Fig. 2A). 
Depletion of MALAT1 results in the alteration of SR splicing factors phosphorylation 
and in the variation of alternative splicing profiles of a subset of pre-mRNAs. The 
noncoding MALAT1 is therefore considered as a pre-mRNA processing element, albeit 
still elusive on its mode of action (Sun et al., 2017). 
b. When cleaved tRNAs impact the ribosome biogenesis 
tRNA-derived small RNAs (tsRNAs) are short ncRNAs formed by the cleavage 
of mature tRNAs, but are not nonsense by-products (Li et al., 2018) (Fig. 2B). In the 
_________________________________________________________________________________________________
Figure 1 – tRNA quality control pathways. The normal tRNA maturation (framed in the centre) includes 5’- and 3’-
trailers removal, 3’-CCA end addition, nucleocytoplasmic export and amino acid (aa in red) charging. (A) Nuclear
surveillance pathway involves the pre-tRNA TRAMP-dependent polyadenylation and subsequent degradation by the
nuclear exosome. (B) Rapid tRNA decay involves the nuclear or cytoplasmic degradation of (3’-modified) mature tRNAs.
Red crosses highlight the lack of tRNA posttranscriptional modifications (Megel et al., 2015).
_________________________________________________________________________________________________
Figure 2 – Functional noncoding RNAs. (A) MALAT1 is a processed long noncoding RNA; a 61nt-long RNA
(mascRNA) is exported to the nucleus and a 7kb-long RNA (mature MALAT1) adopts a stable 3’-triple helix to be localized
to the nuclear speckles (Quinn and Chang, 2016). (B) tRNA-dervied small tRNAs are classified into two classes; tRf
(tRNA-derived fragment) and tiRNA (tRNA-derived stress induced RNA). The cleavage is performed on different tRNA





ciliate Tetrahymena thermophila, 3’-tsRNAs have been shown to modulate the TXT 
complex formation (Ago/Piwi Twi12 protein; Xrn2 exonuclease; Twi-associated novel 
1 Tan1 protein) by specifically interacting with one of its subunits (Twi12). Binding of 
the ncRNA therefore promotes the TXT nuclear localization where it acts as a pre-
rRNA processing factor. Preventing TXT nuclear import induces ribosomal RNA 
biogenesis defect (Couvillion et al., 2012). This example cleverly shows how a 
functional ncRNA (tRNA) can be processed into another ncRNA (tsRNA), which in turn 
works as a regulator of RNA metabolism.   
v. Conclusion  
RNAs are functional; on the one hand they carry the information to the 
translational machinery to allow the protein synthesis (mRNAs) and on the other hand 
they tightly regulate a wide range of biological mechanisms (ncRNAs). Moreover, 
RNAs are subjected to many forms of regulation and some are even catalytically active 
(ribozymes). They can be both information and function, which makes them unique in 
the Central Dogma. In conclusion, it would be a terrible mistake to consider RNAs as 
simple molecular intermediates, trapped between the information and the function. 
RNA-related investigations are of high interest to help deciphering the mysteries of 
biology. 
II. RNA MODIFICATIONS 
All abbreviations used to name RNA modifications are found in the Modomics 
or the RNA modification databases (http://modomics.genesilico.pl/, 
http://mods.rna.albany.edu/) (Boccaletto et al., 2018; Cantara et al., 2011) and in the 
Annexes of this manuscript. For example, U2-m6Am30 stands for the m6Am 
modification occurring at position 30 of the U2 snRNA. In the nomenclature 
posttranscriptional modifications (PTMs), the letters written before the nucleotide refer 
to a modified nucleobase, whereas the annotation written after the nucleotide refers to 
a ribose modification. The m6Am modification carries two methylations; on position 6 
of the nucleobase and on the ribose. The numbering system that is applied to the 
nucleobase(s) and the ribose is depicted in Fig. S1.   
A. Biochemistry of RNA modifications, diversity and 
biosynthesis 
Now we know that 163 post-transcriptional modifications of RNA introduce a 
functional diversity that allows the four basic ribonucleotide residues to gain 
diverse functions. 
 
(Boccaletto et al., 2018) 
 
The RNA backbone is a succession of covalently bound ribonucleotides whose 
nucleobase, ribose or 5’-extremity can be modified. To date, there are more than 150 
known RNA chemical modifications, spanning the three domains of life and viruses. All 
of them seem to be posttranscriptionally synthesized by protein enzymes (Boccaletto 
et al., 2018). RNA modifying enzymes; (i) work as (cofactor-dependent) stand-alone 
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proteins, (ii) are part of a protein complex that is required for modification or (iii) are 
guided by small nucleolar RNAs (snoRNAs). 
 
Due to their diverse features, there is not a single way to classify RNA 
modifications; (i) universally distributed or confined to one domain, (ii) widespread 
localization or restricted to some RNA species, (iii) synthesized in a single- or multi-
step enzymatic process, (iv) impacting the Watson-Crick interaction or not, (v) found 
on the nucleobase, the sugar and/or the 5’-phosphate, etc. (Fig. 3A-E). 
 
The spatiotemporal regulation of RNA modifications is still an elusive aspect of 
RNA maturation. For example, snoRNA-dependent rRNA modifications (2’-O-
methylation and pseudouridines, Fig. 3E) are usually synthesized in the nucleus, 
meaning  early during the rRNA biogenesis (reviewed in (Sloan et al., 2017)). 
Nevertheless, rRNA modifications can also be exclusively cytoplasmic such as the 
yeast 18S-m6,6A1781 and 1782 modifications (Lafontaine et al., 1995). tRNAs are other 
noncoding RNAs for which the PTMs are closely related to the maturation process; 
methylation of position 40 (m5C40) was shown to be intron-dependent in the budding 
yeast tRNAPhe, whereas m1G37 requires intron removal to be installed. The RNA 
structure is impacted by the presence or absence of the intron, therefore changing the 
molecular identity that is essential for the enzyme recognition (Jiang et al., 1997). This 
example will be further discussed within the framework of this study but demonstrates 
that the decision to modify or not to modify is a tidy biological process. 
B. Modified RNA species 




tRNAs are the most heavily modified RNA species with up to 25% and 15% of 
their ribonucleotides being modified in eukaryotes and bacteria, respectively 
(Grosjean, 2009). To date, it is estimated that one fifth of all known tRNA modifications 
is spread across all domains of life (Lorenz et al., 2017). Ribosomal RNAs are also 
widely modified – although to a lesser extent – with up to 2% of modified positions 
(Sloan et al., 2017). The abundance of rRNAs and tRNAs facilitated their study and 
the modification status of their building blocks. However, other RNA species have been 
known to carry PTMs for decades. Besides the well-characterized eukaryotic mRNA 
5’-cap, internal modifications2 are found in coding RNAs, such as the highly abundant 
m6A which was detected in mRNAs more than forty years ago (Desrosiers et al., 1974). 
In bacteria, investigation about mRNA modifications is still in its early stages; a NAD-
based cap-like structure has only been detected on bacterial RNA 5’-ends in 2009 (Fig. 
3E) and the bacterial inosine3 landscape is barely one year old (Bar-Yaacov et al., 
2017; Chen et al., 2009). 
 
                                            
2 An internal modification refers to a residue that is found in the RNA body, in contrast with 5’- and 3’-
end modifications. 





























à Figure 3 – Diversity of RNA modifications. (A) Phylogenetic diversity of tRNA PTMs and distribution across the three
domains of life. Framed modifications are eukaryotic organelle modifications (Jackman and Alfonzo, 2013). (B) m5s2U (5-
methyl-2-thiouridine) is exclusively found on tRNAs (or at least has never been described elsewhere) whereas m7G (7-
methylguanosine) is found on different RNA species. (C) m6A (N6-methyladenosine) is synthesized in a single step
process by a methyltransferase complex whereas the bacterial Q (queuosine) requires at least seven enzymatic reactions
to be synthesized from G. (D) Examples of guanosine modifications that impair the Watson-Crick interaction (m1G, m2G,
m2,2G) or not (m7G) (carbon in green, nitrogen in blue, oxygen in red and hydrogen in yellow) (Chawla et al., 2015). (E)
RNA modifications occurring on the nucleobase (y, pseudouridine), on the ribose (Gm, 2’-O-methylguanosine), on both
(m6Am, N6-2’-O-dimethyladenosine) or on the 5’-end (NAD, nicotinamide adenine dinucleotide). (F) Pyrimidine
modifications (gray frames) found in RNA and DNA (circled) (Grosjean, 2009). (G) Schematic representation of the codon-
anticodon Watson-Crick interaction (purple lines) between tRNALysUUU and an AAA codon-containing mRNA. The wobble
position of tRNALysUUU is modified in mcm5s2U (5-methoxycarbonylmethyl-2-thiouridine) in the fission yeast (S. pombe), is
modified in mnm5s2U (5-methylaminomethyl-2-thiouridine) in E. coli and is modified in mnm5s2U (5-
carboxymethylaminomethyl-2-thiouridine) in the budding yeast mitochondrion (mt-S. cerevisiae). (H) Biochemical features
of mcm5s2U and mnm5s2U. Hydrogen bonds involved in the Watson-Crick interactions are highlighted with purple lines

















In Eukarya, snoRNAs and snRNAs carry 5’-end and internal modifications but 
have a narrow range of PTMs compared to the tRNAs and rRNAs (Boccaletto et al., 
2018; Cantara et al., 2011). Other reports also revealed the presence of modified 
nucleotides at various transcriptomic positions; primary miRNAs require m6A (Fig. 3C) 
to be properly processed by the RNase DROSHA (Alarcon et al., 2015); the human 
telomere RNA stability is increased by the pseudouridylation (Fig. 3E) of one of its 
stems, which was shown to boost the processivity of the telomerase itself in vitro (Kim 
et al., 2010); the methylation status of the XIST lncRNA (X-inactive specific transcript; 
modulating the silencing of one X chromosome during the female mammalian 
development) was experimentally correlated to its ability to repress transcription (Patil 
et al., 2016); etc.  
 
In Bacteria, the RNA modifications world is less extensively described but the 
non-canonical transfer-messenger RNAs (tmRNAs) were shown to hold at least two 
different modifications – y (pseudouridine) and m5U (5-methyluridine) (Felden et al., 
1998). A tmRNA is characterized both by a tRNA-like domain (TLD) with a D-loop-like 
conformation at its 5’-end and by a sequence coding for a proteolytic cleavage-
inducing tag. This latter is added to a nascent polypeptide when the ribosome is stalled 
in the so-called trans-translation process and therefore causes the degradation of the 
truncated protein (reviewed in (Mace and Gillet, 2016)). The possible crosstalk 
between the tmRNA modification pattern – especially on the TLD – and its ability to 
recognize stalled ribosomes is still unknown. 
 
RNA species are structurally and functionally different but they all seem to be 
targeted by modifying enzymes that install a large set of RNA modifications. Although 
it is a tedious work, the functionality of PTMs has been partially unraveled and 
examples are given below. 
C. Functionality of RNA modifications 
Understanding the scope and mechanisms of […] dynamic RNA modifications, 
which could be termed ‘RNA epigenetics’, represents a new frontier in 




Why is there that modification on that RNA? This general question is of high 
interest in RNA biology because the fate and functionality of an RNA also rely on the 
modifications profile. For brevity, only four functional examples will be shortly described 
to give an insight about how a posttranscriptional modification can be meaningful for 
RNA.  
i. Methylation of a lncRNA in Eukarya 
The functionality of a noncoding RNA was illustrated hereabove with the 
MALAT1 example (see Introduction I.B.iv.a); this long noncoding RNA localizes in the 
nuclear speckles and is associated with pre-mRNA splicing. In this section, details are 
given about how this functionality is acquired through an RNA modification. MALAT1 
was indeed shown to be regulated by the m6A-switch mechanism. When the MALAT1 
adenosine 2577 is methylated, RNA pull-down assays demonstrated an enhanced 
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affinity for the RNA-binding protein (RBP) HNRNPC. In other words, the MALAT1-
m6A2577 is more strongly bound to HNRNPC than its MALAT1-A2577 counterpart. The 
same study highlighted that the m6A-methyltransferase KO or HNRNPC KO led to the 
dysregulation of mRNA abundance and alternative splicing (Liu et al., 2015). Because 
MALAT1 is considered as a pre-mRNA processing element (Wilusz et al., 2008), it is 
tempting to establish a direct link between MALAT1 methylation and alternative 
splicing regulation but experimental evidence are still lacking. However, the modulation 
of an RNA-protein interaction through a PTM reveals how an RNA modification 
acquires functionality. 
ii. A rare RNA modification in extreme thermophilic Bacteria 
Extreme thermophilic bacteria optimally grow above 60°C. High temperature 
leads to tRNA destabilization, therefore forcing the extreme thermophilic organisms to 
acquire molecular specificities. An example of such an adaptation relies on the 
biosynthesis of m5s2U (thiolated derivative of a methylated uridine, Fig. 3B) at position 
54 in almost all tRNAs of Thermus thermophilus (whereas absent in non-thermophilic 
bacteria). The thiolation reaction leading to m5s2U formation is dependent of the 
temperature (minimum ~ 55°C), while the archaeon P. furiosus accumulates m5s2U at 
high temperatures (Kowalak et al., 1994; Shigi et al., 2006). With this modification, the 
tRNA thermal stability is then ensured and allows proper translation (Yokoyama et al., 
1987). Coupling RNA modification to environmental cues is therefore essential for 
high-temperature survival. 
iii. Methylation-dependent hijacking by viral RNAs 
m6A is a highly dynamic modification and is usually introduced with the concepts 
of writer, reader and eraser, that is to say enzymes that write, read or erase the 
modification. m6A is synthesized by methyltransferases (= writers), interacts with 
specific RBPs (= readers) and is wiped out by demethylases (= erasers).  
 
As viruses rapidly evolve, they acquire molecular specificities to hijack the host 
cell machinery. RNA modifications-related enzymes are no exception. In 2016, Cullen 
and colleagues mapped m6A on HIV-1 mRNAs and highlighted a cluster of modification 
on the 3’-UTR. They further showed that the loss of m6A deposition led to reduced viral 
RNA expression and that the overexpression of m6A readers (YTHDF proteins) 
resulted in an increase of viral proteins production (Kennedy et al., 2016). This study 
strongly suggests that; (i) the viral genome has evolved to express mRNAs containing 
m6A consensus sequences that are recognized by the m6A readers, (ii) the m6A-
containing mRNAs are bound by the YTHDF proteins that promote viral RNA 
translation and (iii) HIV uses the beneficial m6A dynamic modification to optimize its 
replication. 
iv. The wobble modification: a universal role 
The modifications that occur near or on the anticodon are of high importance for 
the stabilization of the codon-anticodon interaction and subsequent optimal translation. 
The third position of any codon interacts with the 34th position of its cognate tRNA, the 
so-called wobble position. This nucleotide is frequently modified and decorated by a 
plethora of different RNA modifications (Boccaletto et al., 2018), notably by pyrimidine 
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derivatives (Fig. 3F). An example is the hypermodification of the tRNALysUUU wobble 
position (Fig. 3G). The 5’-nucleotide of the UUU anticodon is heavily modified with an 
mcm5s2U modification in the cytoplasmic tRNALys of Eukarya and with a closely related 
mnm5s2U modification in bacterial counterparts (Fig. 3H). It should be noticed that 
mnm5s2U modification is not exclusively found in Bacteria. Remarkably, the tRNALysUUU 
wobble modification was shown to be crucial for translational fidelity and optimization 
both in prokaryotes and eukaryotes (Schaffrath and Leidel, 2017). For example, loss 
of mcm5s2U in the fission yeast is not lethal but results in cell cycle defects. At the 
molecular level, the phenotype was partly explained by the translational control of an 
mRNA coding for a cell cycle regulator; this mRNA was enriched in AAA codons, 
explaining why its expression was tRNALysmcm5s2UUU-dependent. Strikingly, the 
engineered exchange of the AAA codons to AAG codons was sufficient to rescue the 
WT level of protein production in a mutant lacking the mcm5s2U modification (Bauer et 
al., 2012). Similarly, the reading frame maintenance was shown to require the 
mnm5s2U-modified tRNALysUUU in bacteria (Bregeon et al., 2001; Urbonavicius et al., 
2001). The phylogenetic proof-of-concept also relies on the regulation of mitochondrial 
translation; the budding yeast mitochondrial tRNALyscmnm5s2UUU (encoded by the 
mitochondrial genome) is sufficient to decode AAA and AAG codons in normal 
conditions. However, the wobble position is hypomodified at elevated temperatures 
and the mitochondrial translation machinery requires the import of the cytoplasmic 
tRNALysCUU to prevent translational deficiency, demonstrating that the proper 
modification of the tRNALysUUU wobble position is critical for optimized protein 
production (Kamenski et al., 2007). 
 
The functional importance of the wobble position as briefly described here 
shows how a tRNA modification fine-tunes the translation, which is a more direct effect 
compared to what is observed with PTMs that are found on the tRNA body. 
III. FOCUS ON DIHYDROURIDINE 
A. Biochemical and structural identities 




The dihydrouridine (D) RNA modification is a modified pyrimidine nucleoside 
whose corresponding nucleobase is 5,6-dihydrouracil. D is synthesized from uridine 
(U) by hydrogenation (Green and Cohen, 1957) (Fig. 3F, Fig. 4A). Reduction of the 
uridine C5-C6 bond generates a saturated nonplanar and nonaromatic nucleobase 
that is a landmark of dihydrouridine (Fig. 4B). 
 
Although the chemical synthesis of dihydrouracil was already reported in 1896, 
its first detection in a biological sample dates back from 1952 when it was isolated from 
the beef spleen (Ehrlich et al., 1952). Using in vitro approaches, dihydrouridine 
monophosphate (dihydro-UMP) was shown to be efficiently introduced into RNA 
molecules, but whether D was a normal component of the RNA was still to be 




Figure 4 – Biochemistry of dihydrouridine. (A) Reduction of uridine into dihydrouridine. (B) Dihydrouracil is a nonplanar
nucleobase (carbon in black, nitrogen in blue, oxygen in red and hydrogen in gray) (Whelan et al., 2015). (C) First
published structure of a ribonucleic acid (yeast tRNAAla) where D (red arrows) are shown in a loop at the 5’-end (Holley et
al., 1965). (D) Schematic representation of ribose pucker. C5’ (orange dot) is considered as being above the C4’-O’-C1’
plane (red dashed line). On the left, C2’-endo has the C2’ (blue dot) above the plane. On the right, C3’-endo has the C3’
(green dot) above the plane (Moreau et al., 2011). (E) C2’-endo pucker produces a longer 5’-phosphate/3’-phosphate
distance and therefore spans the polynucleotide (Moreau et al., 2011). (F) Schematic representation of ribose gauche-
gauche and gauche-trans conformations. C5’ (white dot) adopts different torsion angles (!) that modulate the positionning













a naturally occurring component of yeast tRNAAla and even included in the first 
published structure of a ribonucleic acid (Holley et al., 1965; Madison and Holley, 1965) 
(Fig. 4C). Despite the lack of evidence, Visser and colleagues were already discussing 
the possibility that “non-random distribution of hydrogenated pyrimidine 
[dihydrouridine] may be explained more readily by a process of enzymatic 
hydrogenation at the polynucleotide level” ((Royburman et al., 1965), p. 297). 
 
In the next decades, optical studies along with X-ray and NMR crystallographic 
analyses were the main focus to elucidate the biochemical properties of dihydrouridine. 
The structures of the nucleobase, the nucleotide, of D-containing tRNAs and D-
containing oligoribonucleotides led to the conclusions that; (i) the carbon 6 of the 
nucleobase (C6) is out of the plane after the C5-C6 double bond reduction, (ii) the 
deviation from the planar nature of the pyrimidine results in the loss of the stacking 
ability with neighboring nucleobases, (iii) the C2’-endo conformation is adopted by the 
ribose moiety whereas RNA prefers the C3’-endo conformation (Fig. 4D) and (iv) the 
C2’-endo pucker is propagated to the 5’-nucleotide (references and comments in Table 
1). In other words, the complete destacking of the bases and the unusual adoption of 
C2’-endo ribose pucker make dihydrouridine a unique modification (Davis, 1998). The 
structural properties of dihydrouridine include the potential destabilization of the RNA 
structure (by promoting C2’-endo conformation) and molecular flexibility (by spanning 
the sugar-phosphate backbone, Fig. 4E). In parallel, the D crystal structures revealed 
the adoption of gauche-trans or trans-gauche conformations around the C4’-C5’ ribose 
bond, rather than the common gauche-gauche rotamer (Fig. 4F, references in Table 
1). Finally, the dihydrouracil nucleobase was shown to be in anti orientation in respect 
to the ribose moiety (i.e. with C2=O pointing away from the sugar) (references in Table 
1). 
B. Methods of detection  
Over the decades, multiple experimental techniques were developed for the 
identification and localization of RNA modifications. Most of them are quite 
laborious […]. 
  
(Motorin et al., 2007) 
i. Sodium borohydride versus alkali 
Distinguishing the RNA modification from its canonical nucleotide is challenging. 
Investigations on chemical reactions specifically acting on D started before its 
description as a natural PTM (Table 2). The dihydrouridine undergoes ring opening 
upon sodium borohydride (NaBH4) or alkaline (OH-) treatments, resulting in the 
formation of an ureido-group (NH2CONH) linked to an alcohol or a carboxylic acid, 
respectively (Fig. 5) (Batt et al., 1954; Cerutti and Miller, 1967; Igo-Kemenes and 
Zachau, 1969). The accumulation of ureido-groups can be quantified by a colorimetric 
assay (Jacobson and Hedgcoth, 1970). The ribosylureidopropanol (D + NaBH4) is 
either used for labeling of RNA with a fluorescent dye (point iii.) or for the cleavage of 
ureidopropanol upon acid conditions (H+) (Betteridge et al., 2007; Cerutti et al., 1968a; 
Cerutti et al., 1968b; Cohn and Doherty, 1955; Pan et al., 2009; Wintermeyer et al., 
1979; Wintermeyer and Zachau, 1971, 1974). The ribosylureidopropionic acid (D + 
OH-) is used as a semi-quantitative tool following the breakdown between ribose and 
structural and 
optical studies comments references
dihydrouracil
C5-C6 and N1 out of the base plane
expectation for Watson-Crick interaction impairment






(Sundaralingam et al., 
1971a)
anti orientation
favoured gauche-trans and trans-gauche conformations




preference for C3’-exo and C2’-endo conformations
preference for gauche-gauche conformation




favoured gauche-trans and trans-gauche conformations
(Suck et al., 1971)
C6 out of the base plane
no base stacking and anti orientation
C2’-endo conformation
favoured gauche-trans and trans-gauche conformations





ApD and GpD low stacking
(Formoso et al., 1971)
yeast or E. coli 
tRNAs
formation of a D-loop with increased hydrophobicity
D provides extra flexibility
interaction of D-loop and TyC-loop
(Davis et al., 1986; Jack et 
al., 1976; Quigley and Rich, 
1976; Westhof et al., 1985; 
Westhof and Sundaralingam, 








C6 out of the base plane
no base stacking
enhanced C2’-endo conformation at low temperature (5°C)
and downstream propagation
(Dalluge et al., 1996b; Deb et 
al., 2014)
_________________________________________________________________________________________________
Table 1 – Seminal studies on optical and structural properties of dihydro-uracil/-uridine. The table is divided into
three columns; (i) studied chemical entities, (ii) main conclusions relative to the nucleobase (written in green) or to the
ribose (written in blue) and (iii) references. C (carbon), N (nitrogen), A (adenosine), D (dihydrouridine), G (guanosine), p
(5’-3’ phosphodiester bond), acp3U (3-(3-amino-3-carboxypropyl)uridine).
principles tRNA comments references
alkaline hydrolysis / sodium hydroxide à cleavage at the N3-C4 linkage of dihydrouracil (Batt et al., 1954)
β-alanine detection Y sodium hydroxide à D-ring opening à partial β-alanine formation 
à ninhydrin colorimectric assay
(Magrath and Shaw, 
1967)
sodium borohydride reduction Y sodium borohydride à cleavage at the N3-C4 linkage of dihydrouridine (Cerutti et al., 1967)
hydrochloric acid hydrolysis B, Y, M sodium borohydride à D-ring opening à hydrochloric acid 
à cleavage of the glycosodic bond
(Cerutti et al., 1968a
and b; Cohn and 
Doherty, 1955)
loss of absorbance Y loss of absorbance at 265nm upon mild sodium hydroxide treatment (Molinaro et al., 1968)
cleavage at D position Y sodium borohydride à D-ring opening à aniline treatment 




ureido-group detection B, Y, M sodium hydroxide à D-ring opening à solution neutralization 
à colorimetric assay after iron chloride addition (550nm)
(Jacobson and 
Hedgcoth, 1970)
replacement of D by proflavine or EtBr Y sodium borohydride à D-ring opening à incubation with the dye (Wintermeyer and Zachau, 1971)
microarray Y differential fluorescent labeling of tRNA from WT and dus strains 
à annealing on a microchip à quantification of A-U vs A-D interaction (Peng et al., 2003)
primer extension B, Y sodium hydroxide à D-ring opening 
à assessment of RT termination by primer extension
(Betteridge et al., 2007; 
Xing et al., 2004)
fluorescent labeling with rhodamine 110 B in vitro tRNA à in vitro dihydrouridylation à sodium borohydride 
à incubation with the dye (Betteridge et al.,  2007)
replacement of D by Cy3 or 5 B, Y sodium borohydride à D-ring opening à incubation with the dye (Pan et al., 2009)
benzoyhydrazide addition B sodium borohydride à THU formation à incubation with benzohydrazide (Kaur et al., 2011)
_________________________________________________________________________________________________________________________________________________
Table 2 – Chemical reactions and techniques specifically applicable to D. The table is divided into four columns; (i) list of principles, (ii) phylogenetic origin of the studied tRNA;
B (bacterial), Y (yeast), M (mammalian), (iii) general comments on the principle. EtBr (ethidium bromide), N (nitrogen), C (carbon), RT (reverse transcritpion), WT (wild type), dus
(dihydrouridine synthase gene), A-U (adenine-uridine Watson-Crick interaction), A-D (adenine-dihydrouridine Watson-Crick interaction), Cy3/5 (cyanines 3 or 5), THU
(tetrahydrouridine) and (iv) references (only the seminal works are cited although most of the techniques were implemented in other studies).
_________________________________________________________________________________________________
Figure 5 – Molecular fate of D upon sodium borohydride (NaBH4) or alkaline (OH-) treatments. R stands for ribose
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ureidopropionic acid, this latter being decomposed to β-alanine that serves as a 
substrate for a colorimetric assay with ninhydrin (House and Miller, 1996; Magrath and 
Shaw, 1967). The D-ring disruption upon OH- condition was also shown to generate 
an RT (reverse transcription) termination assessed by primer extension (Fig. S2) (Xing 
et al., 2004). In both cases (D + NaBH4 or OH-), it is possible to get an abasic site 
(nucleobase-free ribose) that leads to the cleavage of RNA chain with aniline treatment 
(Beltchev and Grunberg-Manago, 1970; Wintermeyer and Zachau, 1970). 
ii. D and Watson-Crick interactions 
The  comparison of binding properties of polyU- vs polyD-nucleotides with polyA 
revealed a diminished ability of polyD to interact with polyA although the reduction 
occurs at Hoogsteen edge (C5=C6) of the nucleobase whereas the hydrogen bonds 
are formed from positions 3 and 4 (N3-C4=O) (Cerutti et al., 1966). The decreased 
binding capacity is nevertheless too weak to induce a clear RT termination in a primer 
extension context (Motorin et al., 2007). Phizicky and colleagues used this low binding 
feature between D and A for the implementation of a microarray-based technology in 
order to assess the presence or absence of a D residue at a specific tRNA position in 
yeast mutants (see point C.i.b.) (Xing et al., 2004). In brief, total RNAs are extracted 
from WT (wild type) and D-defective mutant strains and are differentially labeled with 
fluorescent dyes emitting at non-overlapping wavelengths (e.g. WT RNA is labeled 
with a dye emitting at 546nm and the mutant RNA is labeled with a dye emitting at 
647nm). The capacity of fluorescent RNAs to hybridize with tDNA probes (DNA 
sequences of a tRNA) coated on a chip is dependent on the sequence itself; carrying 
a D (“low” signal due to weak A-D interaction) or not (“high” signal due to strong A-U 
interaction) (Peng et al., 2003). 
iii. D fluorescent labeling 
As stated above, the reduction of D by sodium borohydride is a prerequisite for 
the subsequent incorporation of fluorescent molecules, and more specifically of NH2-
dyes (e.g. proflavine, rhodamine, cyanine hydrazide). Figure 5 shows that the D-ring 
opening forms ribosylureidopropanol in a NaBH4-dependent manner. However, this 
commonly accepted N3-C4 cleavage has been recently challenged (Kaur et al., 2011). 
Cooperman and colleagues induced tRNA reduction with sodium borohydride and 
performed labeling with NH2-containing fluorophores nucleophiles. By combining TLC 
(thin layer chromatography) and mass spectrometry, they detected tetrahydrouridine 
(THU) instead of the expected ribosylureidopropanol. Based on their results, they 
proposed that the dihydrouridine C4 carbonyl group is reduced by the H- donor NaBH4 
to THU. Upon the addition of an NH2-dye in acid conditions, a nucleophilic substitution 
occurs on the C4 hydroxyl group by formation of a Schiff base-bearing intermediate 
called tetrahydrocytidine (THC) and consecutive fluorophore binding. Fig. 6 
summarizes both mechanisms in the context of the addition of the rhodamine 110 
fluorophore. 
iv. General methods 
Besides the above detailed methods that are selective for dihydrouridine only 
(along with a few other RNA modifications sharing the same chemical reactivity, see 
Table 3 in Discussion and Perspectives), general methods are also used to detect and 
possibly quantify D.  
_________________________________________________________________________________________________
Figure 6 – Proposed mechanism of D rhodamine labeling following sodium borohydride (NaBH4) reduction. On
the left, dihydrouridine is reduced to tetrahydrouridine that is characterized by an electrophilic carbonilamine (green
circle), including the C4 hydroxyl group (C-OH). Upon addition of the nucleophilic rhodamine 110 in acid conditions, the
tetrahydrocytidine intermediate is formed with its reactive Schiff base (bleu circle). Covalent binding of rhodamine 110
occurs by substitution of the C4 hydroxyl group. On the right, ureidopropanol generated by D-ring opening is replaced by



























 TLC is a long-standing technique that chemically separates radioactively-
labeled (modified) nucleotides. D was detected in vivo after addition of 14C- and 3H-
uracil in the growth medium, followed by RNA extraction, digestion and separation by 
bi-dimensional TLC (Jacobson and Hedgcoth, 1970). One-dimension TLC was 
efficiently used to assess the formation of D on an in vitro transcribed tRNA incubated 
with GST-purified putative dihydrouridine synthases and various cofactors (Xing et al., 
2002). The detection was also accomplished by 3H-labeling of the ribose moiety. 
Briefly, the RNA was enzymatically digested, oxidized with an inorganic salt – leading 
to the opening of the ribose ring –, and reduced by 3H-borohydride that attacks the 
opened ribose ring by addition of 3H. Labeled mononucleotides are then spotted on a 
cellulose membrane for separation in two dimensions (Randerath et al., 1980). 
 
Reverse-phase high performance liquid chromatography (HPLC) is commonly 
used to sort the nucleosides according to their biochemical properties and are then 
detected by UV. The dihydrouridine has however no appreciable absorbance in the UV 
spectrum. Moreover, D is the earliest eluting nucleoside and is therefore sometimes 
barely distinguished from contaminants with short retention times. These technical 
issues are nevertheless overcome by the detection at 254nm (Buck et al., 1983; 
Pomerantz and McCloskey, 1990) and improvement of D detection by UV is achieved 
by lowering the wavelength at 210 or 230nm (Gehrke and Kuo, 1990; Topp et al., 1993; 
Xing et al., 2004; Xing et al., 2002). Accurate determination of D is readily obtained by 
liquid chromatography coupled to mass spectrometry (LC-MS) (Dalluge et al., 1996a; 
Edmonds et al., 1985). 
C. The biology of dihydrouridine 
Our understanding of the physiological role of dihydrouridine is still in its 
infancy […]. 
  
(Rider et al., 2009) 
 
Dihydrouridine is found in RNA from all domains of life but is mostly described 
within the framework of tRNA biology because it is essentially found on them. Bujnicki 
and colleagues aligned 602 tRNA sequences from more than 100 prokaryotic and 
eukaryotic species. Distribution of PTMs revealed that dihydrouridine is the second 
most prevalent tRNA modification (925 counts) after pseudouridine (1,164 counts) 
(Machnicka et al., 2014). The dihydrouridylated positions include the canonical D16, 
D17, D20, D20a, D20b and D47 and the rare noncanonical D14, D17a, D21 and D48. Strikingly, 
among the most frequent modified positions, D20 is the third with 323 occurrences and 
D16 is the fifth with 216 occurrences. These highly conserved D are positioned in the 
so-called D-loop – for which it is named – that has a pivotal role in the establishment 
of secondary and tertiary structures of tRNAs (Fig. S3) (Dyubankova et al., 2015; 
Grosjean et al., 1998). The biochemical specificities of D (see Introduction III.A.) play 
a role in the cloverleaf-related tRNA secondary structure and in the L-shaped tRNA 
tertiary structure that is achieved through D- and T-loops interaction (reviewed in (Vare 
et al., 2017)). Although the most important residues for the kissing D/T loops are not 
dihydrouridines, a compilation of crystal structures highlighted a set of base pairing 
events where D is involved through various types of interactions (cis or trans 
interactions between Watson-Crick, Hoogsteen and sugar edges) (Chawla et al., 2015; 
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Seelam et al., 2017). In other words, D is a highly conserved and prevalent 
posttranscriptional modification that is also a key player for tRNA structure. 
i. Specificities in Eukarya 
a. Generalities 
Historically, the dihydrouridine was associated with plant and mammalian 
histone-bound RNAs (Huang and Bonner, 1965; Shih and Bonner, 1969). Later, D was 
detected on an enzymatic digest of rat U5 snRNA, but this observation was never 
confirmed since then (Krol et al., 1981). Well-described eukaryotic dihydrouridylated 
positions are found on tRNAs; all tRNA species have been described with at least one 
dihydrouridine, with the exception of tRNAselenocysteine. Particularly, none of the eighteen 
described cytoplasmic tRNAiMet have any D17, D20, D20a, or D20b and only 28% of them 
have a D16 (against 76% for the 210 others cytosolic tRNAs). In mitochondrial tRNAs 
(mt-tRNAs), all six canonical D are found, except D20b (Cantara et al., 2011; Machnicka 
et al., 2014). Importantly, there are dihydrouridylated mt-tRNAs that are encoded by 
the mitochondrial genome; at least three mammalian mt-tRNAs are known to have a 
D20 and accordingly, the putative cognate enzyme (see point b.) was shown to localize 
in human and murine mitochondria (Calvo et al., 2016; Suzuki and Suzuki, 2014). It 
has been shown that a set of mammalian mt-tRNAs have a truncated cloverleaf 
structure by lacking the D-loop (Arcari and Brownlee, 1980; de Bruijn et al., 1980). 
Surprisingly, these tRNAs seem to adopt a functional tertiary structure by establishing 
unique interactions in a Mg2+-dependent manner (de Bruijn and Klug, 1983; Jones et 
al., 2006).  
b. Eukaryotic Dus enzymes 
Determination of RNA modifying enzymes has lagged behind since the 
discovery of the first RNA modification (Davis and Allen, 1957; El Yacoubi et al., 2012). 
A budding yeast strain – characterized by the production of multiple isoaccepting 
tRNAs in specific growth conditions – was shown to have a reduced amount of D (Lo 
et al., 1982). However, the genetic basis of this peculiarity is still unresolved and 
therefore did not allow to isolate a potential dihydrouridine synthase candidate (dus or 
Dus). Phizicky and colleagues accomplished this work in 2002 – 37 years after D was 
shown to be a natural RNA modification – in S. cerevisiae (Xing et al., 2002). More 
specifically, they performed a Dus activity assay by combining in vitro transcribed 
tRNAs (32P-labeled at U positions) and a collection GST-ORF fusion proteins. D 
formation was assessed by TLC. Dissection of the positive candidates led to the 
isolation of a unique ORF that was called dus1. Furthermore, the in silico alignment of 
the Dus1 sequence revealed that three other similar proteins were encoded in the 
yeast genome, and that the Dus1 homologs were found in S. pombe, C. elegans, D. 
melanogaster, A. thaliana, H. sapiens and E. coli. In parallel, the detailed investigation 
on Dus activity highlighted that D was synthesized on tRNAPhe incubated with Dus1 or 
on tRNALeu with Dus2, but not conversely. They therefore hypothesized that the Dus 
proteins could be substrate-specific enzymes. The high specificity of Dus1, 2, 3 and 4 
was demonstrated in a microarray-based experiment (see Introduction III.B.ii and 
Table 2) for yeast cytoplasmic tRNAs; Dus1 targets U16 and U17, Dus2 targets U20, 
Dus4 targets U20a and U20b and Dus3 targets U47 (Fig. 7A). Finally, the budding yeast 
quadruple dus mutant was shown to be viable and to lack any detectable 





Figure 7 – The biology of dihydrouridine. (A) Specificity of yeast Dus enzymes for cytoplasmis tRNAs. (B) Specificity of
E. coli Dus enzymes for tRNAs. (C) Putative enzymatic mechanism of Dus enzymes. Details in the text. (D) Proposed
evolutive scenario of Dus enzymes across the three domains of life. LUCA (last universal common ancestor). LAECA (last
archaeal and eukaryotic common ancestor) (Kasprzak et al., 2012). (E) Currently available structures of Dus enzymes in
different species (Sp.) from different domains (dm; B for Bacteria and E for Eukarya). The references are indicated in the
last column. (F) Bacterial Dus enzymes bind tRNA in reverse orientations. DusC modifies U16 and DusA modifies U20. ASL





















enzyme Sp. dm references
Dus T. maritima B (Park et al., 2004)
DusA T. thermophilus B (Yu et al., 2011)
hDUS2 H. sapiens E (Griffiths et al., 2012)
DusC E. coli B (Chen et al., 2013)
DusC E. coli B (Byrne et al., 2015)
hDUS2 H. sapiens E (Whelan et al., 2015)
hDUS2 H. sapiens E (Bou-Nader et al., 2015)

















c. D and cancer 
The isolated tRNAPhe from malignant human tissues was reported to contain 
more dihydrouridines (Kuchino and Borek, 1978). D is also present in urine samples 
and more significantly abundant in the urine of lymphoma patients (Jiang et al., 2016; 
Reimer et al., 1989). This is in line with the idea that tumor tissues undergo high 
turnover of tRNAs that can be quantified and used as a noninvasive biomarker for 
diagnosis and treatment of cancer (Borek et al., 1977; Dudley and Bond, 2014; Topp 
et al., 1993). The serum is also used to assess the metabolomic changes in various 
disease contexts; D is upregulated in the serum of patients with the major form of oral 
cancer in the world (oral squamous cell carcinoma) (Sridharan et al., 2017). At the 
molecular level, the human DUS2 protein (hDUS2) was shown to act as an interacting 
inhibitory factor of the interferon-induced protein kinase PKR – whose activity is 
enhanced in melanomas and colorectal cancers (Mittelstadt et al., 2008). Similarly, the 
anti-cancer ginsenoside compound was shown to repress the expression of hDUS2 in 
human colorectal cancers cells (Luo et al., 2008). 
 
To date, the most comprehensive study linking D with cancer was provided by 
Nakamura and colleagues (Kato et al., 2005). hDUS2 showed a 3-fold overexpression 
in non-small cell lung carcinomas (NSCLCs) compared to healthy samples. The 
hDUS2 protein followed the same pattern, localized at endoplasmic reticulum and 
harbored a C-terminal double-stranded RNA binding motif (DSRM or dsRBD). The 
research cited above described an in vivo protein-protein interaction between hDUS2 
and the glutamyl-prolyl tRNA synthetase EPRS and also identified in vivo an enhanced 
translational efficiency in the presence of hDUS2. Phenotypically, the suppression of 
the tumor cell growth was observed after siRNA-dependent hDUS2 depletion and the 
NSCLCs patients with high levels of hDUS2 showed shorter survival periods. Their 
subsequent model was that overexpression of hDUS2 led to the hypermodification of 
tRNAs and consecutive increase of conformational flexibility. Because hDUS2 
interacted with EPRS, they hypothesized that the tRNAs were more promptly charged 
in NSCLCs, which globally resulted in a more efficient translation. Strikingly, hDUS1 
was not differentially expressed in the same cell lines, raising the possibility of a 
hDUS2-specific regulation. However, this model is not fully supported by the data and 
requires more evidence; what is the biological relevance of the hDUS2-EPRS 
interaction? Isn’t it an incidental interaction due to their common interaction with 
tRNAs? Because the hDUS2 overexpression does not necessarily mean that the D 
content is increased, are there more dihydrouridine residues in NSCLCs? etc. 
d. Open questions 
In the plant A. thaliana, D was not experimentally shown as a tRNA modification 
but was inferred to be synthesized due to the five putative dus genes encoded by the 
genome (Dus1, 2, 3 and DusA homologs, but never experimentally tested) (Kasprzak 
et al., 2012). Interestingly, these genes are lowly expressed in rosette leaves and apex 
tissues, unlike other RNA modifying enzyme genes (Chen et al., 2010).  
 
The availability of numerous RNA-seq data allows an in silico assumption of the 
presence of RNA modifications that leaves detectable traces during library preparation 
(Findeiss et al., 2011; Ryvkin et al., 2013). Using this kind of pipeline, the plant 
transcriptome was assumed to carry D on lnc-, mi-, sno- and m- RNAs (Vandivier et 
al., 2015). Such predictions are poor evidence of the actual modification profile of a 
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transcriptome due to the weakness of the positive controls provided and the complexity 
to distinguish between more than 150 PTMs. 
 
The reprogramming of yeast tRNA modifications in different conditions was 
thoroughly investigated by Dedon and others (Chan et al., 2015; Chan et al., 2010; 
Patil et al., 2012; Rose et al., 2016). D does not seem to be differentially synthesized 
on tRNAs when cells are exposed to various cellular stresses but is slightly more 
prevalent in the S-phase of the cell cycle. However, this effect is limited compared to 
the increase of mcm5U (5-methoxycarbonylmethyluridine) (Patil et al., 2012).  
 
In cardiomyocytes, the human DUS3 homolog was shown to interact with polyA+ 
RNAs – along with 28 other RNA modification enzymes – raising the possibility of 
mRNAs hDUS3-specific modification in this specialized cell type (Liao et al., 2016). 
hDUS3 was also shown to be an inhibitor of the regenerative ability of the central 
nervous system (Buchser et al., 2012). Strikingly, the dihydrouridine was more 
abundantly detected during neural development in human embryonic stem cells 
(Basanta-Sanchez et al., 2016). 
 
In Trypanosoma brucei, a carboxypropylated dihydrouridine was detected for 
the first time at the position 47 of tRNALysUUU (Fig. S4). This new acp3D RNA 
modification (3-(3-amino-3-carboxypropyl)-5,6-dihydrouridine) has an unknown 
structural function and its synthesis has still to be unraveled (Krog et al., 2011). 
 
Given the biochemical peculiarities of dihydrouridine, it was included into in vitro 
prepared short interfering RNAs (siRNAs). The goal was to find out how to improve the 
pharmacokinetic features of siRNA duplexes for subsequent therapeutic utility (Wang 
et al., 2017). It turned out that the installation of a dihydrouridine at the 5’-end of the 
duplex increased its silencing activity (Sipa et al., 2007). 
ii. Specificities in Bacteria 
a. Bacterial D on tRNA and rRNA 
Dihydrouridine is the most prevalent bacterial tRNA modification with 
pseudouridine (192 counts each). All canonical D residues (D16, D17, D20, D20a, D20b 
and D47) are found in Bacteria. Nevertheless, D47 is a scarce modification with a unique 
count described so far (tRNAMet of B. subtilis), although the position 47 in bacterial 
tRNAs is a U in almost 90% of the 134 known sequences. D20b is also very uncommon 
and found on a cyanobacterial tRNAGlu (Machnicka et al., 2014).  
 
A peculiarity of the bacterial dihydrouridine landscape is the presence of D on 
the 23S rRNA in Gram -negative (E. coli) and -positive (M. hominis, C. sporogenes) 
bacteria (Johnson and Horowitz, 1971; Kirpekar et al., 2018; Kowalak et al., 1995). 
These observations are of high interest because not a single dihydrouridine is reported 
on non-bacterial rRNAs. In E. coli, D turned out to be synthesized from U2449 and from 
U2500 in C. sporogenes, residues that are located in the highly conserved 23S rRNA 
central loop of domain V (Kirpekar et al., 2018; Kowalak et al., 1995; Popova and 
Williamson, 2014). Remarkably, this region is part of the peptidyltransferase center 
that is also one of the sites of interaction with antibiotics targeting ribosomal activity. 
However, D2449 is dispensable in E. coli and an unmodified pyrimidine at that precise 
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rRNA position is sufficient for viability (O'Connor et al., 2001). This suggests that the 
23S-D2449 – instead of being an essential modification – could be involved in a fine-
tuning regulation of translation in Bacteria. 
 
The Gram-positive C. acetobutylicum is the only known organism to have a D 
on its 16S rRNA. The modification occurs on position 1211 or 1212 but its function is 
still unknown (Emmerechts et al., 2007).  
b. Bacterial Dus enzymes 
Taking advantage of the differential distribution of dihydrouridine across 
species, de Crécy-Lagard and colleagues implemented an in silico comparative 
genomic screen in order to find bacterial dus genes. Because no D was ever detected 
in P. furiosus, they assumed that the genome of this organism should not contain any 
dus gene, in contrast to other microorganisms such as E. coli or S. cerevisiae. By doing 
so, they found ortholog genes – or more precisely clusters of orthologous groups – that 
were absent in the D-free P. furiosus species but present in other D-containing species 
(Bishop et al., 2002). This approach led them to the identification of three E. coli Dus 
enzymes that are now called DusA, DusB and DusC. Importantly, they showed that 
the tRNAMet-D20a was DusA-specific and that the viable triple ∆dusABC mutant did not 
display any apparent growth defect and was devoid of tRNA dihydrouridines. 
 
Similarly to eukaryotic Dus, bacterial Dus enzymes have non-redundant 
activities on tRNAs (Fig. 7B). E. coli DusB and DusC are mono-specific proteins that 
target U17 and U16, respectively. The DusA substrates include U20 and U20a (Bou-Nader 
et al., 2018).  
c. Correlating D and growth temperature 
The implementation of a quantitative detection of dihydrouridine led to the 
conclusion that psychrophilic bacteria have up to 70% more D on tRNAs than their 
mesophilic counterparts, which is in contradiction with the general observation that 
tRNAs of psychrophiles tend to be hypomodified (Dalluge et al., 1997). The 
psychrophilic organisms that grow between 0 and 20°C – with an optimum at 15°C – 
have the necessity to cope with low environmental temperatures, unlike the 
mesophiles bacteria that live above 20°C. It has been established that the lower the 
temperature, the higher the [C2’-endo/C3’-endo] ratio for dihydrouridine – this ratio 
representing the equilibrium constants as determined by NMR (Dalluge et al., 1996b; 
Deslauriers et al., 1971). In other words, low temperatures tend to stabilize the C2’-
endo conformation of the dihydrouridine ribose moiety. The accumulation of D in 
psychrophilic prokaryotes could therefore constitute an evolutive adaptation to allow 
these organisms to maintain the conserved L-shaped conformation of tRNA, despite a 
growth at very low temperatures that otherwise could be detrimental for tRNA structure 
and function.  
 
More generally, the set of modifications present on a tRNA depends on 
environmental cues, such as the temperature. In agreement with this idea, the in vitro 
synthesis of dihydrouridine in the hyperthermophilic bacterium T. thermophilus is 
possible on an unmodified tRNAPhe at 60°C but not at 80°C. At this latter temperature, 




At the transcriptional level, the gene coding for the mesophilic Clostridium 
botulinum DusB homolog is downregulated during a heat shock stress at 45°C. In line 
with the above principles, the bacterium would require less D at high temperatures and 
would therefore decrease the expression of its cognate enzyme (Liang et al., 2013).  
d. Open questions 
Surprisingly, unexpected and putative Dus functions were observed, mainly in 
proteobacteria. dusA is upregulated in the β-proteobacterium N. meningitidis when in 
contact with epithelial cells and seems to play a role in bacterial adherence (Hey et al., 
2013). The !-proteobacterium S. typhimurium Y RNA – a ncRNA involved in RNA 
degradation – possesses a DusA-dependent D (Chen et al., 2014). dusC is 
downregulated in the !-proteobacterium E. coli in an antibiotic-induced cell death 
(Kohanski et al., 2007). In other !-proteobacteria, dusB is referred as a determinant 
for biofilm formation (Grasteau et al., 2011; Musken et al., 2010). The question is to 
know whether the modification itself is implicated in these biological processes. If not, 
it could suggest that bacterial Dus are multifaceted proteins that are not only RNA 
modifying enzymes. 
iii. Specificities in Archaea 
Archaebacteria are known to live in extreme conditions. Following the 
correlation established between D and temperature (see Introduction III.C.ii.c.), it is not 
surprising to observe that dihydrouridine is absent in most archaea. It is particularly 
evident for extreme thermophilic organisms such as Pyrobacalum sp. and Pyrodictium 
sp. whose optimal growth temperature is around 100°C. However, the Thermococcus 
species have dihydrouridylated tRNAs despite their optimal growth at 98°C (Edmonds 
et al., 1991). D was detected in other archaeal genera – although less temperature-
extreme – such as Methanococcus (30°C), Methanosarcina (37°C), Thermoplasma 
(56°C) or Methanobacterium (65°C) (Best, 1978; Gupta and Woese, 1980; McCloskey, 
1986). 
 
An interesting case is found with Methanococcoides burtonii that has a thermal 
niche around 2°C and an in vitro optimal growth at 23°C. It was noticed that despite its 
tremendously low percentage of modified tRNA nucleotides – only 2%, which is one of 
the lowest in the living world – this psychrotolerant archaeon has, on average, more 
than one D residue per tRNA. Surprisingly, the D levels do not seem to vary with 
increased growth temperatures (from 4 to 23°C) (Noon et al., 2003). The fact that an 
archaeon living at low temperatures possesses D residues is another clue to consider 
this RNA modification as being involved in the flexibility of tRNAs when it is required to 
allow proper growth. 
  
A biochemical study shed light on the temperature-dependent D-ring opening to 
3-ureidopropionic acid (Fig. 5). The half-life of D at 37°C is about two hundred days 
and decreased to less than ten hours at 100°C (House and Miller, 1996). Extremophilic 
organisms either adopted a degradation/re-synthesis strategy to get rid of the 3-
ureidopropionic acid-containing tRNAs or have acquired other molecular mechanisms 
that prevent the opening of the D-ring. 
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iv. A common feature: the Dus enzymatic mechanism 
Dus are flavin-dependent enzymes that function similarly to the dihydroorotate 
and dihydropyrimidine dehydrogenases. Based on kinetics and structural data, an 
FMN- and NADP-dependent enzymatic mechanism has been proposed (Lombard and 
Hamdane, 2017; Rider et al., 2009; Yu et al., 2011); a hydride anion (H-) is added to 
the  nucleophilic C6 of uridine after the reduction of FMN to FMNH- by NADPH. The 
second hydride transfer to C5 likely occurs through the oxidation of a highly conserved 
Dus cysteine residue (Cys), that argues in favor of an evolutionary conserved 
mechanism (Fig. 7C) (Kasprzak et al., 2012; Savage et al., 2006). 
v. Molecular evolution of Dus enzymes 
An in silico high-throughput study has gathered 11,000 sequences of the Dus 
family for phylogenetic comparison (Kasprzak et al., 2012) (Fig. 7D). They identified 
eight sub-clusters, including the eukaryotic-exclusive Dus1, Dus2, Dus3 and Dus4 
families; the bacterial-exclusive DusC family; the archaeal-exclusive Dus proteins; the 
DusA cluster found in bacteria and plants; and the DusB family that is mainly bacterial 
but also found in Archaea.  
 
It is suggested that DusB is the oldest bacterial dihydrouridine synthase that 
evolved at a slow rate, unlike the rapidly evolving DusA. This latter is mainly found in 
proteobacteria and could therefore be the result of dusB duplication in the ancestor of 
this phylum. DusA orthologs found in other bacteria are likely products of horizontal 
gene transfer, whereas eukaryotic DusA-like proteins (in the fungus Encephalitozoon 
cuniculi or in the plant Arabidopsis thaliana) are probably the consequence of 
endosymbiosis. 
 
In Eukarya, the mono-specific enzyme Dus3 (D47) seems to be the most ancient 
Dus enzyme, followed by Dus2 (D20). Subsequent duplications led to the production of 
enzymes with apparent relaxed specificity; Dus1 (D16 and 17) and Dus4 (D20a and b). It 
is noteworthy that DusB and Dus3 are both the oldest Dus proteins of their own domain 
and are closely related in terms of clusters projection, unlike DusA and Dus1-2-4 
families that are highly different with one another. 
 
Specific evolutive patterns were also observed. The Bacillus subtilis and 
Clostridium acetobutylicum firmicutes have two DusB paralogs encoded in their 
genome. As discussed above, these two bacteria are also characterized by unusual D 
modifications (tRNAMet-D47 in B. subtilis and 16S-D1211 or 1212 in C. acetobutylicum). 
The presence of these noncanonical paralogs could explain the specific 
dihydrouridylation pattern of both species. Furthermore, DusC is missing in α-
proteobacteria but data of tRNA sequences are still lacking and it is thus not known 
whether the DusC absence indeed results in non-modification of tRNAs-U16 (Fig. 7B). 
In the same bacterial class, Rickettsia genus seems to be deprived of DusA proteins. 
The reason of the dusA gene loss is unknown and the impact on the tRNA physiology 
should be investigated to bring answers about the evolutionary mysteries of Dus. 
 
In conclusion, this bioinformatic-based approach revealed widespread 
distribution of dihydrouridine synthases throughout living organisms.  
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vi. Structural studies of Dus enzymes 
To date, eight Dus enzymes structures have been published (Fig. 7E). The 
seminal crystallographic structure of an unknown FMN-binding protein in T. maritima 
revealed an oxidoreductase enzyme with two domains; an N-terminal TIM barrel and 
a C-terminal helical domain (Park et al., 2004). Later, this enzyme was referred as a 
dihydrouridine synthase. The T. thermophilus DusA crystal highlighted the same 
general structure (Yu et al., 2011). Moreover, the FMN cofactor (flavin mononucleotide) 
was captured in a positively charged groove at the center of the N-terminal domain 
corresponding to the catalytic site. DusA-tRNAPhe complex revealed that DusA 
interacts with the DSL, ASL and TSL of tRNA (Fig. S3) and that the D-loop but not the 
D-stem is strongly distorted when DusA is bound. The third published bacterial Dus 
structure was DusC from E. coli that also displays a two-domain conformation with an 
N-terminal catalytic domain and a C-terminal RNA binding domain (Byrne et al., 2015; 
Chen et al., 2013). The structural similarities between T. thermophilus DusA and E. coli 
DusC led to the hypothesis that they share the same catalytic mechanism (see 
Introduction III.C.iv.). Remarkably, notable structural dissimilarities were discovered by 
comparing the bacterial DusA (targeting tRNA-U20 and 20a) and DusC (targeting tRNA-
U16). Both enzymes adopted the same general fold – while having different substrate 
specificities – but bound and recognized the tRNA in different orientations (Fig. 7F). 
The tRNA binding differed by a 160° rotation that resulted in the proper integration of 
the targeted uridine in the catalytic pocket. This trademark way of catalyzing a reaction 
is unique in RNA enzymology and is achieved through specific binding signatures. 
According to its target, each Dus enzyme has a cluster of amino acids – that is 
phylogenetically conserved in Bacteria – that defines the docking of tRNA to allow the 
reduction of a specific uridine (Byrne et al., 2015). The missing DusB structure was 
provided by Hamdane and colleagues (Bou-Nader et al., 2018). Even though the 
crystal was incomplete, it was concluded that E. coli DusB adopted the same overall 
structure with an N-terminal TIM barrel fold carrying the catalytic function and a C-
terminal helical domain. The tRNA docking in DusB was similar to the one of DusC, 
which makes sense since DusB and C modify neighboring nucleotides (17 and 16). 
However, a major difference between DusB and C relied on the positioning of the 
nucleobase into the catalytic center. Reversed polar and nonpolar amino acids in the 
catalytic pocket of DusB led to the nucleobase rotation (180°C) that is targeted for 
reduction. In conclusion, diversification of bacterial Dus specificities was made 
possible through two astonishing strategies; nucleobase rotation or tRNA docking 
rotation (Fig. 8). 
 
The only available eukaryotic Dus structure is the human DUS2. hDUS2 is 
particularly important because it is associated with pulmonary carcinogenesis and, 
unlike other Dus enzymes, harbors a dsRBD (see Introduction III.C.i.c.). This domain 
turns out to be conserved in animals (mammals, amphibia, flatworms, nematodes, 
insects) (Kasprzak et al., 2012). The sequence similarity is quite low between hDUS2 
and bacterial Dus or even yeast Dus2, suggesting a potential novel strategy for the 
substrate recognition (Griffiths et al., 2012). The analogy between bacterial Dus and 
hDUS2 includes; (i) an N-terminal catalytic domain folded in a TIM barrel, (ii) an 
interaction of the catalytic domain with FMN, (iii) a high sequence conservation of the 
residues required in the active site – including the cysteine as an H- donor and (iv) the 
presence of a helical domain (but not C-terminal). The dsRBD domain was shown to 
be necessary but not sufficient for D20 synthesis on yeast tRNA extracted from a ∆dus2 
_________________________________________________________________________________________________
Figure 8 – Molecular strategies of bacterial Dus enzymes for substrate specificities. On the left, interaction of the U
nucleobase (in the context of the RNA chain (R)) with Dus amino acids (orange: F for Phe, N for Asn, K for Lys and Y for
Tyr) through ionic (blue lines) or hydrophobic (purple lines) interactions. In the DusB catalytic pocket, the rotation of the U
nucleobase (180°) is observed in comparison to the DusA and C counterparts. On the right, schematic representations of
the Dus enzymes (orange line) with the N-terminal nucleobase-containing catalytic domain (round) and the C-terminal
RNA binding domain (rectangle). The tRNA (gray line) docking is similar in DusB and C but differs by a rotation (160°) in



















































strain. Furthermore, this domain was suggested to serve as primary tRNA binding site, 
before the canonical helical domain (Bou-Nader et al., 2015). Using a dsRBD for tRNA 
recognition was never reported before, making hDUS2 the only known tRNA modifying 
enzyme to adopt this strategy. 
vii. D and viruses? 
Some viral genome-encoded tRNAs were shown to be dihydrouridylated on 
positions D16, D17, D20, D20a and/or D47 (Machnicka et al., 2014).  
 
Tymoviruses are plant viruses (e.g. turnip yellow and eggplant mosaic viruses) 
and are known to adopt a noncanonical 3’-structure on their genomic RNAs, called 
TLS for tRNA-like structure (Rietveld et al., 1982). Despite the tRNA-like conformation 
with a D-loop/T-loop interaction, no dihydrouridylation was reported on these special 
structures (Becker et al., 1998; de Smit et al., 2002).  
 
IV. THE DAWN OF A NEW ERA: EPITRANSCRIPTOMICS 
Unlike the dihydrouridine-related works, the epitranscriptomic investigations 
have been recently and extensively reviewed (Harvey et al., 2017; Helm and Motorin, 
2017; Kadumuri and Janga, 2018; Li et al., 2016b; Roundtree et al., 2017; Schaefer et 
al., 2017). The goal of this section is not to provide a comprehensive summary of the 
epitranscriptomic studies and breakthroughs, but mostly to introduce the main insights 
that are necessary to understand the concepts presented in this thesis. 
A. Epitranscriptome? 
[…] our understanding of an additional regulatory layer of biology that rests 
between DNA and proteins is still in its infancy; namely, the multitude of RNA 
modifications that together constitute the ‘Epitranscriptome’.  
 
(Saletore et al., 2012) 
i. Definition 
In 2012, the word epitranscriptome was used for the first time in a Cell resource 
(Meyer et al., 2012). The idea is that the complete catalogue of RNAs present in a cell 
at a specific moment (transcriptome) is far more than a set of polyribonucleotides made 
of A, U, G and C. There are, on these building blocks (epi-), a hidden layer of 
modifications that all together account for the epitranscriptome. 
 
The idea of an epitranscriptomic world is conceptually similar to the epigenome 
(DNA modifications) and to the epiproteome (set of posttranslational modifications). 
But it is not revolutionary because; (i) RNA modifications have been known for 60 years 
(Davis and Allen, 1957) and (ii) the notion of a new type of biological regulation through 
the widespread distribution of RNA modifications had already been discussed (He, 
2010). The scientific revolution lies on the possibility that the epitranscriptome; (i) is 
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dynamic and thus even more biologically relevant and (ii) is biotechnologically 
accessible, not only for one or two RNA species but at the omics scale. 
 
An epitranscriptomic analysis is therefore defined as a transcriptome-wide 
mapping of an RNA modification of interest. In ten years (or less), an epitranscriptomic 
study will potentially be described as a transcriptome-wide mapping of several (all?) 
RNA modifications in a single experiment. 
 
The Japanese expert Suzuki said “in the next ten years, I predict that the 
mapping accuracy of RNA modifications will improve, to the extent that it will become 
possible for researchers – irrespective of their discipline – to easily access databases 
containing up-to-date information on RNA modifications” ((Frye et al., 2016), p. 371). 
ii. Epitranscriptomic studies 
Understanding the functionality of RNA modifications is a hot topic in modern 
biology. To help unraveling these roles, the question what for? is not sufficient and 
needs to be supplemented with the question where?. Where are localized the RNA 
modifications on a transcriptome, and why? 
 
To date, less than ten modifications have been studied at the epitranscriptomic 
level; m6A, m6Am, m5C, hm5C, y, m1A and 2’-O-Me (reviewed in (Kadumuri and Janga, 
2018)).  
 
Besides the classic epitranscriptomic marks, there are other RNA modifications 
that are described at the transcriptomic scale. The internal inosine (I) modification was 
also identified in transcriptomic analyses either by comparing the DNA and RNA 
sequences (I is an A modification but is read as a G), or after chemical erasing by 
cyanoethylation (how a chemical treatment leads to PTM mapping is explained 
thereafter) (Li et al., 2009; Sakurai et al., 2010). The 5’-end modifications are other 
well-described and widely distributed modifications like the m7Gppp cap on eukaryotic 
mRNAs. The first and second nucleotides that follow this conserved 5’-cap are often 
modified as well (sugar methylations and possible nucleobase methylation on the first 
nucleotide if it is an A) (Meyer and Jaffrey, 2014). In Bacteria, a novel 5’-structure was 
recently shown to have a widespread occurrence on small regulatory RNAs and some 
mRNAs. The covalently bound NAD cofactor (Fig. 3E) is dynamic and stabilizes 
targeted RNAs (Cahova et al., 2015). 
B. Overview of the techniques 
The major limitation of SBS [sequencing-by-synthesis] is that DNA 
polymerases are relatively blind to almost all DNA and RNA modifications […]. 
 
(Novoa et al., 2017) 
i. Introduction 
The direct sequencing of RNA molecules is still in its infancy and needs 
extensive improvements to become a reliable tool. The detection of RNA modifications 
is currently relying on the synthesis of a complementary DNA (cDNA) from any RNA 
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template that is – or not – decorated with chemical modifications. DNA is then 
sequenced using complementary fluorescent deoxyribonucleotides that are detected 
by an optical instrument. However, reverse transcription reactions (RNA à DNA) are 
usually insensitive to most RNA modifications. If not, discrimination between false 
positive and true positive hits is a painful task because the reverse transcription (RT) 
stops at multiple and non-relevant sites. 
 
The transcriptome-wide mappings of PTMs are mostly achieved by 
implementation of antibody- or chemical-based techniques (subpoints ii. and iii.).  
ii. Antibody-based epitranscriptomics 
Monoclonal or polyclonal antibodies are obtained by the immunization of an 
animal and the targeted epitopes can be RNA modifications. Nevertheless, the 
production of reliable and highly specific antibodies against a modification of interest 
is burdensome, although efforts are made to expand the repertoire of antibodies 
(Feederle and Schepers, 2017; Novoa et al., 2017). 
 
The antibody-based epitranscriptomics consists of the immunoprecipitation of 
RNAs that carry an RNA modification of interest. This protocol was first used in 2012 
by two independent teams to map m6A residues on mammalian transcriptomes 
(Dominissini et al., 2012; Meyer et al., 2012). RNA was extracted, randomly 
fragmented and then incubated with an anti-m6A antibody. After immunoprecipitation 
(IP) of the methylated fragments, RNA was retro-transcribed into cDNA and the DNA 
library was prepared for next-generation sequencing (NGS) (Fig. 9A). The frequency 
of sequenced reads on and around a genomic position permitted the localization of 
m6A residues. The subsequent bioinformatic analyses generated m6A-peaks that 
represented the transcriptomic windows in which one or more methylated residues 
were found (Fig. 9B). This method was therefore not a single-nucleotide mapping 
because the resolution hovered around 200nt. However, the crosslinking-assisted 
sequencings enabled to narrow this quite large window to 23nt with PA-m6A-seq and 
to the single-nucleotide resolution with miCLIP (Chen et al., 2015; Linder et al., 2015). 
PA-m6A-seq stands for photocrosslinking-assisted m6A-sequencing and includes a 
primary growth step with a uridine derivative (4-thiouridine), therefore allowing the 
crosslinking of the anti-m6A antibody during the IP with fragmented RNA. This results 
in a decrease of the m6A peak width along with an increase of the resolution around 
the putative methylated site (Chen et al., 2015). The miCLIP – m6A individual-
nucleotide-resolution cross-linking and immunoprecipitation – experimental pipeline 
also includes a crosslinking step but does not involve a uridine derivative. Here, the 
crosslinked anti-m6A antibody is digested by a protease after the IP and leaves a trace 
that is detectable by sequencing. Because the trace takes place at a specific site (next 
to the modified residue), the mapping allows a single-nucleotide resolution (Linder et 
al., 2015). 
 
The improvement of the antibody-based detection of m6A also relies on a 
quantitative approach called m6A-LAIC-seq for m6A-level and isoform-characterization 
sequencing. For each sample, three sub-samples are sequenced; (i) the input RNA 
before IP, (ii) the supernatant harvested after IP and (iii) the immunoprecipitated 




Figure 9 – Epitranscriptomics-related concepts. (A)
Prinicple of immunoprecipiation (IP) of methylated RNA
and subsequent DNA library preparation (m6A-seq;
Dominissini et al., 2012). (B) Enrichment of sequencing
reads that correspond to m6A-carrying RNAs and
subsequent determination of a peak (purple) for the
localization of the methylated adenosine (MeRIP-seq for
m6A-specific methylated RNA immunoprecipitation with
next-generation sequencing; Meyer et al., 2012). (C) RT
signature due to abortive reverse transcription after
chemical treatment of a y-carrying RNA (Helm and
Motorin, 2017). (D) y nucleobase is chemically modified
by CMC after CMC and alkaline reactions (Song and Yi,
2017). (E) y marked with CMC results in RT termination
one nucleotide downstream of y-CMC, as shown in Fig.
9C. The last retro-transcribed nucleotide is virtually not y,
but N (A, U, G or C). The cDNA 3’-end sequence
therefore indicates where RT was blocked. (F)
Mispriming of the RT primer for cDNA production can
lead to the misinterpreation of a modification of interest

















precisely the stoichiometry of the modification for each mapped position (Molinie et al., 
2016). 
 
The immunoprecipitation-sequencing pipeline was applied to other RNA 
methylations; m5C, hm5C, m1A and m6Am (Delatte et al., 2016; Dominissini et al., 2016; 
Edelheit et al., 2013; Li et al., 2016a; Linder et al., 2015).  
iii. Chemical-based epitranscriptomics 
The chemical-based epitranscriptomic approach relies on the abortion of an RT 
reaction at a specific position, similarly to the concept of primer extension (Fig. S2), 
which was originally used to determine the 5’-end of a transcript. Reverse 
transcriptases (RTases) are RNA-dependent DNA polymerases that cannot produce 
DNA from any RNA template. The structural identity of the ribonucleic acid is indeed 
essential and impairments of the normal RNA architecture can lead to 
misincorporations into the DNA sequence, RTase pausing or even RT termination (Fig. 
9C). 
 
An RNA modification that strongly impairs the Watson-Crick interactions leaves 
RT scars, changes the cDNA sequence compared to the genomic information and is 
thus detected by sequencing (e.g. inosine) (Sakurai et al., 2010).  
 
Most RNA modifications do not impair RT by themselves; a specific chemical 
reagent that modifies the modification is needed. For example, the two-step chemical 
treatment (CMC + OH-) specifically labels y (Fig. 9D) (Song and Yi, 2017). The RTase 
does not process this heavily modified nucleobase, is blocked and thus leaves a 
truncated polymer. The cDNA 3’-nucleotide corresponds to the nucleotide downstream 
of the y residue (Fig. 9E). The epitranscriptomic mapping of y was performed by the 
implementation of the (CMC + OH-) treatment, cDNA production and sequencing in the 
so-called y-seq, PSI-seq and Pseudo-seq experiments (Carlile et al., 2014; Lovejoy et 
al., 2014; Schwartz et al., 2014). The pipelines of these three concomitantly published 
studies were very similar and only differed in the preparation of the library for 
subsequent sequencing, in the controls and in the criteria used to call a 
pseudouridylated site. 
 
Important note: the same nomenclature will be used throughout the manuscript and needs to be 
clearly indicated. When an RT termination is caused by the chemical labeling of an RNA modification 
at a position N, the RT-stop site is considered as the downstream nucleotide (N+1 or 3’-neighbor of 
the modification). The RNA sequence point-of-view is always taken into account. It also means that 
the modified residue is found one nucleotide upstream of the RT-stop site, because the cDNA point-
of-view is never considered here. In other words, the cDNA 3’-end (or last retro-transcribed 
nucleotide) corresponds to the N+1 position of the RNA sequence and is described here as being 
downstream of the modified position. In conclusion, we consider that RT termination occurs one 
nucleotide downstream of the RNA modification.                    
 
RNA sequence: 5’ - Nmodification - N+1RT-stop site - 3’ 
Nmodification   = upstream of the RT-stop site 
N+1RT-stop site = downstream of the modification  
 
The use of a chemical reagent does not necessarily result in RT arrest; (i) after 
bisulfite treatment, cytidines are converted to uridines, whereas the m5C residues 
remain unaffected. Deep sequencing reveals these differences for m5C mapping 
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(Schaefer et al., 2009); (ii) after mild alkaline treatment, the RNA chain is partially 
cleaved but less significantly at 3’-phosphodiester bonds of 2’-O-methylated 
nucleotides because they are more resistant to a nucleophilic attack. A consequence 
of this protection is that the position +1 to the methylated residue is virtually never 
found at the 5’-end of fragmented RNA. The nucleotides that are under-represented at 
the 5’-ends are then detected by a lack of signal in deep sequencing. Differential RNA 
cleavage profiles are therefore analyzed in the epitranscriptomic approach called 
RiboMethSeq (Birkedal et al., 2015; Marchand et al., 2016). 
 
Yet to be applied specific chemical reactions followed by high-throughput 
sequencing exist and the implementation of one of them is the purpose of this work 
(Behm-Ansmant et al., 2011; Helm and Motorin, 2017).  
C. Concerns about the epitranscriptomic studies 
[…] mapping results have been fundamentally challenged, raising doubts 
about the integrity of the field.  
 
(Grozhik and Jaffrey, 2018) 
 
The reliability of the epitranscriptomic investigations has recently been 
questioned in several issues (Grozhik and Jaffrey, 2018; Helm and Motorin, 2017; 
Schwartz and Motorin, 2017). First, the seminal antibody-based mappings of m6A used 
an antibody that was not fully specific for the modification of interest, resulting in 
detection of false-positive hits (Linder et al., 2015). Then, three examples have puzzled 
the scientific community about the main conclusions on transcriptome-wide studies. 
i. m1A: from 7,000 to 15 sites 
In 2016, 7,154 transcriptomic positions were assigned as m1A RNA 
modifications in mammals and m1A was shown to be a prevalent dynamic internal 
mRNA modification in the fission yeast (Dominissini et al., 2016; Li et al., 2016a). One 
year later, Schwartz and colleagues drastically improved the protocol, reported only 
fifteen m1A-sites on the human transcriptome and revealed that the methylation of the 
mitochondrial ND5 mRNA was developmentally regulated (Safra et al., 2017). The 
marked discrepancy (up to 500-fold) between the published epitranscriptomic profiles 
relies on the fact that the last study utilized not only one RT signature (truncated cDNA 
– Li et al., 2016a – or misincorporation at m1A sites – Dominissini et al., 2016) but 
combine both experimental procedures to reliably detect m1A residues.  
ii. 2’-O-Me: the mispriming artifact 
Whereas RiboMethSeq relies on the lack of signal at 5’-ends of RNAs after 
alkaline treatment (5’-Nm-N+1-... and not 5’-N+1-…) to map ribose methylation (see 
Introduction IV.B.iii), the detection of a positive signal has also been used in Nm-seq 
(or 2’-O-methylation-sequencing) (Dai et al., 2017). In this case, the periodate 
oxidation is used to specifically protect 2’-O-methylated nucleotides from digestion in 
the 3’-to-5’ direction. As a consequence, the 3’-end nucleotide is more likely to carry a 
2’-O-Me. The precise determination of the RNA 3’-termini is thus essential for proper 
sugar methylation mapping. To do so; (i) an adapter is ligated to the 3’-end of RNA 
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fragments, (ii) the RT primer is annealed to the adapter and (iii) the first retro-
transcribed nucleotide corresponds to the 3’-end nucleotide of the RNA fragment 
which, in this case, is expected to be 2’-O-methylated. Mispriming of the RT primer 
would thus be dramatic for the correct mapping of modified riboses (Fig. 9F). This 
mispriming artifact is likely to have occurred in the work cited above according to the 
American expert Jaffrey who highlighted the fact that the consensus sequence of 2’-
O-Me was highly similar to the sequence of the 3’-adapter (Grozhik and Jaffrey, 2018). 
iii. m5C: challenging the chemical reaction effectiveness  
m5C detection is based on the fact that it is insensitive to bisulfite reaction (see 
Introduction IV.B.iii). Although it is a true statement, it is not sufficient to overcome two 
major technical boundaries that created concerns about the m5C epitranscriptomic 
reports; (i) other RNA modifications may be resistant to this specific treatment (e.g. N4-
methylcytidine) (Squires et al., 2012) and (ii) all cytidines are not converted to U after 
the bisulfite reaction. Even if only 0.2% of C are not converted, it can represent up to 
20,000 incorrect modification callings in a transcriptome containing 10 millions of 
cytidines (Helm and Motorin, 2017). 
iv. Short conclusion 
The few epitranscriptomic-associated pitfalls presented in this section highlight 
the necessity to find strategies, controls and validations in order to enhance the true 













(Schaefer et al., 2017) 
 
D is a universal RNA modification whose abundance is not equally distributed 
across domains of life. Such a conserved modification is not common in the world of 
posttranscriptional modifications and is therefore of high interest. Furthermore, the 
gene coding for the ancestral dihydrouridine synthase was duplicated – up to three 
times in Eukarya – throughout the story life, suggesting a beneficial role for the global 
fitness of living organisms. 
 
The apparent complete lack of dihydrouridine was achieved by genetic 
manipulation of two unicellular model organisms; the bacterium Escherichia coli and 
the fungus Saccharomyces cerevisiae. The loss of this RNA modification did not result 
in any obvious phenotype, as it is often the case when playing with RNA modification 
enzymes. Nevertheless, structural biologists provided insightful evidence indicating 
that the dihydrouridine strongly impacts the molecular thermodynamic equilibrium and 
brings flexibility to ribonucleic acids by promoting uncommon nucleotide 
conformations. In agreement with these observations, microbiologists detected a high 
prevalence of dihydrouridine in psychrophilic prokaryotes, but not in thermophilic 
archaea, providing a first clue to unravel the physiological role of this RNA modification. 
 
However, a set of intriguing and still elusive facts about dihydrouridine and its 
cognate enzymes shed light to the importance of investigating the biological relevance 
of this modification; overexpression of Dus2 in pulmonary carcinogenesis, potential 
role of DusA in bacterial adherence, interaction of Dus3 with polyA-RNAs in 
cardiomyocytes, subtle role of a dihydrouridylated position on bacterial rRNA, etc. 
 
The cutting-edge technologies such as the next-generation sequencing opened 
the door to the birth of an exciting field in molecular biology; the epitranscriptomics. By 
the implementation of epitranscriptomic layouts, the profiles of transcriptomic marks 
became accessible. Despite this novel available biotechnology, many technical 
challenges have yet to be overcome; this is reflected by the fact that less than 5% of 
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the currently known RNA modifications have been studied at the epitranscriptomic 
level. 
 
We aim at setting up an easy-to-use and reliable technology in order to study 
the transcriptomic distribution of dihydrouridines. Our goal is to provide a powerful 
technique to bring new insights about the physiological relevance of D residues. 
Unbiased approach – such as an epitranscriptomic profiling – is essential to unravel 
the putative biological function of dihydrouridine beyond transfer RNAs. Our purpose 
is also to apply this approach to different model organisms to widen our conclusions 
with a phylogenetic point-of-view. 
 
Our interest on dihydrouridine results – as always in science – from a completely 
different research story. By studying the role of a long noncoding RNA in fission yeast 
(Fauquenoy et al., 2018), we detected Dus2 as an interacting partner of this RNA in a 
pull-down assay (unpublished data). We therefore hypothesized that a dihydrouridine-
dependent regulation acted on this lncRNA. But to decipher this potential mechanism, 
we first needed an answer to the question where does the dihydrouridylation occur?  
 
In summary, the epitranscriptomics is an on-hand resource and should therefore 



























Dihydrouridine is fluorescently-labeled with rhodamine. 
A D-specific chemical reaction was used to detect the presence of D residues 
on RNA. In a two-step protocol, total RNA was first incubated with sodium borohydride 
(NaBH4) and then covalently bound by the rhodamine stable fluorophore (Rho) (Fig. 
6). Uridines are NaBH4-insensitive and were thus not bound by the fluorophore. We 
used rhodamine labeling (Rho labeling) for the specific detection of D in two 
experimental layouts; (i) R+ (NaBH4 + Rho) and (ii) mock or R- (KOH + Rho). Dot blot 
assays revealed that RNA-Rho wass readily detectable at 520nm and that Rho did not 
aspecifically bind RNA in mock-treated samples. Moreover, we generated a quadruple 
mutant for the four putative dihydrouridine synthases (Dus) in fission yeast (∆dus1-2-
3-4 or ∆4). R+ labeling on total RNA from ∆4 showed a decreased signal intensity 
compared to WT RNA (Fig. 10A). The remaining signal in ∆4 demonstrated that D was 
not the only RNA modification to be labeled by Rho, as already shown by others (see 
Discussion and Perspectives). This observation was confirmed by electrophoresis of 
R+ and mock-treated RNAs and subsequent fluorescent detection (Fig. 10B). rRNAs 
were undeniably labeled although D was never reported as a eukaryotic rRNA 
modification, indicated the targeting of other RNA modifications by R+ treatment. 
Moreover, the rRNA was also labeled in a ∆4 R+ background, suggesting a D-
independent signal. Nevertheless, no fluorescence was observed in R- samples, 
demonstrating that Rho binding and detection are not due to secondary structures. 
Strikingly, a sharp decrease of Rho signal was observed on ∆4 R+ tRNAs, as expected. 
Finally, the methylene blue staining used as a loading control revealed a partial 
degradation of both R+ and R- RNAs, as confirmed by microchip analysis (Fig. S5).  
 
These data outline a D-dependent but not D-exclusive Rho labeling of RNA. 
Working with a quadruple dus mutant is thus required to discriminate between D-
dependent and D-independent signals in WT R+ total RNA. 
Dihydrouridine is mapped at the single-nucleotide resolution. 
A primer extension assay was performed on tRNAiMet to test Rho labeling on the 
known D16 position, putatively Dus1-dependent. The reverse transcription reaction 
(RT) on WT R+ RNA generated a 30nt-long radioactively labeled polynucleotide 
corresponding to the occurrence of RT termination one nucleotide downstream of D16. 
WT R- and more importantly ∆dus1 R+ and R- RNAs were devoid of the 30nt-
polynucleotide (Fig. 10C). The in vitro dihydrouridylation on ∆dus1 RNA with GST-
purified Dus1 (but not Dus2 and Dus4, that were shown to be catalytically active in 
other assays) restored the RT termination downstream of D16. Combining fission yeast-
∆dus1 RNA and budding yeast-Dus1 protein also resulted in the restoration of RT 
arrest (Fig. 10D). The primer extension assay performed on a putative Dus2 tRNA 
target led to the same conclusions (Fig. 10E). 
 
An in vitro transcribed synthetic RNA was then used to confirm RT termination 
one nucleotide downstream of a D residue (Fig. 10F). The DNA sequence possessed 
a unique T and the T7-dependent in vitro transcription was performed with uridine or 
commercially available dihydrouridine. The resulting U-containing or D-containing 
(A)
_________________________________________________________________________________________________
Figure 10 – Single-nucleotide detection of dihydrouridine (D) by rhodamine labeling. (A) Comparative Rho
(rhodamine) detection at 520nm on WT (wild type) and ∆4 (∆dus1-2-3-4) total RNAs in R+ and mock-treated (R-) samples.
The intensity of a Rho drop is scaled at 100%, a drop of water is considered as the background, methylene blue staining
serves as loading control, n = 3, error bars represent SEM. (B) Fluorescent Northern blotting of WT and ∆4 total RNAs in
R+ and mock-treated samples. Untreated total RNA from WT strain is shown in lane 3. Representative result from a
biological triplicate, methylene blue staining serves as loading control. (C-D-E) Primer extension assays performed on
total RNAs from WT, single dus (∆dus1, ∆dus2), triple dus (∆dus1-3-4, ∆dus2-3-4) or quadruple dus (∆4) mutant strains,
R+ or R- treated. Before the chemical reaction, in vitro dihydrouridylations are performed with S. pombe GST-purified
proteins (+ Dus1, 2 or 4), S. cerevisiae GST-purified Dus1 (+ Sc Dus1) or no protein (+ buffer) on S. pombe total RNA
from different genetic backgrounds. The ladder consists of 32P-labeled DNA oligonucleotides ranging from 15 to 60 nt. (C-
D) primer specific for tRNAiMet, (E) primer specific for tRNAAspGUC. (F) Primer extension assay performed on an in vitro
transcribed RNA mixed with S. pombe total RNA. In green, decreasing amount of dihydrouridylated and increasing


































































































































































































































































RNAs were mixed in different proportions, R+ labeled and retro-transcribed. The 
presence of D was absolutely essential to generate RT termination one nucleotide 
downstream of the modified residue in R+ conditions. The synthesis of a synthetic RNA 
with three consecutive D generated a strong RT arrest downstream of the third 
dihydrouridylated site in the R+ condition (Fig. S6). This effect was dissipated for the 
following modified residues. Interestingly, a sharp RT termination was observed after 
the three D when they were unlabeled, strengthening the idea that the D modification 
itself can disturb the reverse transcriptase, and even more in a D-rich context. 
 
Altogether, these data show that R+ labeling allows the single-nucleotide 
mapping of D. Moreover, Dus enzymes specificities on tRNAs (Fig. 7A) seem to be 
conserved in fission yeast. 
Transcriptome-wide mapping of D by dihydrouridine-sequencing. 
We developed D-seq (dihydrouridine-sequencing) to map D across the 
transcriptome. The protocol was performed as follows; (i) RNA extraction from WT and 
∆4 strains, (ii) R+ and mock-treatments, (iii) ribodepletion, (iv) cDNA synthesis and 
library preparation, (v) strand-specific deep-sequencing, (vi) data analysis by 
implementation of a multifactorial analysis (Fig. 11A). 
 
The classic library preparation for RNA sequencing does not fit with the purpose 
of D-seq due to the lack of RT termination location. We therefore implemented an RNA 





























Figure 11 – Transcriptome-wide mapping of D by dihydrouridine-sequencing (D-seq). (A) D-seq general pipeline
starting with total RNA (in this case originating from WT and ∆4 yeast strains) and leading to the detection of RT
termination events (red; WT R+ or test condition) or not (gray; WT R-, ∆4 R+, ∆4 R- or control conditions). (B) Comparison
of library preparation strategies from a hypothetical RNA molecule (black line) carrying a Rho-labeled D residue upstream
of a nucleotide N (A, U, G or C). In both cases, the blue arrows indicate the DNA primers used for the production of cDNA
(orange dashed lines) by reverse transcription (RT). The vertical black dashed lines represent RT-stop sites, positions at
which the RTase is blocked. The RT premature termination signatures on cDNA 3’-ends are indicated with red
strikethrough circles. On the left (classic Illumina preparation), the synthesis of the second DNA strand relies on the
enzymatic digestion of the RNA template to form oligoribonucleotides that will act as primers for the cDNA-dependent
DNA synthesis. As indicated in the cartoon, this step leads to the loss of the cDNA 3’-end localization information. On the
right (D-seq preparation), a 3’-end blocked RNA adapter (green line, ddC stands for dideoxycytidine) is ligated to the RNA
of interest and is used for hybridization of a non-random RT primer. After the cDNA production, a second ligation is
performed by addition of a 3’-end blocked DNA adapter (purple line) allowing the imprisonment of the cDNA 3’-end for
subsequent determination of its precise positioning (corresponding to the position where the RTase was blocked). The
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We then based our analysis on the y-seq two-metric system and improved it to 
map positions at which the RTase signal dropped off in a D-dependent manner during 
cDNA synthesis. After the mapping of the reads on the genome, we compared the 
coverage of each position in the four sequenced conditions, that is to say WT R+, WT 
R-, ∆4 R+ and ∆4 R-. The test condition will always refer to the WT R+ condition 
whereas the control conditions encompass the three WT R-, ∆4 R+ and ∆4 R- 
conditions.  
 
Our hypothesis was based on the fact that a portion of RT-stop sites 
(corresponding to the cDNA 3’-end nucleotides) should be downstream nucleotides of 
a D position in the test condition but not in the control conditions. Our goal was 
therefore to find the RT-stop sites that are specific to the test condition (meaning that 
they are labeling- and dus-dependent) to extrapolate about the positioning of an 
upstream D position.  
 
A multifactorial analysis was performed to determine a nucleotide as an RT-stop 
site (Fig. 12); (i) a pre-filtering analysis with the calculation of an average D-ratio that 
was defined as the proportion of reads attesting RT termination out of all reads 
overlapping the position of interest. A minimum standard deviation of this ratio is 
required to ensure that all values were not similar; (ii) a statistical analysis to assess 
the interaction between test and control conditions and (iii) a post-filtering calculation 
of a D-fold change (D-fc) that was the logarithmic transformation of D-ratio by 
comparing the test (where an RT termination was expected) and the control (where an 
RT termination was not expected) conditions. This three-step analysis resulted in a 
high confidence determination of D-dependent RT-stop sites for which the upstream 
nucleotide (with the RNA sequence point-of-view) was considered as a 
dihydrouridylated position (D-site). The D-site was thus defined as a putative 
dihydrouridine. In summary, our bioinformatic pipeline included; (i) the positioning of 
labeling- and dus-dependent RT-stop sites, reflecting the single-nucleotide resolution 
of RT termination events in the WT R+ condition, and (ii) the mapping of D-sites that 
were located upstream of the RT-stop site. 
 
To test the ability of Rho labeling to cause RT termination one nucleotide 
downstream of a labeled D in a deep sequencing context, a synthetic spike-in RNA 
was added to the samples (the same as used in Fig. 10F). The single D of the in vitro 
transcript generated an RT-stop site one base downstream of the modified base in an 
R+ sample (D-ratio 17.5%), but not in a mock-treated RNA (D-ratio 1.0%) (Fig. 13A 
and B). Importantly, an un-dihydrouridylated spike-in (carrying a single U) displayed a 
D-ratio of only 0.1% at the potential RT-stop site in both labeling conditions (Fig. 13C 
and D). Mixed populations of U and D spike-ins in R+ samples revealed a high 
correlation (R2 = 0.94) between the RT-stop site D-ratios and known stoichiometries of 
D (from 0 to 100%) (Fig. 13E), but not in R- treated conditions (Fig. S7). It is noteworthy 
that a fully dihydrouridylated transcript (100% of D spike-in) induced an RT termination 
for only one out of five RT reactions (D-ratio ~ 20%), giving an important insight about 
the stoichiometry of coupling Rho labeling and sequencing. It indicated the limitation 
of one or several steps of the protocol, such as partial NaBH4 reduction of D, partial 
Rho incorporation and/or ability of the RTase to overcome a rhodaminized residue. 
However, a D-ratio of 20% was more than enough to discriminate actual RT 
termination from the general background. Importantly, misincorporation by the RTase 
_________________________________________________________________________________________________
Figure 12 – D-seq analytical pipeline. The D-seq analysis is divided into three main sub-categories; (i) a pre-filtering
analysis consists of an independent determination of reads supporting RT termination (red lines) out of all reads (red +
green lines) overlapping the position of interest (N). This value is called the D-ratio and is calculated for all conditions. A
mean D-ratio is obtained for each position of the transcriptome. Asterik notifies that there are basically eight (not four) D-
ratios that are included in the mean D-ratio (4 conditions x 2 replicates). The pre-filtering also includes other features that
are detailed in the shaded frame, (ii) the statistical analysis aims at answering to the question of RT termination
occurrence significativity in the test condition (WT R+) compared to the control conditions (WT R-, ∆4 R+ and ∆4 R-). To
test whether the potential increase of RT stop events in the test condition is strain- and labeling-dependent, an interaction
coefficient is calculated. Because it is expected to have more RT arrests in WT R+ (> 0), a one-sided Wald test is thus
performed and the resulting p-value is corrected to FDR (false discovery rate), (iii) the post-filtering analysis compares
test and control conditions through a logarithmic transformation of the D-ratios. A minimum D-fc (fold change > 2) ensures
that the mean D-ratio of the WT R+ is at least four times bigger than the mean of all control D-ratios.
pre-filtering 
• minimum mean of the coverage (> 50)
• minimum mean D-ratio (> 1.8%, see Fig. 13F)
• minimum D-ratio standard deviation (> 0.02)
• RT-stop site (N) upstream nucleotide = U 
statistical analysis





strain + labeling + strain:labeling
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for each position of the transcriptome (genome);
= = 28.5%
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Figure 13 – Evaluation of the relative dihydrouridylation stoichiometry . (A-B-C-D) Evolution of the D-ratio (%,
orange) along the synthetic RNA. Spike-in was mixed with total RNA before R labeling and deep sequencing. Coverage is
shown in blue. (A) The D spike-in in the R+ reaction generated a high D-ratio one nucleotide downstream (position 45) of
the unique D present in the sequence (position 44). (B) The D spike-in in a mock reaction did not result in RT termination
neither at the position 45 nor at the position 44. (C-D) The U spike-in was free of RT arrest around the unique U of the
sequence in both chemical reactions. (E) The D-ratio of the spike-in position 45 gradually increased along with D:U
content in R+ condition. 100% means that all spike-in RNAs added to the sample carried a single D whereas 0%
corresponds to a U spike-in. Correlation coefficient (R2) close to 1 indicates a correlation between the parameters
displayed in the chart. (F) Determination of a mean D-ratio threshold for the D-seq analysis (Fig. 12). When half of the
spike-in RNAs are dihydrouridylated, RT termination at position 45 occurred for 7.2% of the reads in the R+ condition. This


















































































































































































Control conditions Virtual D-ratio
WT R- 0%
∆4 R+ 0%
∆4 R- 0% 
virtual mean D-ratio 
= (7.2 + 0  + 0 + 0)/4 = 1.8%













(of a C, G or T) at the D position was not observed within the 80% of cDNAs that did 
not stop downstream of the dihydrouridine (data not shown).  
 
Because a 50:50 proportion of D:U spike-in in R+ condition led to a D-ratio of 
7.2% one base downstream of the D/U position, we hypothesized that a transcriptomic 
position that is dihydrouridylated in 50% of the molecules should have a mean D-ratio 
of 1.8% (Fig. 13F). We chose this value as a requirement to consider a position as a 
D in the pre-filtering analysis (Fig. 12). 
 
Ability of D-seq to map dihydrouridylated residues is effective at a single-



























D-seq is a reliable tool to detect D positions on yeast tRNAs. 
Taking advantage of the well-described modification profiles of tRNAs, we 
detected 228 D-sites on 141 yeast cytoplasmic (87%) and mitochondrial (13%) tRNAs. 
Two randomly chosen positions were confirmed by primer extension assays (Fig. 
14A). Erasing the condition ‘RT-stop site upstream nucleotide = U’ in the pre-filtering 
analysis (Fig. 12) resulted in the detection of 264 putative D-sites (instead of 228) 
where 86% were U and only 14% were G or A (Fig. S8). However, among these 36 
new candidates (for which the D-site ≠ U), 94.4% had a U at the RT-stop site itself, 
strongly suggesting that the RTase terminated at the dihydrouridylated position rather 
than one nucleotide downstream. In order to avoid complexification of the analysis and 
potential false-positive candidates, we did not take the ‘RT-stop site = D’ scenario into 
account.  
 
In S. pombe, nine D positions have been experimentally reported on tRNAs 
(Keith et al., 1993; McCutchan et al., 1978; Vogeli, 1979; Wong et al., 1979; Zallot et 
al., 2014). The D-seq analysis detected six of them (Fig. 14B). Strikingly, 98.7% of all 
detected D were localized on the D-loop, as expected (Fig. 14C). The two most 
prevalent cytoplasmic tRNA positions highlighted by our method were D16 and D20, 
which is in total agreement with the relative D occurrence in cytoplasmic tRNAs of 
another yeast (Fig. S9) (Xing et al., 2004). It is not surprising that we did not detect 
any D20b or D47 on cytoplasmic tRNAs because they are rare modifications. Moreover, 
D47 is localized near the tRNA 3’-end and a cDNA product that would be terminated at 
D47 would be 20 to 50nt-long, which is a too short fragment to be considered in D-seq 
due to a size selection during the library preparation. 
 
Using a 32nt-long window, no consensus sequence was clearly observed 
around the putative D residues on cytoplasmic tRNAs. As already reported for 
cytoplasmic tRNAs, a GG dinucleotide was enriched upstream of the modification (Fig. 
14D). We reasoned that because Dus enzymes have high substrate specificities, the 
potential consensus sequences should vary with the different targets. No substantial 
differences were highlighted between Dus1 (D16 and 17), Dus2 (D20) and Dus4 (D20a) 
targets, arguing that the installation of D in tRNAs is structure- rather than sequence-





















Figure 14 – D-seq detects D on yeast tRNAs. (A) Primer extension assays performed on R+ total RNAs from WT, single
dus (∆dus1, ∆dus2) and triple dus (∆dus1-3-4, ∆dus2-3-4) mutant strains. D-seq analysis suggested U20 modification on
SPCTRNAASP.06 and U16, 17 and 20 modifications on SPMITTRNAARG.02, that are all confirmed here. Above; primer
specific for tRNAAspGUC, below; primer specific for mitochondrial tRNAArgUCG. (B) List of known D positions and their
cognate tRNAs in S. pombe. Last column indicates the detection of the corresponding position (green V) or not (red cross)
in the D-seq analysis. (C) Distribution of the 228 tRNA D-sites according to their relative position on tRNA. Unlike in Fig.
S9, the D-sites were not manually curated to be assigned to a canonical D-site (D16, 17, 20, 20a or 47). (D) Consensus
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As a proof-of-concept, D-ratios and -fc are shown for tRNAArgUCU (Fig. 15). In 
WT R+ sample, the D-ratio evolution across the tRNA can be dissected into five 
regions (Fig. 15A); (i) near the 5’-end, a sharp increase of D-ratio was attributed to the 
natural termination at the end of the transcript, (ii) two close peaks around positions 8-
9-10, (iii) a striking peak around nucleotides 16-17, (iv) a more modest increase of the 
D-ratio at position 21 and (v) a flat region from nucleotide 30 to the 3’-end, 
corresponding to a zone virtually free of RT termination events. In the control 
conditions (WT R-; ∆4 R+ and ∆4 R-), regions (iii) and (iv) were absent, suggesting 
that they were dus- and labeling-dependent (Fig. 15A). By focusing on region 7-22, it 
is clear that the positions 8, 9 and 10 all had a D-ratio above 10% across all conditions 
(Fig. 15B). Based on the conservation of the eukaryotic tRNAArg modifications, the 
position 9 could be an m1G (a naturally RT blocking modification) and the position 10 
could be an m2G (a naturally RT pausing modification), explaining the increase of the 
D-ratio in a dus- and labeling-independent manner. Burst of the D-ratio at the position 
17, specific to the WT R+ condition, suggested the presence of D16. Moreover, the 
position 16 itself was characterized by an out-of-background peak both in WT R+ and 
R-, supporting the idea of a dihydrouridylated residue at this position that naturally 
paused the RTase. The last peak at position 21 suggested the dihydrouridylation of 
position 20. Finally, D-fc values above the threshold of 2 were found exclusively on 
positions 16, 17 and 21 (Fig. 15C). Altogether, these profiles implied that tRNAArgUCU 
is dihydrouridylated on positions 16 and 20. Implementation of the D-seq pipeline (Fig. 































Figure 15 – D-seq is insensitive to RT termination caused by non-D modifications; proof-of-concept with yeast
tRNAArgUCU. (A-B) D-ratio profiles along the entire tRNA (A) or on a zoomed view (B) in test and control conditions. In (B),
green triangles represent D-sites (D16 and D20) as determined by D-seq, orange triangles represent strong RT termination
events that are not taken into account by the analytical pipeline, error bars represent min and max values from two
biological replicates. (C) D-fold change (D-fc) variation on positions 7 to 22 of SPCTRNAARG.08. The red line highlights
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No D residue was detected on rRNAs, which was in line with the fact that D was 
never described as a eukaryotic rRNA modification. We used a ribodepletion kit that is 
not highly efficient on yeast RNA, which permitted to conclude that the detection of D 
by D-seq was not strictly coverage-dependent (Fig. S11). In parallel, we used rRNA 
sequences to confirm that the RTase was obviously blocked at other transcriptomic 
positions (Fig. 16). The profile of 18S-rRNA in WT R+ exhibited three D-ratio peaks 
(representing RT terminations); (i) probably a structure-dependent arrest, (ii) a peak 
corresponding to the naturally blocking m1acp3y1208 RNA modification and (iii) a peak 
depicting the m7G1616 modification (Fig. 16A). Remarkably, the m1acp3y1208 peak was 
invariable across all conditions (WT R+, WT R-, ∆4 R+ and ∆4 R-) in contrast to the 
situation around m7G1616 (Fig. 16B). The example shown here demonstrates that the 
RT termination also occurred; (i) in a dus- and labeling-independent manner (e.g. 
m1acp3y1208) and (ii) in a dus-independent manner (e.g. m7G1616 that is labeled by 
Rho). These positions were not taken into account in the D-seq analysis. 
 
In conclusion, the high prevalence of D on expected positions of tRNAs and 

































Figure 16 – D-seq is insensitive to RT termination caused by non-D modifications; proof-of-concept with yeast
18S rRNA. (A) D-ratio profiles along the entire 18S rRNA in test and control conditions. The m1acp3y modification (blue)
naturally blocks a reverse transcription reaction. The m7G modification (orange) is sensitive to Rho labeling and therefore
blocked the RTase in R+ conditions. Representative example for SPRRNA.43. (B) Zoomed view on both 18S-m1acp3y1208
(above, the modified site is indicated by a blue triangle) and 18S-m7G1616 (below, the modified position is indicated by an
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Yeast coding sequences are dihydrouridylated. 
Almost 40% of all 372 detected D-sites were not on tRNAs (Fig. 17A). 
Interestingly, we detected 143 D-sites spread across 125 protein-coding genes (pcg) 
and 1 site on a lncRNA (Tables S1 and S2). However, this latter overlaps – at the 
genomic – level with a protein-coding gene that is putatively dihydrouridylated. Most of 
the pcg (87.2%) had a unique putative dihydrouridine on their sequence and only two 
genes (fhn1 and ala1) were found to be modified on at least three distinct positions 
(Fig. 17B). D-seq was however not able to discriminate between single mRNAs and it 
is therefore not possible to know whether fhn1 and ala1 carried the three D on the 
same molecule. Out of the 125 pcg with D, 91 (72.8%) are conserved in vertebrates 
whereas less than 1% is specific of the Schizosaccharomyces genus, suggesting that 
dihydrouridylation occurs on mRNAs with conserved functions (Fig. 17C). Analysis of 
gene list (AnGeLi, see Experimental procedures) did not reveal any obvious enriched 
molecular function or transcript feature for the 125 pcg with D (Fig. S12). We then 
implemented a permutation test in which the conditions were randomly mixed before 
the D-seq analysis (Fig. 12) and compared the number of generated D-sites. As 
expected, the 16 permutation tests gave on average less than 12 D-sites, which was 
far less than the 372 detected D-sites when test and control conditions were correctly 
assigned (Fig. 17D). 
 
Another critical parameter is the stoichiometry of dihydrouridylation. The D-seq 
pipeline does not allow to determine the degree of modification. Notwithstanding this 
lack of information, we compared D-ratio distributions between D found on tRNAs or 
mRNAs and observed a decrease for the latter (Fig. 17E), suggesting that mRNAs are 


























Figure 17 – Yeast protein-coding genes products are dihydrouridylated. (A) Repartition of 372 detected D-sites in
fission yeast on three distinct RNA species; transfer, messenger and long noncoding RNAs. (B) Putatively
dihydrouridylated mRNAs had up to three distinct D-sites on their sequence. ala1 (coding for an alanine-tRNA ligase) and
fhn1 (coding for an eisosome assembly factor) are the two mRNAs dihydrouridylated at three different positions (green
triangles). The CDS (coding DNA sequences) are delimited with black dashed lines. (C) Diverse features of the 125
protein coding-genes whose RNA products were modified. (D) Correct assignment of test and control conditions was
essential in the D-seq analysis pipeline. Sixteen permutation tests were performed in which the properly committed
information 1_WT R+; 2_WT R-; 3_∆4 R+; 4_∆4 R- (blue bar, 372 D-sites) was randomly mixed into, for example, 1_WT
R-; 2_ ∆4 R-; 3_∆4 R+; 4_WT R+ (orange bar, average of 11.9 D-sites, error bars represent max and min numbers of
detected D-sites). (E) Box plot representation of WT R+ D-ratios distribution for tRNAs (228 values) and mRNAs (143
values) and corresponding means highlighted by orange dashed lines (note: this is different from the mean of the D-ratio
as presented in Fig. 12, which summarizes the information from test and control conditions). Blue dashed lines indicate
the D-ratios of R+ D100% spike-in (Fig. 13A) and D50% spike-in (Fig. 13F).
372 putative dihydrouridines 
(S. pombe genome = 12.6 Mbp)
◼ 61% (tRNA, 228 sites, 141 genes)
◼ 38% (mRNA,143 sites, 125 genes)
◼ 0.3% (other, 1 site, 1 lncRNA)
◼ 1 D-site/mRNA (87%)
◼ 2 D-sites/mRNA (11%)













specific to Schizosaccharomyces 0.8
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(E)










































In S. pombe, the coding sequence accounts – on average – for 65.0% of the 
mRNA sequence (including 5’- and 3’-UTRs, CDS and introns). Similarly, 62.4% of all 
U nucleotides of mRNAs are found within the coding sequence. We observed a sharp 
enrichment of D on coding sequences with almost 90% of the detected D-sites on CDS 
(Fig. 18A). Consensus analysis of the 124 sequences with a D localized in a coding 
region revealed a slight propensity for the 5’-DNNNAC-3’ sequence (Fig. 18B). 
Interestingly, D seems to be mostly found within the context of a U-tract in the CDS 
(Fig. 18C). In agreement with this observation, the most represented D-containing 
codon was UUU (Fig. 18D). Among the 124 D-sites found on CDS, the most 
represented codon coded for Leu (Fig. 18E). Leucine is coded by six different codons 
and three of them contain two uridines. For these latter (CUU, UUA and UUG), one 
could suggest that if dihydrouridylation is random, D would be found in 50:50 ratio on 
both U. As shown in Fig. 18F, distribution of D on Leu codons CUU, UUA and UUG 
was uneven, suggesting an active mechanism of modification. Moreover, 33% of D-
sites (41/124) found on CDS were localized on a codon containing a single U whereas 
the probability to find D on a single U-containing codon at the transcriptomic level 
raised to 42% (see Experimental procedures), indicating that the dihydrouridylation 
preferentially occurs on codons with two or three uridines (Fig. 18G). Finally, no D-site 
was detected on ten different single U-containing codons even though they represent 
8% of the coding uridines, and thus account for 8% of the possibilities to get a D-site 
on the yeast coding transcriptome (Fig. S13).  
 
The non-random distribution of dihydrouridine across the transcriptome – and 































































Figure 18 – The yeast coding transcriptome is dihydrouridylated. (A) Enrichment of dihydrouridylation on the coding
sequence of mRNAs. Above; when a mRNA is 100nt-long, the coding sequence is on average 65nt-long in S. pombe,
middle; when there are 100 U residues on a S. pombe mRNA, about 62 of them are on the coding sequence, below; 124
(out of 143) detected D-sites were localized on the CDS. pcg (protein-coding gene). One-sided Fisher’s Exact test; *** p <
0.001. (B) Consensus sequence surrounding the 124 coding D-sites. (C) Residue probabilities around the 124 coding D-
sites. (D) The 124 coding D-sites were found on 27 different codons ranging from one occurrence (for AGD, ADC, ADG,
CCD, CDG and DGG) to fifteen (for DUU, UDU and UUD). (E) The 27 represented codons of Fig. 18D code for 17
different amino acids. (F) Non-random distribution of D-sites on Leu codons containing two U residues. (G) Under-
representation of D-sites on codons containing a single U. One-sided Fisher’s Exact test; * p < 0.05.
mRNA anatomy in S. pombe
U distribution on mRNA
D distribution on mRNA
relative position on mRNAD
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(D) occurrence of D-sites for each codon
e.g. D-seq revealed 15 D-sites on codon UUU
occurrence of amino acids coded









◼ 42.2% of U on the coding transcriptome are on 
single U-containing codons
◼ 33.1% of D-sites on the coding transcriptome 






















U - U - A
50%
◼ D is 5’-nt of the codon (↔ anticodon 36)
◼ D is on central position (↔ anticodon 35)
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p = 1.8 x 10-10
 
45 
Absence of dihydrouridine affects tRNA but not mRNA or protein abundances. 
We compared the transcriptomic profiles of WT and ∆4 strains by RNA-seq to 
assess the role of D on RNA stability. Only a limited set of genes were differentially 
expressed (|fc| > 1.5, FDR < 0.1) (Fig 19A) and no overlap between these genes and 
the putatively dihydrouridylated protein-coding genes was observed. On the contrary, 
hypodihydrouridylated tRNAs were affected by the loss of D and were generally more 
abundant, although not always significantly (Fig. 19B). We confirmed this pattern for 
the D16/D17-containing tRNAPheGAA by Northern blotting, but not for tRNACysGCA for 
which no D-site was isolated by D-seq (Fig. S14). The transcriptomic analysis of a 
dihydrouridine-free strain thus provided experimental evidence to show that D is critical 
to control global tRNA abundance. 
 
Among the 125 dihydrouridylated mRNAs, three out of eight mRNAs encoding 
subunits of the CCT chaperonin complex carried potential dihydrouridines (cct1, cct6 
and cct7). The CCT complex is required for the co-translational folding of a set of 
proteins, including tubulins α (nda2) and β (nda3), whose mRNAs were also putatively 
dihydrouridylated. qRT-PCR analyses suggested a slight decrease – albeit not 
significant (see legend of Fig. 19) – of nda2 and cct1 mRNAs relative abundances in 
a strain lacking D. Other mRNAs that were not D-seq candidates displayed the same 
profile; the control RBP nab3 as well as the CCT targets slp1 (non-cytoskeletal) and 
act1 (cytoskeletal). The 25S rRNA control was unaffected by the loss of D (Fig. 19C). 
Surprisingly, Nda2 and Cct4 proteins were somehow more abundant in the ∆4 strain 
(Fig. 19D). 
 
The transcriptomic analysis and the assessment of protein production in the 
quadruple dus mutant revealed that D does not strikingly impact the putatively 




















Figure 19 – Transcriptomic and protein analyses of the ∆4 mutant. (A) Significantly and differentially expressed genes
revealed by RNA-seq on WT and ∆4 total RNA samples. On the left, list of downregulated genes in the quadruple dus
mutant. On the right, list of upregulated genes in the quadruple dus mutant. logFC stands for log2 (fold change). (B)
Volcano plot highlighting all tRNA genes (red dots) and all other fission yeast transcripts (black dots) mapped in the RNA-
seq experiment. (C) qRT-PCR analyses (∆∆CT method) on D-seq candidates whose protein products are targeted by the
CCT folding complex (green V) or not (red cross), are cytoskeletal proteins (green V) or not (red cross). 25S rRNA is a
noncoding transcript control, nab3 is a coding transcript control, WT expression values (blue) are scaled to 1 (au, arbitrary
units), ∆4 expression mean values are in orange, n = 3, error bars represent SEM, normalization is done on adh1
expression. (D) Relative protein expression of one D-seq candidate (Nda2), two tagged CCT subunits (Cct4 and 5) and
one target of the CCT complex (Slp1). Histone H3 is used as a loading control. On the left, ratio (protein of interest/H3) is
scaled at 1 for WT (blue) and variations are shown for the ∆4 mutant (orange), n = 3, error bars represent SEM. On the
right, representative result of a Western blotting triplicate against Nda2 (upper left, anti-Nda2 Ab – antibody), Cct4/5-TAP
(upper middle, anti-TAP Ab), Slp1-HA (upper right, anti-HA Ab) and H3 (lower, anti-H3 Ab) in different genetic
backgrounds. For C and D, Student’s t-tests were performed (on the Cq values or on the ratio (protein of interest/H3),
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logFC gene name associated function
-3.86 dus1 tRNA dihydrouridine synthase Dus1 
-2.95 dus2 tRNA dihydrouridine synthase Dus2 
-1.73 prp4 serine/threonine protein kinase Prp4
-1.56 dus3 tRNA dihydrouridine synthase Dus3
-1.50 mfm2 M-factor precursor Mfm2
-0.99 SPAC27D7.09c But2 family protein
-0.79 SPBC1348.02 S. pombe specific 5Tm protein family
-0.79 SPBPB2B2.19c S. pombe specific 5Tm protein family
-0.77 SPAC977.01 S. pombe specific 5Tm protein family
-0.76 SPAC750.05c S. pombe specific 5Tm protein family
-0.76 SPNCRNA.1071 intergenic RNA
-0.66 hsp9 heat shock protein Hsp9
logFC gene name associated function
0.65 SPMITTRNAGLU.01 tRNA Glutamic acid, mitochondrial
0.69 ura2 dihydroorotase Ura2
0.78 lcp1 cyclin L family cyclin
0.85 SPATRNAGLU.01 tRNA Glutamic acid
0.85 SPBTRNAGLU.06 tRNA Glutamic acid
0.85 SPBTRNAGLU.07 tRNA Glutamic acid
0.85 SPATRNAGLU.02 tRNA Glutamic acid
1.30 SPBTRNAILE.07 tRNA Isoleucine
1.33 SPCTRNAVAL.09 tRNA Valine
1.40 SPATRNACYS.01 tRNA Cysteine
1.52 SPATRNAILE.04 tRNA Isoleucine
1.53 SPATRNACYS.03 tRNA Cysteine
2.06 SPATRNACYS.02 tRNA Cysteine
4.97 SPNCRNA.1212 antisense RNA (predicted)
2
SPATRNAVAL.01
D-seq : D16 and D20
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Dihydrouridylation is limited to tRNAs in fast-growing E. coli cells. 
Because 30% of the fission yeast dihydrouridylated mRNAs were conserved in 
bacteria (Fig. 17C), we performed D-seq on fast-growing E. coli cells. We worked with 
the previously generated triple dus mutant (∆dusA-B-C or ∆3) (Bishop et al., 2002). 
Dot blot and Northern blotting analyses of R+ and R- treated RNAs led to the same 
conclusion drawn for yeast; overall decrease of Rho signal in the ∆3 genetic 
background (Fig. 20A and B). 
 
Details of the E. coli tRNA modifications are available in databases – unlike 
fission yeast tRNAs – providing a thorough set of information to compare D-seq hits 
and previously known D positions. We detected 106 D-sites on tRNA positions 16 to 
23 of 62 different genes. Manual curation (using tRNAmodviz and GtRNAdb) of each 
predicted D-site revealed 63 distinct modified nucleotides on 35 different tRNA 
species. Strikingly, 53 were expected D residues, representing 72% of all known 
dihydrouridylated tRNA positions in E. coli. Furthermore, we propose ten new 
dihydrouridylation events on six tRNA species (Fig. 20C). In total, the 63 D-tRNAs are 
distributed along the D-loop by following the exact same pattern of the 74 known D 
(Fig. 20D). Altogether, these data confirm the reliability of D-seq to detect D at the 
single-nucleotide level.  
 
Not a single D-site was detected on mRNA or rRNA. The 23S-U2449 position is 
nevertheless known to be dihydrouridylated in E. coli. Interestingly, RT termination 
signals were observed around this position in both WT R+ and ∆3 R+, but not in mock-
treated samples (Fig. 20E), as confirmed with a primer extension assay (Fig. 20F). In 
other words, RTase was stopped one nucleotide downstream of D2449 after Rho 
labeling but in a dusA-B-C-independent manner, strongly suggesting that ribosomal 
dihydrouridine in installed by a fourth dihydrouridine synthase. Another possibility is 
that this position was incorrectly considered as a D, but a recent report confirmed the 
position 2449 as dihydrouridylated (Popova and Williamson, 2014). It is reasonable to 
ask whether this putative supplementary Dus enzyme could act on mRNAs. To test 
this hypothesis, we modified the D-seq statistical analysis (Fig. 12) to get rid of the 
dusA-B-C dependency for the determination of RT termination events; if there are D 
residues that are not installed by DusA, DusB or DusC, these sites are inevitably dusA, 
dusB and dusC-independent. To do so, we calculated the p-values on the labeling 
factor (R+/-) alone, therefore ignoring the strain factor (WT/dusA-B-C). In other words, 
the test conditions encompassed both WT R+ and ∆3 R+ whereas the control 
conditions were limited to WT R- and ∆3 R- conditions. The modified pipeline led to the 
detection of RT termination events at 40 additional sites including; (i) five positions on 
different mRNAs (aldA, pheS, putA, yicJ and ynhF), (ii) 23S-U2068 that is upstream of 
the known 23S-m7G2069, (iii) several tRNA positions with notably 13 s4U8 positions and 










Figure 20 – D-seq implementation on E. coli transcriptome. (A) Comparative
Rho detection at 520nm on WT (wild type) and ∆3 (∆dusA-B-C) total RNAs in R+
and mock-treated (R-) samples. The intensity of a Rho drop is scaled at 100%, a
drop of water is considered as the background, methylene blue staining serves as
loading control, n = 3, error bars represent SEM. (B) Fluorescent Northern blotting
of WT and ∆3 total RNAs in R+ and mock-treated samples. Representative result
from a biological triplicate, methylene blue staining serves as loading control. (C)
Ten previously unconsidered positions (tRNAmodviz) on six E. coli tRNA species
are proposed to be dihydrouridylated. (D) On the left, distribution of the 63 unique
tRNA D-sites according to their relative position on tRNA. D20 is the most
represented dihydrouridylated position with 24/64 counts (37.5%). NA stands for
not assigned due to sequence incompatibility (D22 on SerGGA). On the right,
distribution of the 74 unique tRNA D positions as referred by the tRNAmodviz
database. D20 is the most represented dihydrouridylated position with 28/74 counts
(38%). (E) D-ratio (%) profiles around the 23S rRNA-U/D2449 position (orange
triangles) in test and control conditions. Similarities between WT and ∆3 R+
profiles suggest a DusA-B-C-independent synthesis of D2449. D-ratio values were
obtained by the compilation of the seven E. coli 23S rRNA genes (rrlA, B, C, D, E,
G and H) from two biological replicates, error bars represent min and max values
of the D-ratio means from both replicates. (F) Primer extension assay performed
on total RNAs from WT and ∆3 strains, R+ or R- treated. The radiolabeled primer














































































































































x-axes : relative rRNA position
































D is undetectable in strains lacking all predicted dus genes. 
As introduced hereabove (see Introduction III.C.i.b. and III.C.ii.b.), screens for 
bacterial and eukaryotic Dus enzymes did not rely on methods that could undeniably 
recover all genes/proteins coding for/carrying a dihydrouridine synthase activity. HPLC 
analysis was performed on total RNA extracts from WT and ∆4 yeast strains (Fig. 21A) 
and from WT and ∆3 bacterial strains (Fig. 21B). In both cases, no residual D signal 
was observed and proper detection of D was controlled by calibration with a 













































Figure 21 – D is virtually undetectable in yeast and bacterial dus mutants. Analysis of total RNA from S. pombe (A)
and E. coli (B) WT and dus mutant strains by HPLC for three biological samples. Retention time for D was determined















Growth of mutants lacking D is affected by the temperature 
In the light of the correlation between tRNA dihydrouridylation and growth 
temperature (see Introduction III.C.ii.c.), we tested the growth of the yeast ∆4 mutant 
at different temperatures and observed that the viability was impaired at high but not 
low temperatures (Fig. 22A). Importantly, we showed that the ts phenotype was not 
caused by the underexpression of the gene upstream of dus4 in the ∆4 genetic 
background (Fig. S16), which was shown to be less abundant in the quadruple mutant 
(Fig. 19A). Remarkably, yeasts grown at 20°C had significantly more dihydrouridine 
than the ones grown at the optimal temperature (32°C) (Fig. 22B). 
 
The growth phenotype of the ∆3 bacterial mutant was also affected by the 
environmental temperature (Fig. 22C). At 37°C, the mutant displayed a slight growth 
delay that was hardly aggravated at 42°C. At low temperatures, the dus mutant had an 


































Figure 22 – Correlation between D and temperature. (A) Growth phenotype of the quadruple ∆4 yeast mutant
compared to the WT strain. Exponential growing cells were spotted on rich medium and incubated at different
temperatures for 48 (32 and 37°C), 90 (25°C) or 115 hours (20°C). Representative growth from three biological replicates.
(B) Comparative Rho detection at 520nm on WT and ∆4 yeast total RNAs in R+ samples. RNA was harvested from yeasts
grown to mid-exponential phase at 20, 32 or 37°C. The intensity of a Rho drop is scaled at 100%, a drop of water is
considered as the background, n = 3, error bars represent SEM, Student’s t-test; * p < 0.05, ** p < 0.01, NS p > 0.05. (C)
Growth phenotype of the triple ∆3 E. coli mutant compared to the WT strain. Exponential growing cells were spotted on
rich medium and incubated overnight at different temperatures (30, 37 and 42°C) or for 48 hours (20°C). Representative
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Dihydrouridine is not essential in human cells. 
Within the framework of this project, dus mutants were also generated in a 
human cell line (HCT 116 cells producing functional p53) by using the CRISPR-Cas9 
technology (Fig. S17). The strategy relied on the electroporation of two 
ribonucleoprotein complexes (RNPs) per targeted gene. Each RNP was constituted by 
the Cas9 endonuclease and two noncoding RNAs (the sequence-specific crRNA and 
its transactivating partner). The first coding exon of the gene of interest (DUS1, DUS2, 
DUS3 or DUS4) was specifically targeted at two distinct positions – separated by a few 
hundred nucleotides –, therefore necessitating the electroporation of two RNPs, each 
of them inducing a DNA double-strand break. Single homozygous mutants for the four 
DUS genes were obtained and confirmed by sequencing (Table 4, see Experimental 
procedures). Strikingly, the specificities of human DUS enzymes for tRNA substrates 
seemed to be conserved (Fig. 7A), as suggested by primer extension assays on 
different tRNA targets (Fig. 23A). In parallel, HPLC profiles suggested that all four 
enzymes did not contribute equally to the total pool of dihydrouridines with each DUS 
protein supporting ~ 9 to 25% of total D levels (Fig. 23B). 
 
In an attempt to get a quadruple DUS mutant (Hs∆4), eight RNPs were 
electroporated in the same pool of cells (2 RNPs x 4 DUS genes). Because HCT 116 
cells are diploid, sixteen events of double-strand breakdowns were expected to occur 
to get a homozygous quadruple mutant. The procedure was efficient and resulted in 
the generation of a viable Hs∆4 mutant, as confirmed by sequencing. Importantly, the 
Hs∆4 mutant had virtually no D (Fig. 23C), and therefore demonstrated that loss of D 


























Figure 23 – Characterization of human dus mutants. (A) Primer extension assays performed on total RNAs from HCT
116 isogenic cell line and homozygous single DUS mutants (-/-, an exon is partially or entirely deleted, see Fig. S17). The
targeted tRNA is indicated below each panel. Above; R+ treated RNAs, below; aniline-based protocol to induce RT
termination. (B-C) Analysis of total RNA from HCT 116 WT and DUS mutant cell lines by HPLC. Retention time for D was
determined with a commercial dihydrouridine (Fig. S15) and is indicated by a black dotted line. (B) Respective contribution
of the four DUS enzymes to D synthesis in total RNA. n = 3, Student’s t-test; * p < 0.05, ** p < 0.01, n.s. p > 0.05. sd
(standard deviation). (C) HPLC analysis of D content in two quadruple DUS mutants (see Table 4). For B and C,
















Homo sapiens HCT 116
◼ WT
◼ Hs∆4 clone 1


























































































Absence of phenotype in the ∆4 mutant facing different stresses. 
In an attempt to explore the biological relevance of mRNA dihydrouridylation, 
we tested the growth of the ∆4 mutant in the presence of numerous chemical 
compounds that have various targets (Fig. 24A). Strikingly, the dus mutant was much 
more sensitive than the WT strain to the tubulin destabilizing compound TBZ (Fig. 
24B). However, the phenotype was the consequence of the dus4 upstream gene prp4 
differential expression in a ∆4 background (Fig. 19A and Fig. S16). In parallel, we also 
investigated the spindle formation in a dus mutant at 37°C (Fig. 25A). The dynamics 
was not significantly different between WT and mutant strains, but a D-deprived strain 
turned out to be smaller at 37°C (Fig. 25B). Importantly, we worked with a ∆dus1 ∆dus2 
∆dus3 dus4C108A-K149A mutant (Cys108 and Lys149 are important for enzymatic activity) 






































0.1% glucose + 2% galactose (+ adenine) respiration medium (fermentation)
0.1% glucose + 3% glycerol respiration medium (fermentation)
defined medium (EMM) free of adenine, uracil, leucine, histidine, etc.
cold shock 10, 30 or 60min at 4°C /
heat shock 10, 30 or 60min at 42°C /
heat shock 30min at 40°C /
chemical compounds comments
antimycin A bocks e- transfer from cytochrome b to cytochrome c1
myxothiazol prevents e- transfer from Fe-S center to ubiquinone
rotenone prevents e- transfer from Fe-S center to ubiquinone
oligomycin inhibits F0 ATP synthase
methothrexate inhibitor of folic acid and purine metabolisms
thiabendazole* tubulin-destabilizing compound
cycloheximide inhibits translation elongation, disrupts cytoskeleton
sodium chloride* infers actin defects and osmolarity remediability
latrunculin A prevents actin polymerization
benomyl* binds and inhibits MTs
nocodazole insensitivity of WT yeasts, inhibits MT polymerization
hydrogen peroxide oxidative stress, known to increase aggregates in yeast
2-azetidine carboxylic acid prevents folding of newly synthesized proteins









∆4 + empty vector
_____________________________________________________
Figure 24 – Phenotyping the yeast ∆4 mutant. (A) Sensitivity of
the quadruple S. pombe ∆4 mutant was assessed by spot assay
and compared to the WT growth in all listed conditions. Asteriks
indicate that the mutant was more sensitive than the WT strain but
most likely in dus-independent manner, as exemplified in (B). MT
(microtubule). (B) Growth phenotype of the ∆4 mutant compared to
the WT strain. Exponential growing cells were spotted on rich
medium supplemented with 12.5µg/mL of thiabendazole (TBZ) and
incubated at 32°C (5-fold dilutions). All strains carried an
auxotrophic marker for the positive selection of the vector during
(pre-)culturing growth in a defined medium. The vector used in this





Figure 25 – S. pombe ∆dus1 ∆dus2 ∆dus3 dus4C108A-K149A mutant spindle dynamics and cell length. (A) Spindle
dynamics is assessed by measuring the length of the spindle throughout the cell cycle in WT (green) and dus mutant
(orange) strains at 37°C. Microtubules are fluorescently tagged (mCherry-tubulin α2). (B) ∆dus1 ∆dus2 ∆dus3 dus4C108A-





































Within the course of the preparation of this dissertation, new results were 
obtained about the dus dependency of the detected D-sites in S. pombe. These new 
sets of data have not been fully analyzed and interpreted yet, explaining why they are 
found in this special section. 
 
At the experimental level, total RNAs were extracted from five different strains 
(WT and the four single dus mutant; ∆dus1, ∆dus2, ∆dus3 and ∆dus4), subsequently 
labeled (R+ and R-) and prepared for sequencing (Fig. 11B). The analytical pipeline 
was similar to the one shown in Fig. 12, expect that it relied on the comparison of four 
biological replicates for the WT conditions and two for the ∆4 conditions. For each 
detected D-site, the dus dependency was then determined according to the FDR of the 
statistical test (< 10%, Fig. 12). For example, the D-site X was considered as dus1-
dependent if the statistical test on the ∆dus1 strain generated an FDR < 0.1 (and FDRs 
> 0.1 for the tests based on the ∆dus2, ∆dus3 and ∆dus4 strains). 
 
At the tRNA level, 251 D-sites were detected and 96.4% of them were located 
between positions 16 and 22 (Fig. 26A), as it could be expected (Fig. 7A, Fig. S9). 
Interestingly, 87, 113, 9 and 28 D-sites were considered as dus1-, dus2-, dus3- and 
dus4-dependent, respectively (Fig. 26B). For the remaining sites (14, representing 
5.6% of the 251 detected D-sites on tRNAs), the dus dependency could not statistically 
be determined. The single-nucleotide distribution of the D-sites did not perfectly match 
with the substrate specificities of the Dus enzymes (Fig. 7A) (Fig. 26C). This can be 
explained; (i) by the necessity to implement a manual curation of all sites (a predicted 
D18 could actually correspond to D17 [Dus1] or D19 [Dus2]) and (ii) by working on the 
definition of dus-dependency. Indeed, there are many cases where the FDR is below 
the threshold (0.1) not only for one single mutant, but for several or even all of them 
(examples are given in Fig. 26D). In these cases, the dus-dependency was determined 
according to the smallest FDR when several FDRs were below the threshold of 10%. 
This pipeline is not ideal but is convenient for a preliminary analysis and will be 
thoroughly improved for further investigations. 
 
In parallel, D-sites were also detected on protein-coding genes; 104 
modifications on 92 mRNAs. When compared to the Fig. 17, 20 D-sites were found in 
both analyses (Table S3). Importantly, 90% of the D-sites (94/104) were found on a 
coding region (Fig. 26E) and U-rich codons were the most represented (Fig. 26F), thus 
confirming our conclusions about the yeast coding transcriptome dihydrouridylation. 
Fig. 26B depicts the dus-dependency of the D-sites found on mRNAs, although the 
analytical pipeline and thresholds have still to be refined. 
 
These data – even though they are the result of an exploratory and still ongoing 
analysis – highlighted a good correlation between the lack of a Dus enzyme and the 
detection of dihydrouridines on tRNAs. This observation seemed to be more easily 
monitored for dus1- and dus2-dependent modifications (Fig. 26B). However, it 
appeared possible that the deposition of D at a specific tRNA position could not be 
strictly dependent of one Dus enzyme (Fig. 26D). The example of SPBTRNAASN.02 
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dus1 dus2 dus3 dus4 comment
SPATRNAGLU.04 16 16 8.9 x 10-236 1 1 1 Dus1-D
SPATRNAGLU.04 20 20a 1 1 1 0 Dus4-D
SPBTRNAGLN.04 19 20 1.7 x 10-152 0 9.1 x 10-13 5.6 x 10-31 probably Dus2-D 
but not clear
SPBTRNAGLN.04 20 20a 0 5.3 x 10-112 0.5 0 effect of D20 ?
SPBTRNAASN.02 20 20 3.9 x 10-4 9.6 x 10-18 1 1 probably Dus2-D 
but not clear































































à Figure 26 – Preliminary results from the investigation on dus-dependency. (A) Distribution of the 251 tRNA D-
sites according to their relative position on tRNA. NA stands for not assigned, for positions that were out of the D-loop. (B)
Heatmap showing all detected D-sites that were sorted by comparison of their respective D-ratios in test (R+) and control
(R-) conditions. The dark red hue highlights more RT terminations in the test condition (D-ratio R+ > D-ratio R-). The
columns depict all replicates from six different strains (WT, four single dus mutant and the quadruple dus mutant). All sites
were clustered according to their dus1-, dus2-, dus3- or dus4-dependency, as shown to the right of the map. If no
dependency was revealed by the statistical analysis, the sites were clustered in the NS (non statistical) category. (C)
Distribution of the 87 (Dus1-dependent), 113 (Dus2-dependent), 9 (Dus3-dependent) and 28 (Dus4-dependent) tRNA D-
sites according to their relative position on tRNA. NA stands for not assigned, for positions that were out of the D-loop.
The expected modified sites (Fig. 7A) are shown in purple. (D) Examples of dus- (and so Dus-) dependency
determinations for three tRNA genes (column 1). Columns 2 and 3 indicate the relative or manually assigned tRNA
position that is considered as a D-site. FDR values resulting from the statistical analyses on the dus-dependency are
displayed in columns 4 to 7 (FDR < 0.1 as a threshold). SPATRNAGLU.04 is unambiguously decorated by a Dus1-
dependent D16 and a Dus4-dependent D20a. (E) Enrichment of dihydrouridylation on the coding sequence of mRNAs.
Above; when there are 100 U residues on a S. pombe mRNA, about 62 of them are on the coding sequence, below; 94
(out of 104) detected D-sites are localized on the CDS. pcg (protein-coding gene). One-sided Fisher’s Exact test; *** p <
0.001. (F) The 94 coding D-sites are found on 23 different codons.
U distribution on mRNA
D distribution on mRNA
94 D-sites, 85 pcg 
*** 
p = 9.7 x 10-11













dependent and that the D20a installation might require Dus2 or a Dus2-dependent 
dihydrouridylation, explaining why the deletion of dus2 resulted in the loss of D20a both 
in dus2 and dus4 mutants. Deepening the analysis will certainly allow to consider the 
potential enzymatic plurality as a biological truth or as a technical/in silico artifact. 
Furthermore, the patterns observed for mRNAs depicted; (i) that multiplying biological 
replicates of the test condition (WT R+) did invariably lead to the detection of D on 
coding regions of the yeast transcriptome and (ii) that there is apparently not a single 





































Working on dihydrouridine; a wise choice? 
Since the description of dihydrouridine as a naturally occurring RNA 
modification (Holley et al., 1965; Madison and Holley, 1965), molecular biologists have 
tried to unravel the functionality of this unique modification. It is unique because it is 
the sole known nonaromatic modification, feature that promotes noncanonical ribose 
conformation and hinders proper base stacking. Unlike the well-studied 2’-O-
methylation and pseudouridine RNA modifications that are described as enhancers of 
regional stability in ribonucleic acids, D installation is considered as a blueprint of 
conformational flexibility (Dalluge et al., 1996b). In parallel, in silico and structural 
analyses shed on light on the phylogenetic conservation of Dus enzymes and on the 
molecular tricks they acquired for substrate specificities (Bou-Nader et al., 2018; Byrne 
et al., 2015; Kasprzak et al., 2012; Xing et al., 2004). 
 
The singularity of D modification makes it an interesting example to unravel how 
the structural nature of ribonucleic acids is modulated using a simple, yet unique 
modification. All these reasons explain why investigations focusing on dihydrouridine 
are of high significance. 
Rhodamine labeling; a reliable tool? 
In this study, the dihydrouridine mapping at the single-nucleotide resolution is 
achieved through the binding of a stable fluorophore at the modified residue and 
subsequent RT termination one nucleotide downstream. Combination of the 
fluorescent labeling of D with primer extension assay had never been tested before but 
turned out to be a very successful technique. 
 
The first questionable aspect is the reduction of dihydrouridine by sodium 
borohydride (Fig. 5 and 6); is it selective and is the unmodified uridine resistant to this 
chemical? The uracil nucleobase is characterized by a reactive C6 involved in the 
C5=C6 double bond that is part of the electrophilic Michael acceptor. In dihydrouridine, 
C5=C6 is lost and the resulting nucleobase stability is affected in reducing conditions 
(i.e. NaBH4). Sodium borohydride is undoubtedly selective for dihydrouridine as 
confirmed and published for 50 years (Betteridge et al., 2007; Cerutti et al., 1968a; 
Cerutti et al., 1968b; Cerutti and Miller, 1967; Igo-Kemenes and Zachau, 1969; Kaur 
et al., 2011; Molinaro et al., 1968). A uridine can actually be reduced by NaBH4 into 
dihydrouridine but it requires very specific conditions (light-dependent reaction at 50°C 
with excess of NaBH4 in a basic solution) (Cerutti et al., 1968b). Our data are in 
agreement with the selective reduction of dihydrouridine in the tested conditions with 
subsequent covalent binding of rhodamine. Indeed, a reaction of reverse transcription 
was never blocked at an unmodified U position – as verified with synthetic and ∆4 




The second legitimate question is about the selectivity of the chemical reaction 
for dihydrouridine compared to other RNA modifications. The answer is clear; D is not 
the only posttranscriptional modification to be sensitive to sodium borohydride and/or 
to be labeled with rhodamine; many reports indeed established the sensitivity of s4U, 
ac4C, m7G and yW (Beltchev and Grunberg-Manago, 1970; Cerutti et al., 1968a; Igo-
Kemenes and Zachau, 1969; Molinaro et al., 1968; Schleich et al., 1978; Wintermeyer 
et al., 1979; Wintermeyer and Zachau, 1971, 1974, 1979). Dot blot and fluorescent 
Northern blotting were in line with these observations since the loss of (virtually) all D 
residues in ∆4 and ∆3 mutants did not result in a complete drop of rhodamine detection 
(Fig. 10A-B and 20A-B). Moreover, the sequencing data after R+ treatment clearly 
indicate the sensitivities of m7G (Fig. 16B) or s4U (E. coli D-seq) for rhodamine labeling. 
In other words, the rhodamine labeling is not specific for dihydrouridine and it is thus 
reasonable to conclude that other labeled RNA modifications induce RT arrests. That 
is the reason why the dus mutants are not only powerful controls, but essential 
conditions. In all our experiments – including D-seq – the dus mutants served as a 
background control to ensure that the WT R+ signal was indeed dus-dependent. It also 
means that our transcriptome-wide pipeline could easily be transferred to other Rho 
labeling-sensitive modifications; thiI is a nonessential gene in E. coli and is responsible 
for s4U tRNA thiolation (Mueller et al., 2001), Trm8 is a tRNA-methyltransferase whose 
deletion results in loss of m7G in budding yeast tRNAs (Alexandrov et al., 2002), etc. 
(Table 3). 
 
Finally, another issue is to know what precise molecular mechanism leads to 
the rhodamine incorporation. As already mentioned previously (see Introduction 
III.B.iii. and Fig. 6), there are two potential processes following the sodium borohydride 
reduction; the formation of a THU intermediate or the opening of the D-ring. Without 
experimental evidence, it is currently impossible to assume one model more than 
another but it seems that technical details such as NaBH4:uridine ratio, pH and 
temperature are critical for reactivity (Betteridge et al., 2007; Kaur et al., 2011; Pan et 
al., 2009). Moreover, it is important to highlight that we applied the Rho labeling on 
total RNA samples whereas the aforementioned studies worked solely with purchased 
or in vitro prepared tRNAs, which makes the biochemical environment completely 
different. 
 
In conclusion, despite the lack of evidence about the precise mechanism behind 
the Rho labeling of D residues, the technique is undeniably reliable to detect D residues 
at a single-nucleotide resolution. dus mutants are essential controls to discriminate 
between D and other RNA modifications. Biased (primer extension) and unbiased (D-
seq) approaches both confirm selectivity of the Rho labeling for dihydrouridines and 
not uridines. 
D-seq; trustworthy modification calling? 
The pipeline used to assign a nucleotide as a dihydrouridine is an improved 
version of the two-metric system imagined by Regev and colleagues for pseudouridine 
mapping in y-seq (Schwartz et al., 2014). We changed both the technical and 
analytical aspects of the pipeline used to detect putative y-sites, in order to make D-
seq more stringent. First, the calculation of the mean D-ratio constituted a powerful 
pre-filtering step for three main reasons (Fig. 12); (i) it was independent of the statistical 
test (Bourgon et al., 2010), (ii) it was unbiased sensu stricto because it did not compare 
RNA 
modification chemical reactivity E.coli S. cerevisiae S. pombe H. sapiens references
ac4C NaBH4not in the tRNA structure TmcA Kre33 Nat10 NAT10
(Cerutti et al., 1968a; Cerutti and Miller, 1967; 
Igo-Kemenes and Zachau, 1969, Molinaro et al., 1968)
f6A NaBH4not clear FTO (Cerutti and Miller, 1967)















(Cerutti et al., 1968a; Igo-Kemenes and Zachau, 1969; 







(Cerutti et al., 1968a; Macon and Wolfenden, 1968)
















(Igo-Kemenes and Zachau, 1969; 
Wintermeyer and Zachau, 1970, 1971, 1974) 
suggested by D-seq













(Cerutti et al., 1968a; Cerutti and Miller, 1967; 
Igo-Kemenes and Zachau, 1969)
suggested by D-seq













(Beltchev and Grunberg-Manago, 1970; 
Igo-Kemenes and Zachau, 1969; Schleich et al., 1978; 
Wintermeyer and Zachau, 1970, 1971, 1974, 1979)
suggested by D-seq
_________________________________________________________________________________________________________________________________________________
Table 3 – Chemical reactivity of different RNA modifications for sodium borohydride (NaBH4) and dye labeling. The first column (RNA modification) encompasses all the RNA
modifications that are susceptible to be used in a D-seq-like pipeline, although the chemical reactivity shown in the second column (chemical reactivitiy) does not necessarily generate
an RT termination. The four next columns give the associated known or predicted RNA modifying enzymes in four species (Escherichia coli, Saccharomyces cerevisiae,
Schizosaccharomyces pombe and Homo sapiens). Trm82 are non-catalytic proteins. (mt) means that the enzyme has mitochondrial substrates. In yeasts, abd1, pcm1, kre33, S.
cerevisiae gcd10 and gcd14, S. pombe slm3 are essential genes. yW formation also implies the Trm5 methyltransferase that is not indicated here. The last column (references)
depicts all studies that showed the chemical reactivity/ies of the corresponding RNA modifications.
 
55 
conditions to one another, and (iii) it did not imply the usage of an arbitrary threshold 
because the mean D-ratio threshold was based on the stoichiometry of the spike-in 
RNA (Fig. 13F). Moreover, D-seq was performed with two biological replicates, which 
permitted the implementation of a statistical test (Fig. 12). It means that all detected D-
sites were relevant because the downstream nucleotide – or RT-stop site – was 
statistically more represented as being the last retro-transcribed residue in the test 
condition. Finally, the control condition was not limited to a mock-treated sample (R-) 
but extended to the use of a dus mutant that unarguably allows to distinguish the Dus-
dependent RT terminations. The filtering steps established before and after the 
statistical analysis ensured a proper modification calling. 
 
It is also important to highlight that the possible loss of a transcript in the dus 
mutant does not lead to a false positive site calling; if a transcript T is decorated with 
a modification M, if M is labeled by the rhodamine and thus generates an RT 
termination and if T is absent in the mutant – for example because the deletion of the 
dus genes impacts its expression and/or abundance, the D-ratio for M will be high in 
WT R+ and low in all other conditions. However, the low D-ratio in the dus mutant 
would be an artifact simply because the transcript T is absent. The statistical analysis 
will nevertheless not call the M position because the RT termination event occurring 
around M will not be statistically relevant. This example demonstrates how important 
is the implementation of a statistical test. 
 
There are only two scenarios for which a site would be wrongly called (false 
positive); (i) the RT termination randomly occurs more in WT R+ in both biological 
replicates but not in other conditions (which is intrinsically not impossible but the 
probability is low) and (ii) the different thresholds used in the analytical pipeline are too 
permissive. This latter is unlikely because we determined the threshold values to be 
as stringent as possible. Our purpose was to minimize the false positive rate, even 
though it increased the miss rate (or false negative rate). As a consequence, D-seq is 
not exhaustive at all but instead relies on a high confidence modification calling. As a 
proof-of-concept, 98.5% of all detected D-sites (225/228 in yeast and 104/106 in E. 
coli) were found on canonical D positions. The detection of remaining sites is discussed 
in Fig. 27. The modification calling of the only D of the synthetic RNA was also in line 
with proper determination of D-sites (Fig. 13A). Furthermore, not a single D-site was 
detected on yeast r-, sn- and sno-RNAs, as expected (Fig. S11) (Cantara et al., 2011; 
Gu et al., 1996). However, it is important to keep in mind that positive and negative 
controls might have two drawbacks when intended to be compared to the modification 
calling on mRNAs; (i) t- and r-RNAs are highly expressed, decreasing the signal:noise 
ratio compared to the coding transcripts and (ii) the synthetic RNA is not 
dihydrouridylated in vivo and added to total RNA before Rho labeling, potentially 
impacting the biochemical identity of this exogeneous dihydrouridine. These minor 
cons are, though, not sufficient to challenge the trustworthy modification calling applied 
in D-seq. 
 
Another questionable aspect of the method relies on the detection of 
neighboring D. In a sequence 5’-D1D2N-3’, the RT will stop at the N position in the R+ 
condition, allowing the detection of D2. But does the D-seq permit the detection of D1? 
There are several examples where two neighboring D were detected (e.g. 
SPATRNAPHE.01 with D16 and D17, SPATRNAVAL.02 with D20 and D20a or the coding 
SPAC694.02 gene with a predicted UDD codon). Although it is not possible to known 
_________________________________________________________________________________________________
Figure 27 – Rare unexpected D calling sites on tRNAs. D-seq reveals less than 2% of unexpected tRNA D-sites that
could be explained by simple technical artifacts.
S. pombe
tRNA D-site comment
ArgCCU D2 possible 5’-end transcript artifact
MetCAU D8 possible 5’-end transcript artifact
ProCGG D29 position close to the D-stem, could be a structural-based and D-dependent arrest
because a D20 modification is detected on the same tRNA
E. coli
tRNA D-site comment
SerGGA, serX gene D22 sequence incompatibility between tRNAmodviz and BioCyc à D22 is likely D20a
SerGGA, serW gene D22 sequence incompatibility between tRNAmodviz and BioCyc à D22 is likely D20a
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whether the two modified residues were on the same molecule, this observation 
suggests that the D-seq does indeed detect two following D. In parallel, a primer 
extension performed on an in vitro transcribed RNA with three subsequent D indicates 
that the RT arrest is more prominent downstream of the third D (with the RNA point-
of-view, Fig. S6). It is therefore reasonable to speculate that D-seq should highlight 
neighboring dihydrouridylated residues but to a lesser extent for the 5’-dihydrouridines 
(still with the RNA point-of-view). 
 
To sum up, D-seq combines both wet and dry manipulations that turned out to 
be accurately controlled to draw meaningful conclusions. It is worth reiterating that our 
conclusions are not; (i) D-seq provides a full picture of dihydrouridylated mRNAs in 
yeast and (ii) there is no D on bacterial mRNAs. Instead, we assume that; (i) D-seq 
provides a non-exhaustive list of dihydrouridylated mRNA candidates that are 
dependent on Dus1, 2, 3 and/or 4, and (ii) Dus A, B or C-dependent D were not 
detected in our conditions in bacterial mRNAs. 
Yeast D-seq mRNA candidates; what to think? 
About 100 pseudouridines were found onto yeast mRNAs (Carlile et al., 2014; 
Lovejoy et al., 2014; Schwartz et al., 2014), providing an example of a low abundant 
internal mRNA modification in a simple organism grown on normal conditions. y 
profiling was then discussed by Jaffrey: “A central question is whether 
pseudouridylation in mRNA is biologically meaningful. The apparent lack of a 
dedicated mRNA pseudouridylase raises the possibility that these pseudouridines 
reflect nonspecific pseudouridylation” ((Jaffrey, 2014), p. 946). The same concern 
could (and probably will) raise about dihydrouridylation of yeast mRNAs. 
 
The dihydrouridines spread beyond the tRNA pool could be a random 
background that is tolerated by the cell because it is not harmful. Despite the lack of 
experimental evidence, several concepts are important to mention; (i) dihydrouridine 
is such a peculiar RNA modification (does not stack, promotes RNA flexibility, spans 
the RNA chain, etc.) that it is hard to conceive that D deposition does not influence 
structural – so functional – identities of RNA molecules. It is established that D is a 
nonessential modification for normal growth but nonessential does not mean non-
functional. A salient feature of RNA modification enzymes is that they are not 
necessarily required for growth (Phizicky and Hopper, 2010; Sharma and Lafontaine, 
2015). At the structural level, unmodified and native tRNAs adopt the same overall 
shape (reviewed in (Phizicky et al., 2009)), relegating tRNA modifications to a second 
role. In budding yeast, a set of double mutants coding for modifying enzymes are viable 
at 30 but not 37°C (Alexandrov et al., 2006). For example, the double ∆trm8 ∆dus3 
mutant (lacking the tRNA-m7G46 and D47) is not viable at 37°C, phenotype that is 
associated to RTD (see Introduction I.B.iii.a.) (Chernyakov et al., 2008). Even though 
a unique modification does not often seem to be functionally important, it is critical to 
consider a set of intertwining parameters that act together to confer a biological role. 
The same scenario is possible for the dihydrouridylation of eukaryotic mRNAs; 
dihydrouridine plays a subtle role along with other cues (modifications, expression 
level, environment, etc.) that needed to be studied together to unravel the biological 
role of D; (ii) in the same context, the detected D-sites could be a baseline set of 
modified residues whose relevance is prominent in a specific physiological context. 
Two interesting cases are illustrated in the literature; induced pseudouridylation upon 
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heat shock and widespread methylation during the meiotic program (Schwartz et al., 
2013; Schwartz et al., 2014). Due to the prevailing statement that y and D have 
opposite structural functions in RNA (stability vs flexibility), it is remarkable that 
pseudouridylation is induced upon heat shock whereas we observed more D upon cold 
growth (Fig. 22B). Moreover, because D is suggested to be an adaptive response to 
low temperature for psychrophilic bacteria (see Introduction III.C.ii.c.), it could be worth 
performing D-seq on yeast grown at 20°C. In parallel, dot blot assay also revealed a 
higher signal of Rho at 37°C, but both in the WT and ∆4 backgrounds (Fig. 22B), 
suggesting a D-independent increase of the fluorescence. However, because the ∆4 
mutant is thermosensitive (Fig 22A), performing D-seq on yeast grown at 37°C could 
also bring a valuable set of information; (iii) importantly, conservation of the 
modification pattern would be a clue that mRNA-D have a biological significance. That 
is the reason why D-seq is being performed with the mutants generated in a human 
cell line and data will be soon available. However, the absence of detected D-sites on 
bacterial coding transcriptome is a first relevant information because it suggests that 
mRNA dihydrouridylation could be a eukaryotic-specific mechanism. Moreover, it 
means that Dus enzymes do not seem prone to randomly dihydrouridylate nonspecific 
substrates, hence a conceivable biological relevance for eukaryotic mRNA D 
candidates; (iv) finally, the nonrandom distribution of D on mRNAs strongly argues for 
a targeted dihydrouridylation on coding sequences that underlies an active and 
regulated mechanism of modification (Fig. 18), especially on products of conserved 
genes (Fig. 17C).  
dus mutants; what phenotype? 
The function of dihydrouridine synthases is uncovered – i.e. they catalyze the 
formation of D – but their role(s) as biological regulators in a physiological context is 
still unknown. To unravel this issue, we tested the sensitivity of the ∆4 mutant in various 
conditions and facing different chemical compounds (Fig. 24). Moreover, a recent 
study reported dus2 and dus3 mutants as phenotypically associated with promiscuous 
conjugation, incomplete cell disassembly at cell fusion site and decreased mating 
efficiency in fission yeast (Dudin et al., 2017). All these characteristics are correlated 
to aspects of developmental biology involving the cytoskeleton, thus leading to the 
analysis of the spindle formation in a dus mutant, which did not display apparent 
defects in this specific context (Fig. 25). From these observations, we can conclude 
that the thermosensitivity of the yeast ∆4 mutant (Fig. 22A) is probably not explained 
by deficiencies in the biogenesis of microtubules and might be essentially explained 
by the disruption of hypomodified tRNAs at an elevated temperature, which is line with 
the RTD phenotypes described above (see Introduction I.B.iii.a.). It is therefore 
appropriate to point out that the description of a phenotype that would be correlated to 
the dihydrouridylation of mRNAs is/will be a painful/impossible task because of the 
tRNAs are always affected in dus mutants. 
 
The E. coli ∆3 mutant phenotyping is not a simple matter either because the ∆3 
mutant (Bishop et al., 2002) is actually a quadruple mutant consisting of a ∆dusA 
∆dusB ∆fis ∆dusC genetic background (Fig. 28). dus genes were only partially deleted 
in the ∆3 mutant but the regions coding for residues involved in catalysis, cofactor 
binding or tRNA binding were targeted, strongly suggesting that they were catalytically 
inactive (Bou-Nader et al., 2018; Byrne et al., 2015; Savage et al., 2006; Yu et al., 



















Figure 28 – dusA, B and C genomic loci in WT and ∆3
strains. Blue waves represent the D-seq unnormalized
coverage profiles in WT and ∆3 R+ conditions, replicate 1.
Blue recantgles represent protein-coding genes. Above:
dusA deletion includes residues experimentally shown to be
important for catalytic activity, including the highly conserved
cysteine (red). Middle: dusB 3’-end deletion includes
residues involved in polar contacts with the FMNH- proton
donor (blue). fis is completely deleted. Below: dusC deletion
includes one residue involved in polar contacts with the
FMNH- proton donor (blue) and three residues interacting
with the tRNA (green; Arg272 makes a salt bridge with the
tRNA-G19-U20 phosphodiester bond, Leu274 interacts with the
tRNA-C56, Tyr279 participates in recognition of the tRNA-U16-
C17) (Bou-Nader et al., 2018; Byrne et al., 2015; Savage et
al., 2006; Yu et al., 2011).
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(in)directly regulates one fifth of the transcriptome (Cho et al., 2008). Importantly, WT 
and ∆3 expression profiles are not compared to each other in the D-seq experiment. It 
means that the fis deletion should not impact the D-site calling, except if the loss of 
Fis-dependent transcriptional activation results in the loss of a set of transcripts. 
However, the absence of detectable D-sites on the bacterial mRNAs might be caused 
by the large-scale transcriptional disruption provoked by the absence of Fis. It is thus 
not possible to undeniably conclude about the non-dihydrouridylation of E. coli mRNAs. 
At the regulatory level, dusB-fis is a tightly regulated operon with different DNA binding 
sites for Fis itself, the cAMP receptor protein Crp and the DNA supercoiling protein IHF 
(Caspi et al., 2016). In bacteria, operons are often organized in clusters of functionally-
related genes (Ralston, 2008). The fact that dusB and fis are under the control of the 
same genomic elements could give insights about the regulation of dusB and its 
potential physiological role. Interestingly, dusA could also be differentially expressed, 
more specifically upon heat shock because it has a temperature-dependent σ32 
consensus binding site (Zhao et al., 2005). Furthermore, the sensitivity of the ∆3 
mutant at 20°C (Fig. 22C) is somehow interesting for further investigations but needs 
to be confirmed as fis-independent. 
 
Bridging the epitranscriptome to the phenotype is a challenging step. Moreover, 
it happens that the full deletion of an RNA modification enzyme gene results in a 
phenotype that is less severe in the corresponding catalytic mutant (Agarwala et al., 
2012). It suggests the importance of the protein itself – not only the catalytic activity, 
therefore complicating the dissection between modification-dependent and 
modification enzyme-dependent phenotypes. The molecular determinants for Dus 
activity are known and conserved (Kasprzak et al., 2012; Savage et al., 2006), enabling 
the creation of Dus catalytic mutants for proper phenotyping in Bacteria and Eukarya4. 
A last aspect to keep in mind is that the nonessentiality of D modification could imply 
a compensation mechanism in which the cell deals with the loss of D by reinforcing 
other regulatory mechanisms, explaining the difficulty to phenotype strains devoid of 
dihydrouridines. 
D-sites; how to confirm them?  
Our data support that eukaryotic mRNAs are obviously dihydrouridylated. 
However, the 143 detected D-sites remain candidates and should be biochemically 
validated.  
 
A general method to confirm the presence of a modification on RNA polymerase 
II transcripts consists of the isolation of polyA+ RNAs followed by LC/MS. However, a 
polyA-based purification is tricky because it does not allow to get rid of contaminating 
RNAs that are abundant such as rRNAs and tRNAs (Legrand et al., 2017). Concluding 
from such experiments is therefore difficult and may be questionable. 
 
Site-specific cleavage and radioactive-labeling followed by ligation-assisted 
extraction and thin layer chromatography (SCARLET) is a complex name for a 
technique with a simple goal; detecting the presence of a modified residue at the single 
nucleotide-resolution (Fig. S18). It is a very powerful quantitative approach that was 
originally used for m6A detection but could virtually be applied to all modifications (Liu 
                                            
4 Within the framework of this study, we successfully created the catalytic inactive Dus4C108A-K149A and 
Dus2C116A-K159A mutants (data not shown). 
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and Pan, 2015). D-sites could thus be confirmed by such an approach. Moreover, this 
technique would provide a stoichiometric insight about the mRNA degree of 
modification. In D-seq, the only quantitative element is the spike-in control RNA that 
reveals RT termination downstream of the dihydrouridylated position for one fifth of the 
reads (D-ratio of ~20%), although the molecule is fully modified (100% are D, Fig. 13A). 
Although the D-ratio can quantify the relative stoichiometry of a dihydrouridylated 
position (Fig. 13E), comparing the D-ratios of spike-in RNA with mRNA D-ratios 
provides a limited information (Fig. 17E). 
 
In order to confirm the detected D-sites, another conceivable experiment would 
be to benefit from the differential Watson-Crick interaction intensities between A-U and 
A-D (Table 2). As already done with tRNAs, actual dihydrouridylation of mRNAs could 
be assessed in a microarray-based experiment (see Introduction III.B.ii., (Peng et al., 
2003; Xing et al., 2004)). In this case, the detection does not rely on a chemical labeling 
of the dihydrouridine and therefore would consist of a Rho-independent detection of D. 
 
In parallel, other high-throughput techniques to detect D could be set up and 
comparison of the isolated candidates would confirm their relevance. These 
techniques should involve the precipitation of dihydrouridylated mRNAs; (i) by using 
an anti-dihydrouridine Ab (not available yet) or (ii) by using an anti-rhodamine Ab. The 
second option main drawback is that it relies on the Rho labeling as well. The 
immunoprecipitation of R+ RNAs was not successful (data not shown), probably 
because the epitope recognized by the anti-rhodamine Ab is not accessible due to the 
covalent binding of Rho to the RNA chain. We therefore implemented a modified Rho 
labeling protocol with a commercially available biotin-rhodamine molecule (instead of 
the rhodamine alone), followed by a precipitation with streptavidin-beads (Fig. 29A). 
Preliminary data suggest that a dihydrouridylated tRNA is indeed precipitated in R+ (or 
BR+ for biotin-rhodamine effective labeling) but not in mock-treated samples (data not 
shown). The implementation of a high-throughput sequencing after 
(immuno)precipitation of (labeled) dihydrouridines would be highly informative (Fig. 
29B) and could be adapted in a m6A-LAIC-seq manner to be quantitative (see 
Introduction IV.B.ii.) (Molinie et al., 2016). 
Dus enzymes; how do they target mRNAs? 
It is not surprising to observe a lack of apparent consensus sequence for the 
dihydrouridylation of a mRNA (Fig. 18B) despite the high substrate specificity of Dus 
enzymes (Fig. 7A). First, because the D-seq did not establish what enzyme for what 
target (briefly mentioned in the Addendum section), and secondly because the well-
known tRNA Dus substrates do not display a consensus sequence either (Panwar and 
Raghava, 2014). Instead, a structural motif could be recognized by Dus enzymes (e.g. 
a polyuridic sequence, Fig. 18C). Interestingly, a programmed ribosomal frameshifting 
(PRF) of some viruses relies on a U-rich tract called the slippery sequence (e.g. 5’-
UUUUUUA-3’ for HIV, (Jacks et al., 1988)), upstream of a stimulatory sequence (e.g. 
a pseudoknot). Moreover, PRF is also known to occur in yeast and in higher eukaryotes 
(reviewed in (Dinman, 2012)). It would be interesting to know whether; (i) D-sites are 
often found upstream of stimulatory-like sequences, which is not a simple conclusion 
to draw because the prediction of RNA folding can be arbitrary; (ii) D-sites are often 
found upstream of putative novel ORFs that would be translated after the potential 




Figure 29 – Proposed pipelines to confirm D-seq candidates. (A) Precipitation of biotin-rhodamine labeled D residues
is achieved by binding to streptavidin (strepta)-beads. B) Enriched dihydrouridylated RNAs could be sequenced after
































Bacterial Dus were shown to adopt astonishing features for substrate 
specificities (Fig. 8) but these conclusions cannot be extrapolated to eukaryotic Dus 
enzymes because hDUS2 is the sole dihydrouridine synthase with a resolved structure 
in Eukarya (Fig. 7E). Although the recognition mechanisms could be substantially 
different between tRNA and mRNA, the main question is similar in both cases; what 
are the molecular determinants found on the substrate for the synthesis of a 
dihydrouridine? Controversial pieces of evidence do not allow any absolute answer to 
this question. On the one hand, in vitro transcribed tRNAs – i.e. free of modifications – 
were shown to be dihydrouridylated (Byrne et al., 2015; Jiang et al., 1997; Kusuba et 
al., 2015; Xing et al., 2002), but on the other hand, studies suggest that a properly 
modified and folded tRNA is necessary for Dus catalysis (Bou-Nader et al., 2015; 
Cavaille et al., 1999; Yu et al., 2011). In other words, D would be a late modification in 
tRNA processing because the Dus enzymes require a pre-modified molecule, even 
though seminal works reported the presence of dihydrouridine on unspliced yeast 
tRNAs (Etcheverry et al., 1979; Jiang et al., 1997; Knapp et al., 1978). The truth might 
be that it is not a one rule mechanism because it was shown that dihydrouridylation 
occurs on in vitro transcript but the reaction is much faster on in vivo substrates, which 
is more or less in line with the idea that a Dus protein can bind an unmodified tRNA 
but cannot apparently dihydrouridylate it (Bou-Nader et al., 2015; Rider et al., 2009). 
But whatever the tRNA case is, it is certainly different from the mRNA 
dihydrouridylation. However, it can serve as a baseline for reflection; if a highly 
structured tRNA is indeed required for Dus recognition, it means that the D residues 
on mRNAs should be found on peculiar secondary structures, except if Dus enzymes 
are able to bind tremendously different substrates (highly structured for tRNA vs simply 
structured for mRNA) (Lewis et al., 2017). Finally, a guided dihydrouridylation process 
could also occur with the help of a Dus-interactome; the Dus enzymes could indeed 
have specific partners that influence the biology of these proteins (targets, 
localizations, functionality, etc.). 
 
Another clue to answer to ‘how do Dus enzymes target mRNAs?’ is ‘when does 
dihydrouridylation occur?’. Is it a co-transcriptional process? Is it nuclear, cytoplasmic, 
or both? To answer to this question, the localization of Dus proteins should be clearly 
established. Budding yeast Dus1 is likely to carry a mitochondrial motif whereas Dus3 
and Dus4 are not (Xing et al., 2002). In the fission yeast however, Dus4 seems to be 
exclusively mitochondrial unlike the nucleocytoplasmic Dus2 and Dus3 proteins 
(Matsuyama et al., 2006). Once D-sites on mRNAs will be associated with one or more 
dus gene, the spatiotemporal question should be accurately investigated. 
Translating a dihydrouridylated mRNA; structurally possible? 
It is legitimate to ask whether it is structurally possible to translate a 
dihydrouridylated mRNA. Disturbing the coding ability of a transcript can result in 
modulation of the translational speed, impediment of translation and/or miscoding. 
Particularly, Watson-Crick base-pairings between positions 1 and 2 of the codon and 
positions 36 and 35 of the anticodon are critical for ribosomal decoding (Ogle et al., 
2001). The wobble position is more flexible and more tolerant to structural mRNA 
modifications; it was shown that A or G methylation on positions 1 and 2  but not on 
position 3 of the codon impacted the translational speed and accuracy (You et al., 
2017). Strikingly, almost 60% of detected D-sites were on positions 1 and 2 of codons, 
precisely where they can be expected if dihydrouridine is relevant for translational 
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regulation (Fig. 30). In other words, D is found at positions where it is supposed to 
have an impact on translation, that is to say a biological role.  
 
The function of D could be either translation premature abortion and/or induction 
of ribosome stalling and/or miscoding by incorporation of non-cognate amino acids. 
The first hypothesis is supported by previous studies. In the late sixties, several teams 
investigated the in vitro coding properties of D-containing oligoribonucleotides. Despite 
the technical boundaries encountered at that time – e.g. the uncontrolled 
dihydrouridylation of the RNA template –, they concluded that the presence of D 
resulted in the loss of coding ability. Rottman and Cerutti showed that a ribopolymer 
carrying 4.2% of D (and 95.8% of U) lost up to 60% of Phe(UUU) residues incorporation 
into the protein – when the value for a polyU was set at 100% (Rottman and Cerutti, 
1966). Another study highlighted the complete loss of ability for GUD, GDU and GDD 
trinucleotides to code for Val(GUU) (Smrt et al., 1966). The conclusion was the same 
for the dihydrouridylation of the AUG(Met) codon (Lee et al., 1967; Smrt et al., 1970). 
It is outstanding to see that the scientific community was already curious about the 
coding properties of dihydrouridine… half a century ago! They were the first to show 
that D-mRNA could act as a repressive translational regulator, or at least to lack the 
ability to be recognized as a conventional nucleotide. 
 
To precisely dissect this hypothesis, we are currently working on an in vitro 
translation assay with an in vitro transcribed mRNA that contains a unique D residue 
at a known position (Karijolich and Yu, 2011). Our goal is to assess the stoichiometry 
of putative translation termination when a template is dihydrouridylated. 
The missing enzyme; ‘DusD’ in E. coli? 
Our data indicate that the 23S-D2449 deposition in E. coli is independent of the 
dusA-B-C genes (Fig. 20E-F). To our knowledge, this is the first experimental evidence 
suggesting that D could be synthesized by a noncanonical dihydrouridine synthase. 
This issue was already discussed previously and is based on Dus homologs (Bishop 
et al., 2002). Interestingly, the pyrimidine catabolism in bacteria and in higher 
eukaryotes includes the reduction of uracil to dihydrouracil by a dihydropyrimidine 
dehydrogenase (Fig. 31). In E. coli, the uracil reductases PreA and PreT were shown 
to catalyze this reaction (Hidese et al., 2011). They form a complex that could be 
responsible for D formation on RNA, raising the possibility of a fourth bacterial Dus 
enzyme. However, two major points should be addressed; (i) are these proteins able 
to bind RNAs? Many metabolic enzymes were recently shown to unexpectedly interact 
with RNAs in mammalian cells without apparent RNA-binding motifs (Castello et al., 
2015). Furthermore, assays to evaluate Dus-tRNA interaction have already been set 
up and could be used to assess the PreA/T ability to bind (t)RNAs (Byrne et al., 2015; 
Yu et al., 2011), (ii) is it structurally possible for PreA/T to target nucleic acids? Their 
known substrate is the nucleobase alone and the RNA structure could be inaccessible 
for these enzymes. Crystallographic structures of dihydropyrimidine dehydrogenase 
and homolog enzymes are available and should, by analogy, provide a partial answer 
to this question (Dobritzsch et al., 2001; Rowland et al., 1998; Schnackerz et al., 2004). 
Noticeably, the dihydropyrimidine dehydrogenase is of clinical importance in human 
because deficiency in this enzyme (DPYD in H. sapiens) leads to a severe sensitivity 
to the administration of 5-fluorouracil, an agent used widely to treat cancer 
(Schnackerz et al., 2004).  
 
____________________________________________________________
Figure 30 – D-sites are found at positions that do not face the flexible
tRNA wobble position. D-seq in yeast revealed 124 D-sites on codons.
56.5% are found on positions 1 and 2 of codons, interacting with the tRNA
positions 36 and 35, respectively. For information, 47.5% of uridines found
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Figure 31 – Pyrimidine catabolic pathway. Metabolic degradation of a uracil nucleobase as found in bacteria and




Remarkably, the catalytic activity of this potential D writer is reversible, allowing 
uracil formation from dihydrouracil. In a short communication published in 1967, 
Kosinski and colleagues said that “[…] the presence of one or more dihydrouridylic 
acid residues […] together with the existence […] of a nucleotide-specific 
dihydrouridine dehydrogenase might constitute a translational control mechanism […]” 
((Lee et al., 1967), p. 25c). Saying it with modern concepts, the dihydropyrimidine 
dehydrogenase activity could act as a D eraser. In agreement with the idea of reverse 
dihydrouridylation, an in vitro assay depicted that the incubation of bacterial bulk tRNA 
with yeast Dus2 resulted in the oxidation of dihydrouridine, in other words in a reaction 
where dihydrouridine is transformed into uridine (Rider et al., 2009). Dihydrouridine 
could therefore be a dynamic RNA modification. 
Long-term perspectives; what is on the list? 
The characterization of potential novel D writer or eraser has been discussed 
above. Another critical information to get for functional analysis of dihydrouridine would 
be to depict possible D-interacting proteins, the so-called readers. A straightforward 
method was used for isolation of both m6A and m5C readers and could be applied to 
find out  potential D readers (Dominissini et al., 2012; Yang et al., 2017). It relies on 
incubation of a cell extract preparation with biotinylated RNAs containing or not the 
modification of interest, followed by LC-MS. Complexification of the screen – to make 
it more relevant – could consist of ChIRP (chromatin isolation by RNA purification, Fig. 
S19) experiments on WT and ∆4 – or single dus mutants – strains by targeting a D-
seq mRNA candidate. 
 
The coding properties of dihydrouridine also suggest that the dihydrouridylation 
of a codon could lead to miscoding, that is to say to the incorporation of non-cognate 
amino acids. Mass spectrometric analyses of proteins generated from a D-containing 
RNA template would be of high interest to investigate this possibility. 
 
Last but not least, ribosome profiling seems essential to bring insights about the 
ribosome behavior in the absence of a dihydrouridine (for a review see (Brar and 
Weissman, 2015)). Rando and colleagues recently provided ribosome occupancy 
maps for almost all single mutants of tRNA modifying enzymes in the budding yeast 
(Chou et al., 2017). Importantly, the codon occupancy was shown to be reduced for 
Leu codons in a ∆dus2 mutant (Fig. 32), suggesting that the loss of Dus2-dependent 
dihydrouridylation prevents the ribosome pausing. A possible scenario is that D on 
mRNAs generate ribosome stalling, which is line with the nonrandom 
dihydrouridylation of Leu codons revealed by D-seq (Fig. 18F). It is however essential 
to keep in mind that this kind of technique does not allow to dissect between tRNA-
dependent and -independent effects. And it is not trivial because a mutation in the D-
loop can lead to miscoding, proving that the tRNA body also modulates the decoding 
ability (Hirsh, 1971). However, in the aforementioned study, the most affected codons 
in a ∆dus2 mutant are U-containing codons, raising the possibility of an mRNA-




mutant site codon aa
∆dus2 A UUA Leu
∆dus2 A CUG Leu
∆dus2 A CUA Leu
∆dus2 A CUU Leu
∆dus1 P GCG Ala
____________________________________________________________
Figure 32 – Ribosome profiling in budding yeast. Deletion of dus2
(mutant, column 1) results in lower codon occupancy (highlighted in red) in
ribosomal A-site (column 2) for a set of codons (column 3). The cognate
amino acid (aa) is depicted in column 4. Higher codon occcupancy in the
mutant is highlighted in green. Only results for dus mutants and (-0.3 >





Even though the function of dihydrouridine is not well understood, its high 
content in tRNAs from psychrophilic bacteria or cancer cells obviously 
emphasizes a central role in cell adaptation. 
 
(Bou-Nader et al., 2018) 
 
The universal dihydrouridine RNA modification is synthesized by the highly 
conserved Dus enzymes. Although a precise molecular function of D is still lacking, 
plenty of indications were gathered by the scientific community that argue in favor of a 
biological relevance of this simple but fascinating posttranscriptional modification. In 
this study, we set up a unique transcriptome-wide mapping of dihydrouridine, 
permitting its detection at the single-nucleotide resolution. The efficient base 
modification calling on transfer and synthetic RNAs is a good evidence to trust 
unexpected dihydrouridylation on eukaryotic mRNAs. Remarkably, nonrandom 
distribution of D residues on U-rich coding regions, along with the absence of effect on 
the abundance of mRNAs devoid of dihydrouridine, are all in line with a concept already 
mentioned 50 years ago; dihydrouridine could be a regulator of translation. Thus, our 
unbiased investigation shed light on the importance of focusing on correlation between 
mRNA dihydrouridylation and translational regulation. Further experiments will help 
unraveling the biology of this structurally unique modification that could also be 
dynamically installed – and erased? – upon different physiological contexts, such as 
the environmental temperature. Remarkably, the D-seq pipeline could be easily 
applied to other RNA modifications that are sensitive to the rhodamine labeling and for 
which the cognate RNA modifying enzyme mutants are available. In a time when the 
epitranscriptomic approaches are still lacking, the pipeline proposed in this study turns 
out to be possibly useful for other transcriptome-wide studies. Herculean efforts have 
still to be made to improve the detection of RNA modifications by nanopore 
technologies, hence the necessity to provide epitranscriptomic tools that enable single 
modification detection. D-seq is virtually applicable to RNA from any organism/cell 
type, grown in any condition and is therefore a reliable assay for functional studies on 
dihydrouridine. As a proof-of concept, a bacterial transcriptome was also studied and 
opened the possibility of a still to be confirmed new dihydrouridine synthase. In 
conclusion, this epitranscriptomic study reveals the dihydrouridine as a novel 
eukaryotic internal mRNA modification that specifically targets coding regions. 
 
 
Various experts in the field suggest that some modified nucleotides decorate 
mRNA as a result of the nonspecific off-target activity of enzymes that are 
involved in the modification of much more prevalent RNA species such as 
rRNA and tRNA. I believe that although this possibility cannot be disregarded, 
many modified nucleotides will be brought into the limelight when their 
cellular activities are elucidated in the coming years. 
 




Growth conditions and spot assays. 
Schizosaccharomyces pombe strains were grown in YES (Formedium 
PCM0310) or EMM (for Fig. S16 and Fig. 24B) (MP 4110-012) at 32°C to OD595nm 0.5-
0.8. For spot assays, strains were cultured in liquid YES or EMM media at 32°C and 
harvested at late-exponential phase, spotted (5-fold dilutions) on YES agar plates (+ 
chemical compound for Fig. 24) and incubated up to 5 days at 20, 25, 30, 32 or 37°C. 
Escherichia coli strains were grown at 37°C in LB (Invitrogen 12780-029) to OD595nm 
0.6-0.7. For spot assays, strains were cultured in liquid LB medium at 37°C and 
harvested at late-exponential phase, spotted (10-fold dilutions) on LB agar plates and 
incubated up to 2 days at 20, 30, 37 or 42°C. Human cells (HCT 116, human colorectal 
carcinoma, epithelial cells, ATCC CCL-247) were grown at 37°C under 5% CO2 in 
McCoy’s 5a medium (ATCC 30-2007) with 10% fetal bovine serum and 1% PEN-
STREP. 
Strains, vectors and oligo(ribo)nucleotides. 
Strains are listed in Table 4 and vectors in Table 5. All oligo(ribo)nucleotides 
were purchased from IDT and are listed in Table 6.  
 
For gene conversions in S. pombe, Expand High Fidelity-generated PCR 
products (Roche 19012322) were generated by amplification of a nucleotide sequence 
(consisting of a resistance cassette against an antibiotic or a tag sequence cloned in 
a pFA6A vector) with primers designed by the Pombe PCR Primer Program 
(developed by the Bahler lab, http://www.bahlerlab.info/resources/, 3’-end 20nt 
homology with the vector and 5’-end 60nt homology with the genome). Purified PCR 
products (Qiagen 28106) were transformed by following the lithium acetate procedure 
(Murray et al., 2016). Gene deletions resulted in [ATG-STOP] replacement and gene 
taggings resulted in a C-terminal tagging by removal of the endogenous STOP codon 
and insertion of the TAP (tandem affinity purification tag) or HA (human influenza 
hemagglutinin tag) sequence.  
 
dus4 and prp4 cloning in a pREP3 vector was achieved as follows; Phusion 
High Fidelity-PCR amplification (NEB M0530) of the gene of interest was performed 
on genomic DNA, purified (Qiagen 28106), enzymatically restricted (SalI-BamHI for 
dus4 and SmaI-BamHI for prp4), ligated (Promega M180A) into the restricted pREP3 
vector, transformed in E. coli DH10B competent cells and sequenced. The cloning 
strategy resulted in expression of the gene of interest under the control of the nmt1 
promoter (no message in thiamine 1). Vectors were transformed on S. pombe cells as 
described above. 
 
S. pombe GST-dus1 was prepared as follows; Phusion High Fidelity-PCR 
amplification (NEB M0530) of dus1 (without its start codon) was performed on genomic 
DNA, purified (Qiagen 28106), enzymatically restricted (BamHI-XhoI), ligated 
(Promega M180A) into the restricted pGEX-4T1 vector (downstream and in phase with 
the GST sequence), transformed in E. coli DH10B competent cells and sequenced. S. 
pombe GST-dus2 was prepared as follows; Phusion High Fidelity-PCR amplification 
_________________________________________________________________________________________________ 
Table 4 à
strain or cell line # genotype references
Schizosaccharomyces pombe
WT 94 h- (Leupold, 1950)
WT* 13 h- leu1-32 Stratagene SpQ01
WT** 1943 h- Z::natR-ADH15-mCherry-atb2 (Lynch et al., 2014)
∆dus1 1779 h- dus1::natR this study
∆dus2 1654 h- dus2::genR this study
∆dus3 1659 h- dus3::hphR this study
∆dus4 1493 h- dus4::bleR this study
∆dus1-3-4 1795 h90 dus1::natR dus3::hphR dus4::bleR this study
∆du2-3-4 1794 h90 dus2::genR dus3::hphR dus4::bleR this study
∆4 1755 h- dus1::natR dus2::genR dus3::hphR dus4::bleR this study
∆4* 1922 h- dus1::natR dus2::genR dus3::hphR dus4::bleR leu1-32 this study
cct4-TAP 1863 h- cct4-TAP-genR this study
cct4-TAP ∆4 1887 h- cct4-TAP-genR dus1::natR dus2::genR dus3::hphR dus4::bleR this study
cct5-TAP 1864 h- cct5-TAP-genR this study
cct5-TAP ∆4 1888 h- cct5-TAP-genR dus1::natR dus2::genR dus3::hphR dus4::bleR this study
slp1-HA 1895 h- slp1-HA-genR this study
slp1-HA ∆4 1891 h- slp1-HA-kanR dus1::natR dus2::genR dus3::hphR dus4::bleR this study
∆dus1 ∆dus2 ∆dus3 dus4C108A-K149A /
h- dus1::natR dus2::genR dus3::hphR dus4C108A-K149A Z::natR-
ADH15-mCherry-atb2 this study
Escherichia coli
WT JC8679 recombination strain (Zhang et al, 1998)
∆3 PS5107 dusA::cmR dusB-fis::kanR dusC::specR (Bishop et al., 2002)
_________________________________________________________________________________________________
à Table 4 – List of strains used in this study. natR (resistance gene for noursethricin), genR (resistance gene for
geniticin), hphR (resistance gene for hygromycin), bleR (resistance gene for phleomycin), cmR (resistance gene for
chloramphenicol), kanR (resistance gene for kanamycin), specR (resistance gene for spectinomycin), * (used for Fig. S16
and Fig. 24B only), ** (used for Fig. 25 only). The S. pombe strains are associated with a number (#) that represents the
classification in our collection of strains. The E. coli ∆3 mutant was generated from the JC8679 recombination strain, as
explained in (Bishop et al., 2002). The human cell lines used in this study are all HCT 116 p53 +/+ (as depicted for the WT
line). The CRISPR-Cas9 mediated deletion of DNA sequences (∆) are precisely indicated with genomic coordinates for
each targeted allele (HCT 116 cells are diploid).
strain or cell line # genotype references
Homo sapiens
WT / HCT 116 p53 +/+ ATCC CCL-247
DUS1 -/- (clone 1) / allele 1 : ∆82,064,820_82,065,063allele 2 : ∆82,064,820_82,065,063 this study
DUS2 -/- (clone 1) / allele 1 : ∆68,038,060_68,038,144allele 2 : ∆68,038,060_68,038,144 this study
DUS3 -/- (clone 1) / allele 1 : ∆5,791,033_5,791,152allele 2 : ∆5,791,021_5,791,136 this study
DUS4 -/- (clone 1) / allele 1 : ∆107,567,102_107,567,272allele 2 : ∆107,567,102_107,567,272 this study
Hs∆4 (clone 1) /
DUS1 allele 1 : ∆82,064,820_82,065,063
DUS1 allele 2 : ∆82,064,022_82,064,815
DUS2 allele 1 : ∆68,038,060_68,038,144
DUS2 allele 2 : ∆68,038,060_68,038,144
DUS3 allele 1 : ∆5,791,037_5,791,138
DUS3 allele 2 : ∆5,791,037_5,791,139
DUS4 allele 1 : ∆107,567,102_107,567,273
DUS4 allele 2 : ∆107,567,102_107,567,274
this study
Hs∆4 (clone 2) /
DUS1 allele 1 : ∆82,064,820_82,065,063
DUS1 allele 2 : ∆82,064,022_82,064,815
DUS2 allele 1 : ∆68,038,060_68,038,144
DUS2 allele 2 : ∆68,038,060_68,038,144
DUS3 allele 1 : ∆5,791,027_5,791,041
DUS3 allele 2 : ∆5,791,027_5,791,041
DUS4 allele 1 : ∆107,567,102_107,567,272
DUS4 allele 2 : ∆107,567,102_107,567,272
this study
________________________________________
Table 5 – List of vectors used in this study.
pDH (plasmid of Damien Hermand lab), GST
(sequence coding for glutathione-S-transferase),
pnmt1 (promoter repressed by the presence of
thiamine).
usage # features









usage # 5’-sequence-3’ F/R
Schizosaccharomyces pombe
resistance cassette gene 244 CGGATGTGATGTGAGAACTGTATCCTAGC R
dus1 deletion check 2049 GCTACAAATCTACAAAATCCTGCC F
dus2 deletion check 1950 GAGAATCGTTAATTGTGTCCG F
dus3 deletion check 2061 TGTGTACCTAAAAGCATATAGCG F
dus4 deletion check 2065 TAGTAGAAACGCCAACTGG F
tRNAiMet primer extension 2540 ACCTACGGGTTATGAGCCCGTCGG R
tRNAAspGUC (SPCTRNAASP.06) primer extension 2743 GGGCTGCAAGCGTGAC R
SPMITTRNAARG.02 primer extension 2746 CTAACAATTTCGAAGATTGTTAC R
tRNAPheGAA northern blotting 2552 TGACCAACAGATCTTCAGTCTGTC R
tRNACysGCA northern blotting 3026 AGGGACCAGCCGGATTTGAACCA R
5S rRNA northern blotting 2202 TTCCCATGTTGTCTCCAACC R
cct4-TAP for Expand PCR 2837 CAGCTGGCTGCTGAAACGACCAAGATGATCATGAAGATTGACGACATTACCTTAGCTCGT-
CGGATCCCCGGGTTAATTAA
F
cct4-TAP for Expand PCR 2838 ACAATGTAAATTCTTCTTTTCTCTTTCCTGTAATCCAATTTTCGGAAGGGAGACGAAACC-
GAATTCGAGCTCGTTTAAAC 
R
cct4-TAP tagging check 2850 GCGGGTATTAATGTTCGTAAGGG F
cct5-TAP for Expand PCR 2839 AGAATGGTACTCAAAGTTAACGATATTATCGTTGCCGGTTCTAAGGATGATGACTATAAC-
CGGATCCCCGGGTTAATTAA 
F
cct5-TAP for Expand PCR 2840 GCTTGCCGTATGAAATGAAGTAAATTAAATTTCCTTTAGCCGTGCGGATGAAAATGCCAT-
GAATTCGAGCTCGTTTAAAC 
R
cct5-TAP tagging check 2851 GCAGACCGGAAGTAATGATATGAG F
slp1-HA for Expand PCR 2873 GACCACGTTAAAAGGCCCATTCCAATTACCAAAACCCCGTCCAGCAGCATAACAATCCGT-
CGGATCCCCGGGTTAATTAA
F
slp1-HA for Expand PCR 2874 CTGATGCAACATAGTGATTCGACGAGCTAAACGTTGAAATCTAAAAGAAACTGGTGTTGT-
GAATTCGAGCTCGTTTAAAC
R
slp1-HA tagging check 2875 GCAGCCAGTGATGAGAATCTG F
nda2 qRT-PCR 1242 CTGTTTCATCCTGAACAGATGG F
nda2 qRT-PCR 1243 GCCATACGACGTATCCTTTC R
cct1 qRT-PCR 2824 CCACAAAGGGCATTGATGATC F
cct1 qRT-PCR 2825 CTTGGCGATACGTCTCAAATC R
act1 qRT-PCR 739 CCACTATGTATCCCGGTATTGC F
act1 qRT-PCR 740 CAATCTTGACCTTCATGGAGCT R
25S rRNA qRT-PCR 815 TTGTCCATGAAATTCCATTGAA F
25S rRNA qRT-PCR 816 CTTACAATACCCCGTTCCACAT R
nab3 qRT-PCR 2363 GAAAGTATAATGTCAAACTGGTATCCA F
nab3 qRT-PCR 2364 CTATCTGTGCTAAAGGCCCATAA R
adh1 qRT-PCR 785 GAAGGAAGCCGACATGATTG F
adh1 qRT-PCR 786 CAGCTTGCTCGTAAGACTTGG R
dus4 cloning in pREP3 2667 GGCAGCGTCGACATGAGAGATCGTTTAAAGGACCCTG R
dus4 cloning in pREP3 2668 ACACGGGGATCCTTAATAGCGGCGACAAGGC F
prp4 cloning in pREP3 2716 ACACGGGGATCCATGAGTGACGATAGATTTGC F
prp4 cloning in pREP3 2717 TCCCCCGGGGGATTATTTTTTTATAAAGAAAGGATGCTTC R
dus1 cloning for GST-Dus1 production 2932 CGCGGATCCGCGGCTTCAAAAAAGCTTCATGG F
dus1 cloning for GST-Dus1 production 2933 CCGCTCGAGCGGCTATGCCACAGAAGCATTGAC R
gBLOCK dus2cDNA / https://www.pombase.org/gene/SPBC1709.06, exons sequence F
dus2 cloning for GST-Dus2 production 2934 CGCGGATCCGCGGGTCTGCTAAATTATAGCAATAAAG F
dus2 cloning for GST-Dus2 production 2935 CCGCTCGAGCGGCTAAACGACTTGAGCTTTCTCTTC R
Escherichia coli
23S rRNA primer extension 3080 ATATGAACTCTTGGGCGGTATC R
_________________________________________________________________________________________________
à Table 6 – List of DNA primers, RNA primers and synthetic gene fragments used in this study. RNA
oligonucleotides are shown in blue, ddC (dideoxycytidine), 5’-P (5’-phosphate extremity), F (forward), R (reverse), T7P
(promoter for T7 RNA polymerase). The barcoded primer is characterized by a 6nt-long index (XXXXXX in red), which
corresponds to the reversed sequence provided by the TruSeq Stranded Total RNA Sample Preparation Guide (Illumina).
For example, the barcoded PCR primer AR005 (Illumina ACAGTG) will contain the CACTGT sequence instead of
XXXXXX.
usage # 5’-sequence-3’ F/R
Homo sapiens
DUS1 deletion check / AATTGAGCTGTCTCTGGAAAGG F
DUS1 deletion check / CTGCCTCTGAGTTGAGTCTTAAG R
DUS2 deletion check / GGCTGTAACAGAGGAGGAAATG F
DUS2 deletion check / CAGTGTCACACATGTTTGTCTC R
DUS3 deletion check / ATCTCAGGTACCTCCGCTGAC F
DUS3 deletion check / GAAGGTCTTCCCGCCACAC R
DUS4 deletion check / ATATATGTTGTTGGCAGTTGAAATTG F
DUS4 deletion check / CATATATACTAGGCAAGTAGTAGCATC R
DUS1 crRNA / CCCTCATCGTGCAGGTGCGCAGG F
DUS1 crRNA / GCAGCTTTGGCATCGTCTCCAGG R
DUS2 crRNA / GGGCCAGGATTAGCTTATTATGG F
DUS2 crRNA / AGCGGACATTGTTTACTGTGAGG R
DUS3 crRNA / TAAGCGTCAGTGAGTCGCCGGGG F
DUS3 crRNA / TCCGCCGTTCCCTCCGCCATCGG R
DUS4 crRNA / CATGCAAACGACAATATGTCAGG F
DUS4 crRNA / GTTTGAAGTTCCCATATGGTGGG R
tRNAPheGAA primer extension 2963 AGATCTTCAGTCTAACGCTC R
tRNAGlyGCC primer extension 2960 GAATCGAACCCGGGCCTCCC R
tRNAiMetAUG primer extension 2962 TGGTAGCAGAGGATGGTTTCGATC R
tRNAHisGUG primer extension 2964 GAGGTTGCTGCGGCCACAAC R
Other




T7P, first transcribed nucleotide, unique transcribed U (or D)
/




T7P, first transcribed nucleotide, transcribed U (or D)
gBLOCK PCR 2576 TAATACGACTCACTATAGGGG F
gBLOCK PCR 2577 TTTTGCTGGTGCGTTG R
synthetic RNA primer extension 2567 GTCTTTGCTTCCGCTTCGGTGTCC R
synthetic RNA with 3 D primer extension 3079 CGCGTTGTTCGCTTTTGTGG R
D-seq
RNA adapter 2661 5’-P-AGATCGGAAGAGCGTCGTG-ddC /
DNA primer for RT 2662 ACACGACGCTCTTCCGA R
DNA adapter 2674 5’-P-AGATCGGAAGAGCACACGTCTG-ddC /
universal PCR primer 2679 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT F
barcoded PCR primers / CAAGCAGAAGACGGCATACGAGATXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT R
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(NEB M0530) of dus2 cDNA sequence (without its start codon) was performed on a 
gBLOCK gene fragment (IDT), purified (Qiagen 28106), enzymatically restricted 
(BamHI-XhoI), ligated (Promega M180A) into the restricted pGEX-4T1 vector 
(downstream and in phase with the GST sequence), transformed in E. coli DH10B 
competent cells and sequenced. Vectors were eventually transformed in E. coli BL21 
cells for protein expression in LB + 1mM IPTG at 37°C for 120min and recombinant 
proteins were purified by combining the Poly-Prep Chromatography Columns (Bio-Rad 
731-1550) with Glutathione Sepharose 4B (GE 17-0756-01). 
Gene inactivation by implementation of CRISPR-Cas9 in human cells. 
CRISPR-Cas9 mediated deletion was performed as described by IDT (Alt-R 
CRISPR-Cas9 System) but with important modifications (Dr. F. Ernst, Pr. Lafontaine 
lab, ULB). The strategy relies on the electroporation of ribonucleoprotein complexes 
(RNPs). First, 100µM of RNA duplexes were formed by mixing equal volumes of 
200µM crRNA and 200µM of tracrRNA for 5min at 95°C, then cooled for 15min at RT. 
Each electroporation reaction required a 25µL-RNP solution and 1.75 x 106 of HCT 
116 cells. The RNP solution was prepared by mixing the following for 20min at RT; 5µL 
of 1X PBS, 10µL of Cas9 enzyme (612 pmol) and 10µL of the crRNA:tracrRNA 
duplexes (for single-gene targeting: 5µL of crRNA forward:tracrRNA + 5µL of crRNA 
reverse:tracrRNA, for quadruple-gene targeting: 4 x 1.25µL of crRNA 
forward:tracrRNA + 4 x 1.25µL of crRNA reverse:tracrRNA). Subcultivation ratio of 
1:10 was implemented 2-3 days before the CRISPR experiment. 1.75 x 106 of early 
passaged HCT 116 cells were centrifuged for 5min at 120g, washed in 1X PBS, 
resuspended in 100µL of Nucleofector solution (Lonza VCA-1003) and added to the 
RNP-solution. The RNP/cells mix was transferred to a Nucleofector cuvette with 5µL 
of Electroporation Enhancer, electroporated on Nucleofector Device (D-032 program) 
and immediately supplemented with 400µL of RPMI medium. After 10min of incubation 
at RT, the electroporation product was divided into three replicative wells and 
incubated for 24h at 37°C under 5% CO2 with 825µL of McCoy’s 5a + FBS medium. 
Primary diagnostic consisted of PCR amplification(s) of the targeted locus/loci on the 
so-called CRISPR population to assess the generation of a DNA fragment that was 
shorter than the WT band (revealing expected deletion). Individual clones were 
obtained by diluting the CRISPR population on a 96-well plate. The clones were then 
diagnosed with PCRs and the homozygous candidates were sequenced and checked 
for Mycoplasma contamination (GATC Biotech). 
RNA extraction. 
50 mL of S. pombe (OD595nm ~ 0.5) or E. coli (OD595nm ~ 0.6) were harvested by 
centrifugation and washed in DEPC water. Humans cells (confluency ~ 90%) were 
collected by trypsinization and washed in 1X PBS. The cell pellets were resuspended 
in 750µL of TES buffer (10mM Tris pH 7.5, 10mM EDTA pH 8, 0.5% SDS) and the 
RNA was isolated by hot phenol extraction; equal volume of phenol:chloroform 5:1 was 
added (Sigma P1944), heated and shaken at 65°C for 60min, the upper phase was 
collected after centrifugation, mixed with an equal volume of phenol:chloroform:IAA 
125:24:1 (Sigma 77619); the upper phase was then collected after centrifugation, 
mixed with an equal volume of chloroform:IAA 24:1 (Sigma 25666); the upper phase 
was collected again and the RNA was alcohol-precipitated with 2.5 volumes of 100% 
ethanol and 0.1 volume of 3M sodium acetate pH 5.2 for minimum 30min at -80°C or 
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overnight at -20°C. After centrifugation, the pellet was washed with 70% ethanol, air-
dried and resuspended in DEPC (Sigma D5758) water or pure water (Sigma 900682). 
Microchip analysis of RNA. 
Total, chemically treated and ribodepleted RNA samples were visualized by 
RNA 6000 Pico Assay by using the Bioanalyzer microchip technology according to the 
manufacturer’s instructions (Agilent 5067-1513). Total RNAs were expected to have a 
RIN (RNA integrity number) > 8.5 and > 6 for Rho labeled RNAs. 
Rhodamine labeling and dot blot assay. 
Rhodamine labeling was performed as previously described with slight 
modifications (Betteridge et al., 2007). Briefly, 30µg of total RNA were resuspended in 
a 400µL volume with 0.04M Tris-HCl pH 7.4 and 4mg of sodium borohydride (Sigma 
452882, freshly resuspended in 1mM potassium hydroxide) for 60min at 25°C in dark 
with constant shaking (750rpm). Mock samples (R-) were treated similarly but without 
sodium borohydride. The reaction was stopped by addition of glacial acetic acid to a 
final concentration of ~0.3M. The reduced RNA was then ethanol-precipitated as 
described above and the dried pellet was resuspended in 5µL of DEPC water and 85µL 
of 0.1M sodium formate pH 4 (Sigma 71539) by heating at 65°C for 7min. Fluorescent 
labeling was performed for 90min at 37°C in dark with 2.2mM of rhodamine 110 
chloride (Sigma 83695) or 2.2mM of biotin-rhodamine 110 (Biotium 80022). 10X dye 
concentrates were prepared in advance in 100% methanol and conserved at -20°C in 
dark for maximum 26 months. The pH of the reaction was then lowered to 7.5 with 
0.8M Tris-HCl pH 8.5 and the dye excess was eliminated by phenol extraction (Sigma 
P1944) for 60min at 65°C. After centrifugation, the labeled RNA-containing upper 
phase was collected and RNA was ethanol-precipitated as described above. For dot 
blot assay, RNA was resuspended in < 10µL of DEPC water by heating at 65°C and 
0.2 to 1µg/µL of RNA was spotted on a Hybond-N+ membrane (GE RPN1210b). The 
signal intensity was immediately monitored with a Cy3 channel (GE ImageQuant LAS 
4000) and the quantification was performed with ImageJ (Schneider et al., 2012). The 
intensity of a DEPC water drop was considered as the background, subtracted to all 
other values and the subsequent signal of a 22mM rhodamine 110 in methanol drop 
was scaled to 1. Methylene blue staining was used as a loading control; the membrane 
was incubated for 5min at RT with 0.5M sodium acetate and 0.04% methylene blue, 
then washed twice in 1X PBS-T. 
in vitro dihydrouridylation. 
S. cerevisiae GST-Dus1 was a gift of E.M. Phizicky (URMC, NY, US). in vitro 
dihydrouridylation was based on a previously published protocol (Xing et al., 2002). 
30µg of total RNA were incubated for 40min at 30°C with 1µg GST-Dus, 100mM Tris-
HCl pH 8, 100mM ammonium acetate, 5mM magnesium chloride, 2mM DTT, 0.1mM 
EDTA, 1mM NADH and 1mM NADPH. The mock reaction (depicted as ‘+ buffer’) was 
done with 10mM glutathione instead of GST-Dus (GE 27-4570-01). The 
dihydrouridylated RNA was then purified with an equal volume of 
phenol:chloroform:IAA 125:24:1 (Sigma 77619), ethanol-precipitated as described 
above and resuspended in DEPC water for subsequent rhodamine labeling. 
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Synthetic RNA preparation. 
Synthetic RNA was prepared similarly to (Schwartz et al., 2014). An ordered 
gBLOCK gene fragment (IDT, Table 6) was resuspended in 1X TE buffer. 20ng were 
amplified with Phusion High-Fidelity DNA Polymerase (NEB M0530S), the subsequent 
PCR product was selected on an agarose gel and purified with QIAquick PCR 
Purification Kit (Qiagen 28106). For RNA production, 200ng of DNA were in vitro 
transcribed by following the RiboMAXTM Large Scale RNA Production Systems’ 
instructions (Promega P1300). For D spike-in, rUTP was replaced by rDTP (Tebu-bio 
040N-1035-1). The synthetic RNA was purified with ProbeQuantTM G-50 Micro 
Columns by following the manufacturer’s instructions (GE 28-9034-08). A total of 30ng 
of spike-in was added to 30µg of total RNA for primer extension and 3ng for D-seq. 
Primer extension. 
Primer extension was performed essentially as described (Sakurai et al., 2010). 
First, 10pmol of 5’-unphosphorylated primer were 32P-labeled with 10U of PNK 
(Promega M4101) and 3µL of [Ɣ-32P]-ATP (Perkin NEG002A250UC). The reaction was 
performed at 37°C for 10min and stopped at 90°C for 2min. The resulting labeled 
primer was diluted to 0.4pmol/µL. 5 to 25µg of denatured R+/R- RNA were retro-
transcribed for 60min at 50°C with 150µM dNTPs (Applied biosystems 4368814), 1µL 
of 32P-labeled primer and 100U of SSIII in 1X first-strand buffer (Invitrogen 18080-044). 
The reaction was stopped by addition of 2X sample buffer (98% formamide, 10mM 
EDTA, 0.1% blue bromophenol, 0.1% xylene cyanol) and incubation for 10min at 90°C. 
The samples were immediately resolved on a 15 to 20% PAGE with 7M urea at 225V 
in 1X TBE buffer (Sigma T4415) and visualized with Super RX-N film (Fujifilm 47410 
19289). The ladder was composed of DNA oligonucleotides (0.5 µM each) that were 
32P-labeled as described above and mixed with 2X sample buffer. For Fig. 23A, the 
aniline-dependent RT termination at D sites was performed as described previously 
(Marchand et al., 2018).  
Fluorescent Northern blotting. 
10µg of R+/R- or untreated total RNA were denatured in 1mM Tris-HCl pH 7.4, 
6mM EDTA, 6% glycerol and were electrophoresed on a 1.2% agarose gel (0.67% 
formaldehyde, 20mM MOPS, 5mM sodium acetate, 1mM EDTA) in 1X FA buffer 
(20mM MOPS, 5mM sodium acetate, 1mM EDTA, pH 7). The gel was washed once in 
50mM sodium hydroxide and twice in neutralization buffer (1.5M sodium chloride, 0.5M 
Tris-HCl pH 7.4). The nucleic acids were capillary transferred overnight in 1X SSC 
(Sigma S6639) on a Hybond-XL membrane (GE RPN203S). After crosslinking for 
120min at 80°C, the rhodamine signal was monitored as described above. Methylene 
blue staining was used as a loading control; the membrane was incubated for 5min at 
RT with 0.5M sodium acetate and 0.04% methylene blue, then washed twice in 1X 
PBS-T. 
tRNA Northern blotting. 
Small RNA fraction was enriched from 200-400µg of total RNA by incubation 
30min on ice with 190mM sodium chloride and 7.3% PEG 8000. The supernatant was 
carefully collected after centrifugation for 20min at 15,500g at 4°C and ethanol-
precipitated as described above. The pellet was washed with 95% ethanol, air-dried 
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and resuspended in DEPC water. 5µg of small RNA were denatured in 1X sample 
buffer (50% formamide, 2.5mM EDTA, 0.01% blue bromophenol), electrophoresed on 
a 10% PAGE with 7M urea at 225V in 1X TBE buffer (Sigma T4415) and transferred 
on a Hybond-XL membrane (GE RPN203S) by semi-dry transfer for 45min at 3mA/cm2 
(Thermo Owl HEP Series Semidry Electroblotting System). Membrane was rinsed in 
2X SSC before UV crosslinking for 30sec at 254nm (Vilbert Lourmat). For probe 
preparation, 20pmol of 5’-unphosphorylated primer were 32P-labeled with 10U of PNK 
(Promega M4101) and 2µL of [Ɣ-32P]-ATP (Perkin NEG002A250UC) in a 20µL-
reaction for 60 min at 37°C. The probe was purified using ProbeQuantTM G-50 Micro 
Columns following the manufacturer’s instructions (GE 28-9034-08), denatured and 
hybridized to the crosslinked membrane overnight at 42°C in PerfectHybTM Plus 
Hybridization Buffer (Sigma H7033). The membrane was then washed in 2X SSC 0.1% 
SDS, twice in 0.1X SSC 0.1% SDS at 42°C and visualized with Super RX-N film 
(Fujifilm 47410 19289). 
D-seq library preparation. 
Libraries for sequencing were prepared by combining previously published 
pipelines (Engreitz et al., 2013; Shishkin et al., 2015). 2-5µg of R+/R- total RNA were 
ribodepleted (Thermo A15020 and K155005 [modified protocol provided by the 
manufacturer] for S. pombe and H. sapiens and Illumina MRZGN126 for E. coli), 
quantified with Qubit RNA HS assay (Thermo Q32852) and analyzed by microchip as 
described above. Zinc-mediated fragmentation was performed at 70°C for 15min with 
90-125 ng of ribodepleted RNA and the reaction was stopped by following the 
manufacturer’s instructions (Thermo AM8740). Simultaneous DNA digestion and RNA 
extremities dephosphorylation were performed at 37°C for 30min with 2U of TURBO 
DNase (Thermo AM2238) and 3U of FastAP Thermosensitive Alkaline Phosphatase 
(Thermo EF0654) in 10mM Tris-HCl pH 7.4, 1mM magnesium chloride, 0.12mM 
calcium chloride, 10mM potassium chloride, 0.002% Triton X-100 and 2mM DTT. 40U 
of RNase inhibitor were added to prevent RNA degradation (NEB M0314). 20pmol of 
RNA adapter were then added to the sample, followed by denaturation for 2min at 
70°C. 3’-end ligation was performed for 90min at 25°C with 39U of T4 RNA ligase (NEB 
M0437) and 12U of RNase inhibitor (NEB M0314) in 1X NEB Ligase 1 Buffer, 9% 
DMSO, 1mM ATP and 20% PEG 8000. After ligation, 10pmol of DNA primer were 
added, the sample was denatured for 2min at 70°C and the reverse transcription was 
performed as described above with SSIII (Invitrogen 18080-044). The excess of DNA 
primer was subsequently digested with 2µL of ExoSAP-IT (Affymetrix 78250) by 
incubating 4min at 37°C and the enzyme was then inactivated by incubating 1min at 
80°C. The RNA was degraded for 10min at 70°C with 100mM sodium hydroxide and 
the solution was neutralized by addition of acetic acid. 40pmol of DNA adapter were 
then added to the sample, followed by denaturation for 2min at 75°C. The 3’-end 
ligation was performed overnight at 25°C with 48U of T4 RNA ligase (NEB M0437) in 
1X NEB Ligase 1 Buffer, 4% DMSO, 1mM ATP and 23.75% PEG 8000. Nucleic acid 
clean-ups were performed between each step by using MyOne SILANE magnetic 
beads (Thermo 37002D) resuspended in the chaotropic Buffer RLT (Qiagen 74104). 
PCR amplification was performed in a 50µL-reaction by mixing cDNA, 1µM of 
barcoded PCR primer, 1µM of universal PCR primer and 25µL of NEBNext High-
Fidelity 2X PCR Master Mix (NEB M0541) with the following program; 30sec at 98°C, 
5 cycles of (10sec at 98°C, 30sec at 67°C, 30sec at 72°C), 13 cycles of (10sec at 98°C, 
30sec at 72°C) and 60sec at 72°C as a final extension. Finally, two successive rounds 
of DNA polymer size selection were performed by mixing PCR products with 1.2 and 
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1.1 volume of AMPure XP beads (Beckman A63880). The DNA library was quantified 
(Thermo Q32851), examined on a DNA microchip (Agilent 5067-4626, ~250-300nt 
polymers) and sequenced on Illumina HiSeq 2500 [1 flow cell, 2 lanes, 300M clusters] 
or on Novaseq S1 [100 cycles, 1 flow cell, 2 lanes, 1600M clusters] (paired-end reads, 
2 x 50nt). 
Gene list and motif analyses. 
The S. pombe lists of genes were analyzed by the fission yeast-specific platform 
called AnGeLi (Bitton et al., 2015). The sequence motif analyses were performed with 
the web-based application WebLogo (Crooks et al., 2004). 
Codon occurrence in S. pombe transcriptome. 
The probability to get a D-site on the coding S. pombe transcriptome was 
calculated as follows; there are 27 codons containing a single U, representing 
1,099,338 occurrences, 9 codons containing two U residues, representing 612,597 
occurrences and 1 codon containing three U residues, representing 92,872 
occurrences. There are therefore 2,603,148 possibilities to get a D-site on a coding 
region [(1 x 1,099,338) + (2 x 612,597) + (3 x 92,872) = 2,603,148]. Expressed in 
percentages, single U, double U and triple U-containing codons represent 42.2, 47.1 
and 10.7% of the possibilities to get a D-site, respectively.  
qRT-PCR. 
0.5µg of RNeasy-purified total RNA (Qiagen 74104) was retro-transcribed with 
the High-Capacity cDNA Reverse Transcription Kit (Thermo 4368813) by following the 
manufacturer’s instructions. The real-time PCR amplification was performed with 
SYBR Green Supermix (Bio-Rad 172-5124) in a Bio-Rad CFX96TM Real-Time 
machine. The PCR program was 3min at 95°C and 40 cycles of (15sec at 95°C and 
30sec at 60°C). Relative RNA quantification relied on the ∆∆CT method. 
Western blotting. 
Proteins were extracted from 10mL of yeasts cultured in YES at 32°C. Cells 
were pelleted, washed in water and disrupted with 0.3M hydroxide sodium for 10min 
at RT. The lysate was then centrifuged and the supernatant was discarded. The pellet 
was resuspended in 70µL of alkaline extraction buffer (60mM Tris-HCl pH 6.8, 4% β-
mercaptoethanol, 4% SDS, 0.01% bromophenol blue, 5% glycerol) and boiled for 5min 
at 95°C. 10µL of the samples were loaded on a 4-15% Mini-PROTEAN TGX Precast 
Protein Gel (Bio-Rad 456-1083), transferred on a nitrocellulose membrane (Bio-Rad 
1704158) and blocked for 60min at RT or overnight at 4°C in 50:50 1X PBS:Odyssey 
Blocking Buffer PBS (Westburg LI 927-40100). The membrane was incubated with the 
primary antibody for 60min at RT or overnight at 4°C with Odyssey Buffer containing 
0.05% Tween20 (Bio-Rad 161-0781) and a 1:500-1,000 dilution of anti-tubulin (Sigma 
T5168), anti-HA (Sigma H6908) or anti-TAP (Sigma P1291) primary antibodies. After 
three washes in PBS-T, the membrane was incubated with a 1:10,000 dilution of anti-
mouse (Westburg LI 925-32210) or anti-rabbit (Westburg LI 925-32211) secondary 
antibodies for 60min at RT in Odyssey Buffer containing 0.05% Tween20. After three 
washes in PBS-T and three washes in PBS, the membrane was dried for 60min at 
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37°C and visualized on a LiCOR scanner on channel 800. The quantification was 
performed with ImageJ (Schneider et al., 2012). 
RNA-sequencing. 
1µg of total RNA was ribodepleted as described in the D-seq section and 
analyzed by microchip electrophoresis as described above. 125ng of ribodepleted 
samples were prepared for strand-specific NGS with the TruSeq Stranded Total RNA 
Sample Preparation Protocol (Illumina). The library was sequenced on Illumina HiSeq 
2500 (paired-end reads, 2 x 50nt). Reads were mapped on the genome using TopHat2. 
The quantification was made with featureCounts function on R and the differential 
expression analysis was performed with DESeq2. The genes following these criteria 
were considered as differentially expressed; false discovery rate < 10% and absolute 
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ANNEXES   
I. ABBREVIATIONS 
y pseudouridine 
∆3 E. coli triple dusA-B-C mutant 
∆4 fission yeast quadruple dus1-2-3-4 mutant 
5’-3’ nucleic acids polarity 
A adenosine 







ASL tRNA anticodon stem and loop domain 
Asn asparagine  
Asp aspartic acid 
bp base pair 
C carbon  
cDNA complementary DNA 
CDS coding DNA sequence 
CMC N-cyclohexyl-N′-β-(4-methylmorpholinium)ethylcarbodiimide  
cmnm5s2U 5-carboxymethylaminomethyl-2-thiouridine 
crRNA CRISPR RNA 
Cys(-SH) cysteine 
D dihydrouridine 
D-seq dihydrouridine sequencing 
ddC dideoxycytidine  
dihydro-UMP dihydrouridine monophosphate or dihydrouridylate 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleotide triphosphate 
DSL tRNA D stem and loop domain 
dsRBD double-stranded RNA binding motif 
DSRM double-stranded RNA binding motif 
dus or DUS dihydrouridine synthase gene 
Dus or DUS dihydrouridine synthase protein 
EtBr ethidium bromide 
fc fold change 
FDR false discovery rate 




GST glutathione-S-transferase  




Hs∆4 HCT 116 cell line quadruple DUS1-2-3-4 mutant 




LC/MS high performance liquid chromatography-mass spectrometry 
Leu leucine  
lincRNA long intergenic noncoding RNA 














MALAT1 metastasis-associated lung adenocarcinoma transcript 1 




mRNA messenger RNA 
mt-tRNA mitochondrial tRNA 
N nitrogen 
NAD nicotinamide adenine dinucleotide 
NADP nicotinamide adenine dinucleotide phosphate 
ncRNA noncoding RNA 
NGS next-generation sequencing 
nm nanometer 
NMR nuclear magnetic resonance 
nt nucleotide 
OD optical density 
ORF open reading frame 
p 5’-3’ phosphodiester bond 
Phe phenylalanine 
pmol picomole  
pre-mRNA precursor-messenger RNA 
pre-rRNA precursor-ribosomal RNA 
pre-tRNA precursor-transfer RNA 
pre-tRNAiMet precursor of initiator methionine transfer RNA 
PRF programmed ribosomal frameshifting 




QC quality control 
qRT-PCR quantitative reverse transcription-polymerase chain reaction 
RBP RNA binding protein 
RNA ribonucleic acid 
RNA-seq RNA sequencing 
rRNA ribosomal RNA 
RT reverse transcription or room temperature  
RTase reverse transcriptase 
RTD rapid tRNA decay 
s4U 4-thiouridine 
SEM standard error of mean 
Ser serine  
snoRNA small nucleolar RNA 
snoRNP small nucleolar ribonucleoprotein 
snRNA small nuclear RNA 
sp. species 
T7P promoter sequence for the T7 RNA polymerase 
tDNA DNA sequence of a tRNA 
THC tetrahydrocytidine 
THU tetrahydrouridine  
tiRNA tRNA-derived stress induced RNA 
TLC thin layer chromatography 
TLD tRNA-like domain 
tmRNA transfer-messenger RNA 
tracrRNA transactivating crRNA 
tRF tRNA-derived fragment 
tRNA transfer RNA 
ts temperature-sensitive 
TSL tRNA T stem and loop domain 
tsRNA tRNA-derived small RNA 
Tyr tyrosine 
U uridine 
UTR untranslated region 
UV ultraviolet 




II. SUPPLEMENTAL INFORMATION 
The supplemental figures (S1 to S19) are found on the following pages. The 



































Supplemental Figure 1 – Nucleosides numbering system. (A) The adenosine ribonucleoside (a purine) has nine
numbered atoms on its nucleobase (red) and five numbered carbons on its ribose (green). (B) The uridine ribonucleoside
(a pyrimidine) has six numbered atoms on its nucleobase (red) and the annotation for the ribose remains unchanged
(Boccaletto et al., 2018).
_________________________________________________________________________________________________
Supplemental Figure 2 – Principle of primer extension, tRNAinitiation of Schizosaccharomyces pombe. A
radiolabeled primer (solid red line) is added into a denatured sample of total RNA. The sequence of the primer is
complementary to the RNA molecule of interest. After hybridization, the reverse transcription is performed and the product
of this reaction (solid and dashed red lines) is loaded on a polyacrylamide gel. The detection of the radiolabed
polynucleotides of different sizes corresponds to the positions where the reverse transcriptase was stopped or blocked. In
this specific example, the reaction is stopped 22 nucleotides upstream of the 3’-end of the 24nt-long radiolabeled primer
(22 + 24 = 46nt-long polynucleotide). The N2-methylguanosine (m2G) disturbs the Watson-Crick interaction and is
therefore a naturally-blocking modification for the reverse transcriptase. Finally, the dihydrouridine (D) is positioned 31
nucleotides upstream of the 5’-end of the primer. After R+ treatment (see Results and Discussion), the rhodamine
incorporated at the D position blocks the reverse transcription reaction one nucleotide downstream of the D position,




Supplemental Figure 3 – Secondary (cloverleaf) (A) and tertiary (L-shaped) (B) structures of a tRNA. DSL in black
(D stem and loop domain), ASL in purple (anticodon stem and loop domain), V-loop in green (variable loop domain), TSL













Supplemental Figure 5 – Microchip analysis of yeast total RNA. The Rho
labeling on total RNA extracted from WT yeast moderately degrades the
RNA as observed by a decrease of the RIN values (0 > RNA Integrity
Number > 10). FU (fluorescence units), nt (length expressed in nucleotides).
_________________________________________
Supplemental Figure 6 – Effect of three
consecutive dihydrouridines on RT termination.
Primer extension assay performed on an in vitro
transcribed RNA mixed with S. pombe total RNA
before R+ or R- chemical reactions. 3 D indicates
an in vitro RNA containing three consecutive D
residues that could virtually generate three
truncated polynucleotides after the RT in the R+
condition at 25, 26 and 27nt, respectively. 3 U
indicates an in vitro transcribed RNA without
dihydrouridylated residues (there are three uridines
instead). 1 D and 1 U are synthetic RNAs as in Fig.
10F with a unique (dihydro)uridine.





























Supplemental Figure 7 – D-ratio of the spike-in
position 45 does not gradually increase along with
D:U content in the R- condition. 100% means that
all spike-in RNAs added to the sample carry a























Supplemental Figure 8 – Effect of the ‘RT-stop site
upstream nucleotide = U’ condition on the detection of D
on yeast tRNAs. Getting rid of the last condition of the D-seq
pre-filtering analysis (Fig. 12) led to the detection of 36 new D-
sites on yeast tRNAs (for a total of 264 putative D). 94.4% of
these new sites were not downstream of a U but were U
themselves.
36 putative D-sites but D-site ≠ U 
à for 34; D-site ≠ U but RT-stop site = U
_________________________________________________________________________________________________
Supplemental Figure 9 – Comparison of the dihydrouridylated positions on tRNAs between fission and budding
yeasts. On the left, the 198 cytoplasmic tRNA D-sites are manually curated and assigned to a canonical D positions (D16,
17, 20, 20a or 47) if possible. NA stands for not assigned (D2-tRNAArgCCU, D8-tRNAMetCAU and D29-tRNAProCGG). On the right,
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Supplemental Figure 10 – Seeking for a dihydrouridylation motif in yeast tRNAs. Consensus sequence surrounding

























































































































































































































































































































relative position on tRNA
D-sites are centered
_________________________________________________________________________________________________
Supplemental Figure 11 – Absence of a strict correlation between number of detected D-sites and coverage. D-
seq in fission yeast resulted in 372 detected D-sites that are all represented by the light gray bars. Black bars represent














Category_Name GeneSet_Name Representation Corrected p-value
GO Molecular Function oxidoreductase activity, acting on NAD(P)H Enriched 0.00540684
GO Molecular Function oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor Enriched 0.00545604
Gene Expression Highly expressed genes Enriched 0.000199905
Phenotypes (FYPO) inviable after spore germination, without cell division, with normal germ tube morphology Enriched 0.000142192
Phenotypes (FYPO) inviable after spore germination with normal, unseptated germ tube morphology Enriched 0.000142192
Phenotypes (FYPO) inviable spore Enriched 0.00119614
Phenotypes (FYPO) inviable after spore germination, without cell division Enriched 0.00809965
Protein Features Alanine Higher 2.46E-11
Protein Features Number of amino acids Higher 4.65E-08
Protein Features Protein copies per proliferating cell Higher 4.65E-08
Protein Features Molecular weight (kDa) Higher 2.44E-07
Protein Features Glycine Higher 1.96E-06
Protein Features Charge Lower 0.000125472
Protein Features Isoelectric point (predicted pH) Lower 0.000230274
Protein Features Nitrogen content Lower 0.00228755
Transcript Features mRNA copies per proliferating cell Higher 1.31E-32
Transcript Features mRNA level (WT) Higher 2.45E-22
Transcript Features mRNA copies per quiescent cell Higher 1.45E-20
Transcript Features Relative Pol II occupancy Higher 2.72E-11
Transcript Features Annotated transcript length Higher 3.43E-06
Transcript Features Ribosomal density (rb/kb) Lower 0.00086295
Transcript Features mRNA stabilities Higher 0.00545604
_________________________________________________________________________________________________
Supplemental Figure 12 – Putatively dihydouridylated protein-coding genes enrichment analysis. A S. pombe-
specific tool (AnGeLi) was used to determine potential over- or under-representation of the 125 mRNAs D-seq candidates
in various categories. Results with a p-value smaller than 0.01 are shown.
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Supplemental Figure 13 – Non-represented codons in yeast D-seq. None of the 124 detected D-sites on coding
sequences were found on the listed codons although they represent almost one tenth of the U residues found the coding
transcriptome (↔ one tenth of the possibilities to get a D-site on the coding transcriptome). One-sided Fisher’s Exact test;












codons not represented in D-seq (S. pombe)
100% have a single U
possibilites to have a D-site on these codons = 207,964 
à 8% of the possibilities on the coding transcriptome
à 0 D-sites
*** 





Supplemental Figure 14 – Hypodihydrouridylated tRNA
abundance. tRNA Northern blotting was performed on two
RNA species in WT and ∆4 yeast strains. 5S rRNA is used as a




Supplemental Figure 15 – Calibration of HPLC system for detection
of D. Commercial D nucleoside is efficiently detected and is eluted from
the HPLC column after 4.7min. Detection at 247nm. mAU (milli-
absorbance units).
_________________________________________________________________________________________________
Supplemental Figure 16 – Yeast quadruple dus mutant thermosensitivity is prp4-independent. Above: dus4 locus;
prp4 is an upstream gene, SPNCRNA.1212 is an antisense long noncoding RNA. In the ∆4 genetic background, the dus4
CDS (delimited by the red dotted lines) was replaced by a phleomycin-resistance cassette gene (bleR). As shown in Fig.
19A, prp4 and SPNCRNA.1212 expressions were deeply disturbed by this genomic manipulation. Below: growth
phenotype of the ∆4 mutant compared to the WT strain. Exponential growing cells were spotted on rich medium and
incubated at 32 or 37°C (5-fold dilutions) for 47h. All strains carried an auxotrophic marker for the positive selection of the
vector during the (pre-)culturing growth in a defined medium. The vector used in this study resulted in the overexpression
of the cloned gene (dus4 or prp4). prp4 overexpression did not suppress the ∆4 thermosensitivity whereas dus4

























Supplemental Figure 17 – CRISPR-Cas9 strategy implemented for inactivation of human DUS genes in the HCT
116 cell line. Coding exon 1 is targeted for Cas9 mediated-cleavage by two guide RNAs (crRNAs or CRISPR RNAs, red
arrows). For each deletion, two ribonucleoproteins (Cas9 + crRNA:transactivating-crRNA duplex) were electroporated,
each of them carrying a different crRNA. Deletion diagnostic relied on PCR amplification (primers are depicted by blue
arrows and the full-length DNA product size – i.e. in WT context – is indicated for each gene). bp (base pairs).
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Suplemental Figure 18 – SCARLET approach for the single-site detection of an RNA modification. RNA of interest
(black line) is targeted for a specific cleavage upstream of the putative modified candidate (X). The cleavage is performed
by the RNAse H nuclease by means of an RNA-DNA chimeric oligonucleotide (the green line highlights RNA with
methylated C2’ ribose [2’OMe] and the blue line highlights DNA with deoxygenated ribose [2’H]). 5’-ends are then
radioactively labeled with phosphate (32p). Splint ligation with an oligonucleotide (splint, green line) that overlaps the RNA
of interest and a synthetic ssDNA (2’H, blue line) is performed, followed by RNA degradation and gel purification. The
resulting product is analyzed by one-dimension TLC (Liu and Pan, 2015).
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Suplemental Figure 19 – Chromatin isolation by RNA precipitation.
ChIRP relies on the in vivo crosslinking of an RNA with its interacting
partners (DNA or proteins). The RNA of interest is isolated by specific
biotinylated oligonucleotides and streptavidin-dependent precipiation.
For the determination of RNA-binding proteins, RNA and DNA are









gene description ATG codon position
aat1 amino acid transmembrane transporter Aat1 250 UUG 1
abc2 glutathione S-conjugate-exporting ATPase Abc2 4069 UUC 1
ace2 transcription factor Ace2 1392 AUU 3
adg2 conserved fungal protein Adg2 1257 UCU 3
ags1 alpha glucan synthase Ags1 6736 UGG 1
ala1 mitochondrial and cytoplasmic alanine-tRNA ligase Ala1 (predicted) 2430 CAU 3
ala1 mitochondrial and cytoplasmic alanine-tRNA ligase Ala1 (predicted) 1972 UGU 1
ala1 mitochondrial and cytoplasmic alanine-tRNA ligase Ala1 (predicted) 1051 UUC 1
apl4 AP-1 adaptor complex gamma subunit Apl4 2109 GCU 3
arg12 argininosuccinate synthase Arg12 451 UUU 1
bfr1 brefeldin A transmembrane transporter Bfr1 127 UCU 1
bms1 GTP binding protein Bms1 (predicted) 1757 CUU 3
brr2 U5 snRNP complex subunit Brr2 6478 UUU 1
but2 But2 family protein But2 -283 NA NA
cbr1 cytochrome b5 reductase Cbr1 (predicted) 197 CUU 2
ccr1 NADPH-cytochrome p450 reductase 1070 GUU 2
ccr1 NADPH-cytochrome p450 reductase 167 UUC 2
cct1 chaperonin-containing T-complex alpha subunit Cct1 1829 CUU 2
cct6 chaperonin-containing T-complex zeta subunit Cct6 639 UUU 1
cct7 chaperonin-containing T-complex eta subunit Cct7 1259 UGU 3
cct7 chaperonin-containing T-complex eta subunit Cct7 267 AUU 3
cek1 serine/threonine protein kinase Cek1 3473 GUU 2
cfr1 Chs five related protein Cfr1 846 AAU 3
cip2 RNA-binding protein Cip2 1405 UUU 1
cop1 coatomer alpha subunit Cop1 (predicted) 2298 UAU 3
deb1 transcription factor Deb1/Rdp1 692 CUG 2
def1 RNAPII degradation factor Def1 (predicted) 338 UUG 2
def1 RNAPII degradation factor Def1 (predicted) 934 UCU 1
dis3 3'-5' exoribonuclease subunit Dis3 1537 CUU 2
dld1 dihydrolipoamide dehydrogenase Dld1 456 UAU 3
ekc1 protein phosphatase regulatory subunit Ekc1 (predicted) 1972 UUG 1
elp1 elongator subunit Elp1 (predicted) 1859 GUU 2
elp2 elongator complex subunit Elp2 (predicted) 1101 GUA 2
eng1 endo-13-beta-glucanase Eng1 945 GAU 3
eng1 endo-13-beta-glucanase Eng1 275 UUA 2
erg27 3-keto sterol reductase Erg27 (predicted) 401 UUU 3
fhn1 plasma membrane organization protein Fhn1 66 GAU 3
fhn1 plasma membrane organization protein Fhn1 426 GUU 3
fhn1 plasma membrane organization protein Fhn1 1281 NA NA
fim1 fimbrin 1786 CUU 3
fip1 iron permease Fip1 31 UUC 1
fra1 iron responsive transcriptional regulator peptidase family (predicted) 1429 ACU 3
gas2 13-beta-glucanosyltransferase Gas2 (predicted) -31 NA NA
glo3 ARF GTPase activating protein (predicted) 823 GCU 3
gls2 glucosidase II alpha subunit Gls2 1845 GUU 3
gls2 glucosidase II alpha subunit Gls2 675 GAU 3
gpd2 glycerol-3-phosphate dehydrogenase Gpd2 477 UCU 3
gpt1 UDP-glucose-glycoprotein glucosyltransferase Gpt1 2989 UUC 1
grs1 mitochondrial and cytoplasmic glycine-tRNA ligase Grs1 1597 UCU 1
hhp1 serine/threonine protein kinase Hhp1 446 AUA 2
his7 phosphoribosyl-AMP cyclohydrolase/phosphoribosyl- ATP pyrophosphohydrolase His7 24 GAU 3
hta1 histone H2A alpha -223 NA NA
hta1 histone H2A alpha -258 NA NA
kap104 karyopherin Kap104 776 GAU 3
lys2 homoaconitate hydratase Lys2 793 UUG 1
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lys3 saccharopine dehydrogenase Lys3 2 AUG 2
mae2 malic enzyme malate dehydrogenase (oxaloacetate decarboxylating) Mae2 152 UUG 2
mms2 ubiquitin conjugating enzyme Mms2 877 NA NA
msy1 MS calcium ion channel protein Msy1 2535 ACU 3
mug157 conserved protein Mug157 346 UCU 1
mug161 CwfJ family protein splicing factor (predicted) 1857 UUA 2
nda2 tubulin alpha 1 1133 GUU 2
nda2 tubulin alpha 1 1477 NA NA
nda3 tubulin beta Nda3 803 UCU 1
nop14 U3 snoRNP protein Nop14 (predicted) 245 GUU 2
npl4 Cdc48-Npl4-Ufd1 complex subunit Npl4 (predicted) 740 UCU 3
nro1 negative regulator of Ofd1 Nro1 -1 NA NA
nrs1 cytoplasmic asparagine-tRNA ligase Nrs1 (predicted) 1050 CAU 3
nuc1 DNA-directed RNA polymerase I complex large subunit Nuc1 389 CUU 2
pap1 transcription factor Pap1/Caf3 969 GUU 3
pdi1 protein disulfide isomerase (predicted) 777 ACU 3
pgr1 mitochondrial glutathione reductase Pgr1 1146 AUA 2
pik1 1-phosphatidylinositol 4-kinase Pik1 1797 AUU 2
plb1 phospholipase B homolog Plb1 36 UUU 3
ppp1 pescadillo-family BRCT domain protein Ppp1 (predicted) 1550 GUU 2
prp2 U2AF large subunit (U2AF-59) 41 AUA 2
ptc2 protein phosphatase 2C Ptc2 99 CGU 3
pub1 HECT-type ubiquitin-protein ligase E3 Pub1 1439 UAU 1
pup1 20S proteasome complex subunit beta 2 (predicted) 737 UGU 3
rar1 cytoplasmic methionine-tRNA ligase Mrs1 (predicted) 808 ACU 3
rhp23 Rad23 homolog Rhp23 233 CUU 2
rmn1 RNA-binding protein 552 UUG 1
rmn1 RNA-binding protein 349 GUU 2
rpl2502 60S ribosomal protein L25 (predicted) -10 NA NA
rrb1 WD repeat protein Rrb1 (predicted) 501 GAU 3
rrp5 U3 snoRNP-associated protein Rrp5 (predicted) 3855 GGU 3
sal3 karyopherin Sal3 2614 UAC 1
sam1 S-adenosylmethionine synthetase 1412 NA NA
scl1 20S proteasome complex subunit alpha 1 (predicted) -26 NA NA
sds23 PP2A-type phosphatase inhibitor Sds23/Moc1 434 UUU 2
sec17 alpha SNAP (predicted) 452 AUU 2
sec21 coatomer gamma subunit Sec21 (predicted) 2009 UUU 3
ser2 phosphoserine phosphatase Ser2 (predicted) 890 CUU 3
sfp1 transcription factor Sfp1 (predicted) 204 GAU 3
slc1 1-acylglycerol-3-phosphate O-acyltransferase Slc1 (predicted) 8 UUU 2
smb1 Sm snRNP core protein Smb1 441 UAU 1
SPAC1635.01 mitochondrial outer membrane voltage-dependent anion-selective channel 519 CCU 3
SPAC1639.01c GNS1/SUR4 family protein (predicted) 2140 NA NA
SPAC1786.02 phospholipase (predicted) 372 CGU 3
SPAC17G6.03 phosphoprotein phosphatase (predicted) position overlapping a tRNA -1089 NA NA
SPAC17G6.03 phosphoprotein phosphatase (predicted) position overlapping a tRNA -1092 NA NA
SPAC1F5.03c FAD-dependent oxidoreductase involved in late endosome to Golgi transport 1170 AAU 3
SPAC26H5.07c seven transmembrane receptor protein (predicted) 711 UAC 1
SPAC56E4.03 aromatic aminotransferase (predicted) 1078 UAU 1
SPAC589.06c pho88 family protein (predicted) 541 ACU 3
SPAC694.02 DEAD/DEAH box helicase 2303 UUU 2
SPAC694.02 DEAD/DEAH box helicase 2304 UUU 3
SPAC977.12 L-asparaginase (predicted) 1117 NA NA
SPAPB2C8.01 cell surface glycoprotein adhesion molecule (predicted) 3009 GCU 3
spb1 rRNA methyltransferase Spb1 (predicted) 828 GUA 2
_________________________________________________________________________________________________ 
Supplemental Table 1 à
103
gene description ATG codon position
SPBC119.09c ORMDL family protein (predicted) 773 NA NA
SPBC119.17 mitochondrial metalloendopeptidase (predicted) 769 UUC 1
SPBC1271.10c transmembrane transporter (predicted) 1687 UUA 1
SPBC12C2.11 glutamine-fructose-6-phosphate transaminase (predicted) 1502 AUC 2
SPBC1E8.05 conserved fungal protein 126 AAU 3
SPBC354.04 Schizosaccharomyces specific protein -16 NA NA
SPBC3F6.01c serine/threonine protein phosphatase (predicted) 1206 CGU 3
SPBC3H7.03c 2-oxoglutarate dehydrogenase (lipoamide) (predicted) 1539 UCU 3
SPBC409.08 spermine family transmembrane transporter (predicted) 104 NA NA
SPBC530.11c transcription factor zf-fungal binuclear cluster type (predicted) 2233 GUG 2
SPBC646.08c oxysterol binding protein (predicted) 1356 UAU 3
SPCC1739.01 zf-CCCH type zinc finger protein 377 UUA 2
SPCC4B3.03c mitochondrial morphology protein (predicted) 806 CUU 2
SPCC550.11 karyopherin (predicted) 1310 UUU 1
SPCC553.10 conserved fungal protein 21 UUU 3
SPCC584.01c sulfite reductase NADPH flavoprotein subunit (predicted) 223 UUG 1
SPCC584.11c Svf1 family protein Svf1 1433 CUU 2
SPCC584.11c Svf1 family protein Svf1 584 UUC 2
spp27 RNA polymerase I upstream activation factor complex subunit Spp27 711 UUG 2
tif471 translation initiation factor eIF4G 588 AGU 3
tif471 translation initiation factor eIF4G 3720 GAU 3
tim23 TIM23 translocase complex subunit Tim23 (predicted) 96 GAU 3
toa1 transcription factor TFIIA complex large subunit Toa1 (predicted) 489 UUU 1
trp3 anthranilate synthase component I (predicted) 483 GGU 3
trr1 thioredoxin reductase Trr1 881 AUU 3
trr1 thioredoxin reductase Trr1 560 GUU 3
ubx3 UBX domain protein Ubx3 Cdc48 cofactor 1127 UUC 2
usp107 U1 snRNP-associated protein Usp107 384 UUU 2
usp107 U1 snRNP-associated protein Usp107 1262 UUG 1
utp3 U3 snoRNP-associated protein Utp3 (predicted) 266 UUA 2
uvi15 UV-induced protein Uvi15 -54 NA NA
vma2 V-type ATPase V1 subunit B 839 UUA 2
zwf1 glucose-6-phosphate 1-dehydrogenase (predicted) 1091 AUU 3
_________________________________________________________________________________________________
à Supplemental Table 1 – List of mRNAs with at least one D-site in fission yeast. 143 D-sites were detected on 125
products of protein-coding genes (gene column). The known or predicted function of the gene is depicted in the second
column (description). The position of the D-site compared to the ATG start codon is indicated in the third column (ATG),
where A is the nucleotide 1. A negative number means that the D-site was located on the 5’UTR, a positive number
implies that the D-site was either on the coding sequence, or on an intron, or on the 3’UTR. When the D-site was found on
a codon, the line is shaded, the corresponding codon is indicated (codon) and the position on the codon (5’-123-3’) is
precised (position). NA stands for not applicable.
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Supplemental Table 2 – Noncoding RNA that is not a tRNA and that carries a D-site. The lncRNA SPNCRNA.113
overlaps with the 3’UTR of the fhn1 protein-coding gene (see Table S1). The D-seq pipeline did not allow to discriminate




gene description codon position
ags1 alpha glucan synthase Ags1 UGG 1
bms1 GTP binding protein Bms1 (predicted) CUU 3
cct1 chaperonin-containing T-complex alpha subunit Cct1 CUU 2
dld1 dihydrolipoamide dehydrogenase Dld1 UAU 3
fim1 fimbrin CUU 3
gas2 13-beta-glucanosyltransferase Gas2 (predicted) NA NA
hta1 histone H2A alpha NA NA
lys2 homoaconitate hydratase Lys2 UUG 1
nop14 U3 snoRNP protein Nop14 (predicted) GUU 2
ptc2 protein phosphatase 2C Ptc2 CGU 3
rhp23 Rad23 homolog Rhp23 CUU 2
ser2 phosphoserine phosphatase Ser2 (predicted) CUU 3
slc1 1-acylglycerol-3-phosphate O-acyltransferase Slc1 (predicted) UUU 2
SPAC17G6.03 phosphoprotein phosphatase (predicted) position overlapping a tRNA NA NA
SPAC17G6.03 phosphoprotein phosphatase (predicted) position overlapping a tRNA NA NA
SPBC119.17 mitochondrial metalloendopeptidase (predicted) UUC 1
SPBC3F6.01c serine/threonine protein phosphatase (predicted) CGU 3
SPCC4B3.03c mitochondrial morphology protein (predicted) CUU 2
tif471 translation initiation factor eIF4G AGU 3
zwf1 glucose-6-phosphate 1-dehydrogenase (predicted) AUU 3
_________________________________________________________________________________________________
Supplemental Table 3 – List of protein-coding genes with a detected D-site in both D-seq analyses with or without
including the single dus mutants (see Addendum). 20 D-sites were detected on 19 different products of protein-coding
genes in both analyses (gene column). The known or predicted function of the gene is depicted in the second column
(description). When the D-site was found on a codon, the line is shaded, the corresponding codon is indicated (codon) and
the position on the codon (5’-123-3’) is precised (position). NA stands for not applicable for D-sites on 5’ or 3’-UTRs.
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